Document:

Exhibit 10.1

​
​
MASTER
SERVICES
AGREEMENT
AS AMENDED
​
​
​
between
​
​
​
LONZA BIOLOGICS TUAS PTE LTD
​
​
​
and
​
​
​
OMEROS CORPORATION
​
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

THIS AGREEMENT is made on the 28th day of July 2019 (the “Effective Date”) and amended as of the 5th day of July 2021
BETWEEN
1. LONZA BIOLOGICS TUAS PTE LTD of 35 Tuas South Ave 6, SG Singapore 637377 (“Lonza”) and
2. OMEROS CORPORATION, of 201 Elliott Avenue West, Seattle, WA 98119, USA (“Omeros”).
Omeros and Lonza are hereinafter also collectively referred to as the “Parties” and each individually also as a “Party”.
WHEREAS
A. Omeros is the proprietor of the human IgG known as narsoplimab (OMS721), an antibody that binds to and inhibits MASP-2; and
B. Lonza and its Affiliates have the expertise in the production of monoclonal antibodies for therapeutic use;
C. Omeros wishes to contract Lonza for the Launch and commercial supply of narsoplimab and for related support Services, as described in this Agreement; and
D. Lonza is prepared to perform such Services for Omeros on the terms and conditions set out herein.
NOW IT IS AGREED AS FOLLOWS:
1. Definitions and Interpretation
The following terms shall have the following meanings unless the context requires otherwise:
	“Affiliate”
	means any Company, partnership or other entity which directly or indirectly Controls, is Controlled by or is under common Control with the relevant Party to this Agreement.

	“Agreement”
	means this agreement incorporating all Appendices and Schedules as amended or varied from time to time by written agreement of the Parties.

	“Applicable Laws”
	means all applicable laws, including relevant federal, state and local laws, statutes, rules, and regulations which are applicable to a Party’s activities in the Territory hereunder, including, without limitation, the applicable regulations and guidelines of any Governmental Authority, Food and Drug Administration (FDA) and EMA (European Medicines Agency) and all applicable cGMP together with amendments thereto, all of the clauses required to be inserted into this Agreement as set forth in U.S. Federal Acquisition Regulations (FAR) 52.244-6 that are applicable to Lonza for Manufacturing Services at the Facility, which shall be deemed to be inserted herein, and the United States Foreign Corrupt Practices Act and the UK Bribery Act 2010.

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	“Approval”
	means marketing approval by the FDA or the EMA, of Product manufactured at the Facility for commercial supply and the date of first Approval shall be the date on which the earliest of these approvals occurs (hereinafter “First Approval"), but excludes any authorizations for limited distribution, use or sale of Product on an early access, expanded access or compassionate use basis in advance of authorization to broadly market the Product.

	“Batch”
	means the total Product obtained from one (1) fermentation and associated purification using the Process, which fermentation and purification will be carried out in accordance with cGMP unless otherwise agreed and specified in a SOW.

	“Binding Order”
	has the meaning given to it in Clause 6 3.2.

	“Biosimilar”
	means [***].

	“Campaign”
	means a series of cGMP Batches at the Facility.

	“Cell Line”
	means the Omeros Cell Line used by Lonza to express Product specified in Specifications Document, and any clones or derivatives thereof.

	​
	For the purposes of this Agreement, "Omeros Cell Line" means a cell line provided by Omeros and any clones or derivatives thereof, used by Lonza to express Product specified in the Specifications Document.

	“Certificate of Analysis”
	means a document prepared by Lonza listing and certifying the tests performed by Lonza or approved external laboratories, the Specifications and test results.

	“Certificate of Compliance”
	means a document prepared by Lonza: (i) listing the manufacturing date, unique Batch number, and concentration of Product in such Batch, (ii) certifying that such Batch was manufactured in accordance with the Master Batch Record and, unless otherwise specified in a SOW for development work, cGMP.

	“cGMP”
	means those laws and regulations applicable in the U.S. and Europe, relating to the manufacture of medicinal products for human use, including, without limitation, current good manufacturing practices as specified in the ICH guidelines, including without limitation, ICH Q7A “ICH Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients”, US Federal Food Drug and Cosmetic Act at 21CFR (Chapters 210, 211, 600 and 610) and the Guide to Good Manufacturing Practices for Medicinal Products as promulgated under European Directive 91/356/EEC, 2003/94/EC, as amended, and 2001/83/EC, as amended. For the avoidance of doubt, Lonza’s operational quality standards are defined in internal cGMP policy documents as will be further detailed in the Quality Agreement (as such term is defined in Clause 2.14 herein).

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	“cGMP Product”
	means Product that is required under this Agreement or a SOW to be manufactured in accordance with cGMP; for purposes of clarity, all Product manufactured under this Agreement or a SOW shall be manufactured under cGMP unless expressly agreed otherwise in a SOW for development work.

	“Commencement Date”
	means the date of removal of the vial of cells from frozen storage for the production of a Batch.

	“Competing Contract Manufacturer”
	shall mean any Third Party who, together with its Affiliates, undertakes or performs more than fifty per cent (50%) of their business as a Third Party manufacturer of monoclonal antibodies and/or therapeutic proteins or any product of a similar nature to which this Agreement relates.

	“Control”
	means the ownership of more than fifty percent (50%) of the issued share capital or the legal power to direct or cause the direction of the general management and policies of the Party in question.

	“Development Agreement”
	means the Master Services Agreement between the Parties dated 1 October 2015 and as subsequently amended, inclusive of the Reservation Letter dated 11 August 2017.

	“Deliver”, “Delivered” or “Delivery”
	has the meaning given to it in Clause 5.

	“Extension Term” 
	has the meaning given to it in Clause 12.1.1.

	"External Laboratories" 
	means any Third Party instructed by Lonza, only with Omeros’ advance written consent, to conduct activities required to complete the Services, including but not limited to, third parties that synthesise DNA or perform tests on the Cell Line, Product or materials derived therefrom.

	“Facility”
	means Lonza’s manufacturing facilities in [***], or such other Lonza facility as may be mutually agreed upon in writing.

	“Failure Notice”
	has the meaning given to it in Clause 5.9.

	“Forecast”
	has the meaning given in to it in Clause 6.2.1.

	“Latent Defect” 
	means a defect which may be present at Delivery but which cannot be detected at the time of inspection as specified in Clause 5.9 despite diligent inspection by Omeros and which is directly attributable to a breach of Lonza’s obligations under this Agreement. Latent Defect shall exclude any failures due to mishandling, improper storage or contamination of the Product by Omeros or Third Parties after Delivery by Lonza.

	“Launch”
	means and shall be deemed to occur at such time that (i) the First Approval has been obtained and (ii) the Product has been shipped for commercial sale by or on behalf of Omeros to a wholesaler or hospital. Omeros shall provide notice of such shipment to a wholesaler or hospital in writing to Lonza (such notice not to be unreasonably delayed).  For the avoidance of doubt, Launch excludes any shipment or sale of Product pursuant to authorizations

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	​
	for use, distribution or sale of Product on an early access, expanded access or compassionate use basis.

	“Intellectual Property”
	means all patents, copyright, rights in designs, know-how, trade secrets, and all other intellectual or industrial property rights, in each case whether registered or unregistered and including applications or rights to apply for them and together with all extensions and renewals of them, and in each and every case all rights or forms of protection having equivalent or similar effect anywhere in the world.

	“Initial Term”
	has the meaning given to it in Clause 12.1.

	“IP-Respecting Entity”
	means[***].

	"Lonza Know-How" 
	means all technical and other information relating directly or indirectly, to the Process and/or the performance of the Services known to Lonza from time to time other than Omeros Information and information in the public domain.

	"Lonza Patent Rights" 
	means all inventions, patents and patent applications of any kind throughout the world relating to the Process which from time to time Lonza is the owner of or is entitled to use, which for purposes of clarity shall not include inventions, patents and patent applications related to the Process to the extent specific to the Product and not generally applicable to other products.

	“Master Batch Record”
	means the document, proposed by Lonza and approved by Omeros, which defines the manufacturing methods, test methods and other procedures, directions and controls associated with the manufacture and testing of Product.

	“Minimum Campaign”
	has the meaning given to it in Clause 6 1.1.

	“Minimum Exclusivity”
	has the meaning given to it in Clause 4.5.

	“Minimum Order”
	has the meaning given to it in Clause 6 1.2.

	“New General Intellectual Property”
	has the meaning given to it in Clause 8.2.

	“New Omeros Intellectual Property”
	has the meaning given to it in Clause 8.3.

	“Omeros Information”
	means all technical and other information that was not known to Lonza independently of Omeros and this Agreement, or that is generated by Lonza for Omeros during the performance of Services under this Agreement, relating to the Product, the Omeros Cell Line, to the extent specific to the Product, from time to time supplied by Omeros to Lonza or generated by Lonza during the term of this Agreement and excluding any Lonza Know-How, Lonza Patent Rights and New General Application Intellectual Property.

	“Omeros Materials”
	means the materials supplied by Omeros to Lonza (if any) and identified as such in a Specifications Document hereto or any SOW or otherwise demonstrated by substantial written evidence to have been provided by Omeros.

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	“Omeros Patent Rights” 
	means all inventions, patents and patent applications of any kind throughout the world relating to the Product and improvements or modifications thereof, the Omeros Cell Line and improvements or modifications thereof, the Process to the extent specific to the Product, excluding the Lonza Patent Rights, or Lonza Know-How and New General Application Intellectual Property.

	“Price”
	means the price specified in (i) a SOW for the Services other than Batch manufacture or (ii) a Binding Order in accordance with Schedule 1 for manufacture of Batches.

	“Process”
	means the production process for the manufacture of the Product from the Cell Line, including any improvements or modifications thereto from time to time.

	​
	For the purposes of this Agreement, "Omeros Process" means a Process provided by Omeros for the production of the Product from the Omeros Cell Line, inclusive of adaptations of such process by Lonza to substitute animal components (e.g., amino acids) with non-animal components, and shall, to the extent applicable, be subject to Clause 8.4 below, and "Lonza Process" means a Process provided by or developed by Lonza for the production of Product from the Omeros Cell Line using inter alia Lonza-proprietary media and feeds.

	“Product”
	means Omeros’ proprietary narsoplimab (OMS721) antibody to MASP-2 product manufactured using the Process (including any test sample thereof), particulars of which are set out in the Specifications Document and includes all derivatives thereof.

	“Proprietary Feed License”
	has the meaning given to it in Clause 2.8.

	“Purchase Order”
	means a purchase order placed by Omeros for the production and delivery of Batches or other Services.

	“Quality Agreement”
	has the meaning given to it in Clause 2.12.

	“Raw Materials”
	means those materials procured by Lonza and including those filters and other consumables as required and used by Lonza in the production of the Product at the Facility.

	“Raw Materials Fee”
	means the procurement and handling fee of [***] of the acquisition cost of Raw Materials by Lonza that is charged to Omeros in addition to the cost of such Raw Materials (excluding Resins, which are not subject to a handling fee).

	“Recall”
	has the meaning given to it in Clause 5.13.

	“Regulatory Authority(ies)”
	means the FDA, EMA, European national regulatory authorities, and any other similar regulatory authorities as may be agreed upon in writing by the Parties.

	“Release”
	has the meaning given to it in Clause 5.1.

	“Resins”
	means the purification Resins, UF membranes and any other materials that are used across multiple Batches as part of the provision of Services.

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	“Services”
	means all or any part of the services performed by Lonza (including, without limitation, cell culture evaluation, purification evaluation, master, working and extended cell bank creation, Processing and sample and bulk production of the Product), particulars of which are set out in one or more SOWs.

	“Specifications”
	means all written requirements, standards, quality control testing and other data for Product, particulars of which are set out in Specifications Document.

	“Specifications Document”
	means the mutually agreed document setting out the requirements, standards, quality control testing and other parameters for the Product, as may be amended from time to time by written agreement of the Parties.

	“Statement of Work” and SOW”
	means a document setting out particular Services to be performed, including a description of the Services to be performed, any agreed Price and terms of payment for the Services to be performed, and any changes or additions to previously agreed Specifications, which shall be incorporated into this Agreement upon execution by authorized representatives of each Party. In the event of any conflict between the provisions of this Agreement and the provisions of any SOW, the provisions of this Agreement shall control except to the extent that specific terms are expressly indicated in a SOW as superseding terms of this Agreement.

	“Supply Failure”
	has the meaning given to it in Clause 6 6.1.

	“Term”
	has the meaning given to it in Clause 12.1.

	“Termination Fee”
	means the fees payable on termination in accordance with Clause 12.6.

	"Terms of Payment" 
	means the terms of payment specified in this Agreement with respect to Purchase Orders for Batches and the terms of payment specified in a SOW for other Services. In the event of a conflict between the provisions of this Agreement and the provisions of any Purchase Order or SOW, the provisions of this Agreement shall control.

	“Territory” 
	means [***] and any other additional territory(ies) for which Omeros provides Lonza with reasonable prior written notice and subject to Lonza’s agreement that it can support such additional territory(ies) (such agreement not to be unreasonably withheld).

	“Third Party”
	means any party other than Omeros, Lonza and their respective Affiliates.

​
References to the singular number include the plural and vice versa, references to Clauses and Schedules are references to clauses and schedules to this Agreement.
2. Provision of the Services
	2.1 (a)
	Lonza shall itself and through its Affiliates, diligently carry out the Services as provided in this Agreement and each SOW, and shall use reasonable endeavours to perform the Services without defect and according to the estimated timelines as set forth in this Agreement and each applicable SOW or Binding Order. Lonza will, in accordance with the terms of this Agreement and the Quality

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Agreement, manufacture at the Facility and Release to Customer, cGMP Batches that comply with the Master Batch Record, cGMP and the Specifications, and provide a corresponding Certificate of Analysis and Certificate of Compliance for each such cGMP Batch.
	2.1 (b)
	Lonza shall retain appropriately qualified and trained personnel with the requisite knowledge and experience to perform the Services in accordance with this Agreement. Lonza may subcontract or delegate any portion of the Services under this Agreement to a Third Party analytical laboratory or other Third Party only with Omeros’ advance written approval, not to be unreasonably withheld; provided, that any such subcontracted Third Party shall be subject to the same obligations and other provisions contained in this Agreement and any applicable SOW or Binding Order and Lonza shall be responsible for such subcontracted services, unless such subcontracted Third Party has been selected by Omeros, in which case Lonza shall not be responsible for such subcontracted services.

	2.2
	Lonza shall manufacture cGMP Product in accordance with the Master Batch Record to meet the Specifications using the Omeros Cell Line, provided that there shall be no such obligation to meet the Specifications in respect of the [***] cGMP Batch manufactured following any material change in the Process agreed to or requested by Omeros in writing, provided, however, that in such cases Lonza shall still be required to use commercially reasonable efforts to meet the Specifications and shall still comply with all Applicable Laws and Lonza’s standard operating procedures.

	2.3
	The quantities of Product for Delivery set out in Purchase Orders are estimates only, which quantities Lonza shall use commercially reasonable efforts to meet. Promptly following First Approval and the manufacture of the [***] cGMP Batch manufactured on or after [***] by Lonza for Omeros at each facility at which Lonza manufactures Batches for Omeros, (not including batches manufactured under the Development Agreement or other development batches), and taking into account sampling from Batches, the Parties shall mutually determine and agree in writing on target yield quantities and an acceptable range of yield for future cGMP Batches along with associated pricing adjustments.

	2.4
	Without prejudice to Lonza’s obligations under Clauses 2.1 and 2.2, Omeros shall be entitled to cancel any unfulfilled part of the Services or to refuse to accept the Services on grounds of late performance or late delivery to the extent specified within this Agreement.

	2.5
	Lonza shall perform the Services in compliance with this Agreement, the applicable SOW, all Applicable Laws and Lonza’s standard operating procedures applicable to the Services.

	2.6
	Lonza shall not use the Cell Line, the Omeros Process, Omeros Patent Rights, Omeros Materials or Omeros Information (or any part thereof) [***] for any purpose other than the performance of the Services for Omeros under this Agreement. [***].

	2.7
	Lonza shall:

(a) at all times use commercially reasonable efforts to keep the Cell Line, the Omeros Information and/or Omeros Materials secure and safe from loss and damage in a commercially reasonable manner that is as rigorous as such manner as Lonza stores its own material of similar nature;
(b) not part with possession of the Cell Line and/or Omeros Materials or the Product or the Omeros Information, save for the purpose of activities at the authorized External Laboratories or as otherwise authorised in writing by Omeros; and
(c) ensure that all External Laboratories are subject to obligations of confidence substantially in the form of those obligations of confidence imposed on Lonza under this Agreement.
	2.8
	Omeros acknowledges and agrees that this Agreement is entered into so that Lonza can provide the Services based on the options provided below:

(a) Omeros Cell Line and Lonza Process.
Lonza shall provide notice to Omeros, and obtain Omeros’ consent, prior to the incorporation into the Product or the Process of a material or process that would require a license from Lonza or a
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Third Party, which notice shall include the proposed license terms for such new material or process applicable to technology transfer in accordance with Clause 12.8 but which, in the case of any new material or process that requires a license from Lonza rather than a Third Party, such license shall be royalty free for the Process during the Term of this Agreement, but Omeros acknowledges that the terms of any license with any such Third Party shall be subject to terms and price to be agreed between Omeros and such Third Party.. If Omeros consents to such terms, the material or process may be incorporated into the Product or the Process; if Omeros does not consent to such terms, Lonza shall continue to manufacture the Product using the Process without such incorporation. Omeros shall have the option to purchase Lonza’s proprietary media and feeds from Lonza or a Third Party supplier. Lonza agrees that it shall make available to Omeros a license for purchase of Lonza’s proprietary feeds from Third Party suppliers or Lonza and to use the Lonza Process in connection with nonclinical and in vivo human clinical research and development, manufacture, marketing and sales and commercialization purposes (a “Proprietary Feed License”).  For current and any future media and feeds, the Proprietary Feed License shall be fully paid up and subject always to Clause 12.8, no royalties or other compensation owed other than as may be charged by Third Party media and feed suppliers for supply of such current media and feeds. The Proprietary Feed License for any future media and feeds incorporated into the Process after approval by Omeros will be provided on these same terms to the extent that Lonza is able to so provide such terms. The option to purchase proprietary feeds and the Proprietary Feed License shall be assignable by Omeros to a Third Party which is an IP-Respecting Entity.
(b) Omeros Cell Line and Omeros Process.
Where the Cell Line is the Omeros Cell Line and Product is produced using the Omeros Process, Lonza acknowledges that, other than as conveyed to Omeros under Clause 8.4 herein, no license shall be required from Lonza for Omeros to exploit the Omeros Cell Line, the Omeros Process or the Product provided that no New General Application Intellectual Property has been applied by Lonza in the Omeros Process other than as provided under Clause 8.4 herein. Subject to the foregoing provision, Omeros shall also have the option to purchase Lonza’s proprietary media and feeds from Lonza or a Third Party supplier and use such media and feeds to modify the Omeros Process. Omeros shall have the right to require a technology transfer in accordance with Clause 12.8. The option to purchase proprietary feeds and the Proprietary Feed License shall be assignable by Omeros to a Third Party which is an IP-Respecting Entity.
	2.9
	Unless otherwise agreed by the parties in writing or specified in the applicable SOW, Lonza shall provide all supplies (other than the materials as provided for in any SOW) and standard processing and manufacturing equipment needed for completion of the Services, at its sole cost and expense unless otherwise provided for in a SOW (including, without limitation, shipping costs in connection with such supplies and equipment). All Omeros-specific supplies and Omeros-dedicated equipment shall be specified in the SOW and shall be purchased at Omeros’ reasonable cost and expense.

	2.10
	At Lonza’s expense, Lonza shall be responsible for destruction of any and all waste, including hazardous waste, including, without limitation, rejected Product, in accordance with the Applicable Laws. Provided, however, the destruction by Lonza of any Resins owned by Omeros shall be at Omeros’ request and expense.

	2.11
	Lonza shall, at its own cost and expense, with a reputable and solvent insurance provider, obtain and maintain in full force and effect the following insurance during the Term: (a) commercial general liability insurance with a per-claim limit of not less than [***] USD; and (b) products and completed operations liability insurance with a per-occurrence limit of not less than [***] USD and an annual aggregate limit of not less than (i) [***] USD prior to Launch and (ii) not less than [***] USD after Launch. Lonza shall supply Omeros with a copy of the certificate of insurance upon reasonable request and shall not terminate or materially decrease the level of coverage of such policies during the Term of this Agreement.

	2.12
	The Parties shall enter into a separate quality agreement (the “Quality Agreement”) to define their responsibilities in relation to the disposition of the Product. In the event of any conflict between the

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

terms of this Agreement and the terms of the Quality Agreement, the terms of the Quality Agreement shall control in relation to the disposition of the Product and this Agreement shall control all other aspects.
	2.13
	Omeros shall be permitted to have, at no additional cost, one (1) employee or contracted representative at the Facility as reasonably requested by Omeros, at any time during the Process for the purpose of observing, reporting on, and consulting as to the performance of the Services. Such employee or contracted representative shall be subject to abide by confidentiality obligations as set forth herein and Lonza’s customary practices and operating procedures regarding persons in plant, and such employee agrees to comply with all instructions of Lonza’s employees at the Facility.

	2.14
	Lonza reserves the right to initiate any and all required investigational work, such as that related to out of Specification (“OOS”) investigations as set out further under a separate Quality Agreement. Lonza will inform Omeros of such investigational work as soon as reasonably practicable. Lonza will seek Omeros’ approval prior to beginning such investigational work if any costs would be incurred in connection with such work would be chargeable to Omeros at Lonza’s standard rates.

	2.15
	Raw Materials. Lonza shall procure all required Raw Materials other than those raw materials that are Omeros Materials. Omeros shall be responsible for payment of Raw Materials irrevocably committed to be procured by Lonza under a Binding Order hereunder that are not (as reasonably determined by Lonza) returnable or useable for other customers.

	2.16 
	For any regulatory support services for Approval of the Product in each Territory that Omeros requests, the cost of any such regulatory support will be paid for by Omeros in accordance with Schedule 1 to this Agreement.

3. Scale Up Within Lonza Network
In the event that the Parties agree to transfer the manufacture of Product to a larger scale at the same Facility or such alternate Lonza facility as may be mutually agreed to meet the supply requirements, then the cost of transferring the manufacture of the Product to the larger scale or from the Facility to such other Lonza facility will be agreed in good faith between the Parties by way of an amendment to this Agreement, with manufacturing at such larger scale or at such other Lonza facility to be undertaken under the terms of this Agreement, amended solely as may be necessary to address such transfer and incorporate applicable adjustments to Batch pricing.
4. Omeros Obligations
	4.1
	Omeros has supplied to Lonza the Omeros Information, together with full details of any known hazards relating to the Omeros Cell Line, if applicable, and/or Omeros Materials, their storage and use. Title to the Omeros Cell Line and/or Omeros Materials and/or Omeros Information supplied to Lonza is and shall remain vested in Omeros.

	4.2
	Omeros shall pay the Price set out in each SOW for provision of the Services other than Batch manufacture performed in accordance with this Agreement or in accordance with Schedule 1 for Batches manufactured under this Agreement, as set out in each Binding Order, together with any additional costs and expenses that fall due under this Agreement in accordance with the Terms of Payment.

	4.3
	Omeros hereby grants Lonza the non-exclusive right to use the Omeros Cell Line, the Omeros Materials and the Omeros Information for the sole purpose of performing the Services in accordance with this Agreement.

	4.4
	Omeros shall, at its own cost and expense, obtain and maintain in full force and effect products liability insurance with a reputable and solvent insurance provider with a per occurrence limit of not less than [***] USD and an annual aggregate limit of not less than (i) [***] USD prior to Launch and (ii) not less than [***] USD following Launch. Omeros shall supply Lonza with a copy of the certificate

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

of insurance upon reasonable request and shall not terminate or materially decrease the level of cover of such policy during the Term of this Agreement.
	4.5
	During the Term of the Agreement, Omeros and Lonza intend Lonza to be the supplier of a minimum of [***]% of Omeros’ requirements for Product sold by Omeros or its Affiliates, to customers, to distributors, or commercial partners (“Minimum Exclusivity”), as measured on [***] sales (i.e., [***]), over any [***] calendar year period following Launch. [***].

5. Delivery, Transportation of Product and Omeros Tests
	5.1
	Product shall be Delivered EXW (ex-works) (as defined by Incoterms 2010) Lonza’s Facility which means (a) Delivery shall occur when Lonza places Product, packaged for transport in accordance with the Specifications, at the disposal of Omeros at Lonza’s premises (not cleared for export and not loaded onto a carrier’s vehicle) and (b) risk and title to Product shall pass to Omeros upon Delivery (“Deliver,” “Delivery,” or “Delivered,” as appropriate); provided, however, that Lonza shall remain responsible for storage of Product in accordance with the Specifications until Product is loaded into a carrier’s vehicle and shall remain liable for any damage or loss of Product due to improper storage during this time period. Subject to Clause 5.2, Lonza shall deliver to Omeros the signed Certificate of Analysis and a completed Certificate of Compliance not later than the date of Delivery (“Release”). Transportation of Product packaged in accordance with the Specifications, whether or not under any arrangements made by Lonza on behalf of Omeros, shall be made at the sole risk and expense of Omeros. Lonza shall provide such deliverables in accordance with the shipping and packaging instructions set forth in the Specifications or applicable SOW or as otherwise provided in advance by Omeros and agreed to by Lonza and shall provide all necessary supporting shipping information.

	5.2
	At Omeros’ request and subject to the agreement of both parties, Lonza will Deliver Product in quarantine prior to delivery of the Certificate of Analysis. Such request shall be accompanied by Omeros’ written acknowledgement that the Product has been Delivered without the transmittal to Omeros of a Certificate of Analysis, that accordingly the Product cannot be administered to humans until transmittal of the Certificate of Analysis, and that Omeros nevertheless accepts full risk of loss, title and ownership of the Product. The Delivery of Product in quarantine shall be subject to such testing requirements as Lonza may reasonably require, and the forty-five (45) day period referred to in Clause 5.9 shall run from the Release of Product Delivered to Omeros.

	5.3
	Lonza or any subcontracted Third Party that performs testing on behalf of Lonza shall perform quality control tests in accordance with the Quality Agreement and as necessary to ensure that each Batch of Product is produced in accordance with and conforms to the Specifications and all Applicable Laws, including cGMP when applicable. All quality control test results, raw data associated with these test results and copies thereof, including notebook entries, generated by or at Lonza or by or at any subcontracted Third Party analytical laboratory, shall be made available to Omeros upon written request of Omeros at Lonza’s Facility to the extent that such information is specific to Lonza’s Facility or such subcontracted Third Party’s facility. Lonza shall provide Omeros with timely access to properly completed copies of batch records for such Batch, prepared in accordance with the Master Batch Record, Specifications and Applicable Laws, which shall accurately reflect in all material respects the processes and procedures followed by Lonza in Processing Product.

	5.4
	Unless otherwise agreed, Lonza shall package and label Product for Delivery in accordance with its standard operating procedures, the Master Batch Record and the Specifications. It shall be the responsibility of Omeros to inform Lonza in writing in advance of any special packaging and labelling requirements for Product. All reasonable additional costs and expenses of whatever nature to be incurred by Lonza in complying with such special requirements shall be agreed to in advance with Omeros and then charged to Omeros in addition to the Price.

	5.5
	If requested in writing by Omeros, Lonza will (acting as agent for Omeros for such purpose) arrange for insurance of Product whilst held by Lonza after Delivery (awaiting transportation) for a maximum of fourteen (14) days on terms equivalent to those under which Lonza insures product prior to

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Delivery. All additional costs and expenses of whatever nature incurred by Lonza in arranging such insurance shall be charged to Omeros in addition to the Price.
	5.6
	If requested in writing by Omeros, Lonza will (acting as agent of Omeros for such purpose) arrange the transportation of Product from Lonza’s premises to the destination indicated by Omeros together with insurance coverage for Product in transit at its invoiced value. All additional costs and expenses of whatever nature incurred by Lonza in arranging such transportation and insurance shall be charged to Omeros in addition to the Price.

	5.7
	Where Lonza has made arrangements for the transportation of Product, Omeros or its Third Party designee shall diligently examine the Product for transportation damage as soon as practicable after receipt. Notice of all claims (time being of the essence) arising out of:

(a) visible damage to or total or partial loss of Product in transit shall be given in writing to Lonza and the carrier within three (3) working days of receipt by Omeros; or
(b) non-delivery shall be given in writing to Lonza within ten (10) days after the date of Lonza’s despatch notice, which despatch notice shall be e-mailed contemporaneously with shipment to an Omeros project manager designated by Omeros.
	5.8
	Omeros shall make damaged Product and associated packaging materials available for inspection and shall comply with the requirements of any insurance policy covering the Product notified by Lonza to Omeros. Lonza shall offer Omeros all reasonable assistance (at the cost and expense of Omeros) in pursuing any claims arising out of the transportation of Product.

	5.9
	Promptly following receipt of Product or any sample thereof, Omeros may carry out any of the tests outlined or referred to in the Specifications or any SOW. Subject to Clause 2.2, if such tests show that the Product fails to meet Specifications, then Omeros shall provide Lonza written notice thereof (“Failure Notice”) within forty-five (45) days from the date of Release and shall, upon Lonza’s request and with Omeros’ agreement, return such Product to Lonza’s premises for further testing (at Lonza’s cost and expense if the Product is shown to fail to meet Specifications and such failure is due (in whole or in part) to the acts of omissions of Lonza). In the absence of such Failure Notice, Product shall be deemed to have been accepted by Omeros as meeting Specifications.

Subject to Clause 2.2, if a Batch fails to meet the Specification prior to Delivery, or if Omeros has reasonably demonstrated to Lonza that Product that has been Delivered fails to meet Specification and that such failure is not due (in whole or in part) to acts or omissions of Omeros or any Third Party after Delivery, Lonza shall propose to Omeros a schedule for manufacture and Delivery of a replacement for the failed Batch. Omeros may accept or reject the proposed replacement schedule of any failed Batch. If Omeros accepts the proposed replacement schedule of any failed Batch, then Lonza shall Process and Deliver the replacement Batch in accordance with the agreed replacement schedule, and following Delivery, Omeros shall pay Lonza the remaining [***] of the Batch Price (taking into account the [***] payment already made by Omeros in respect of the failed Batch), provided, however, that if the agreed scheduled thaw date for the replacement Batch is later than [***] months after the scheduled Commencement Date of the original failed Batch, Lonza shall if requested by Omeros refund the initial [***] payment already made by Omeros and reinvoice Omeros for such payment to be made upon the rescheduled Commencement Date. If Omeros rejects the proposed replacement of any failed Batch, then Lonza shall issue a credit or, if requested by Omeros, pay a refund to Omeros for the amount of the Price previously paid that relates to the production of such failed Batch. In the event that Lonza is required to replace such Product, Lonza shall use all reasonable endeavours to do so with the minimum delay having regard to its commitments to third parties in the timing of such replacement. Omeros shall notify Lonza of any Latent Defect immediately upon discovery. Lonza shall be responsible for Latent Defects which are directly attributable to Lonza’s breach of obligations under this Agreement and Omeros shall have the same remedies available to it hereunder.
	5.10
	Subject to Clause 2.2, if there is any dispute concerning (i) whether Product fails to comply with Specifications or cGMP or (ii) whether such failure is due (in whole or in part) to acts or omissions of Omeros or any Third Party after Delivery, such dispute shall be referred for decision to an

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

independent expert (acting as an expert and not as an arbitrator) to be appointed by agreement between Lonza and Omeros. The costs of such independent expert shall be borne equally between Lonza and Omeros. The decision of such independent expert shall be in writing and, save for manifest error on the face of the decision, shall be binding on both Lonza and Omeros.
	5.11
	Except as otherwise expressly set forth in this Agreement, the provisions of Clauses 2.4, 5.9 and 5.10 shall be the sole remedy available to Omeros in respect of Product that fails to meet Specification.

	5.12
	Following completion of each Batch of Product retained samples will be stored at Lonza’s Facility in accordance with the Applicable Laws, the Master Batch Record and any instructions set forth in a SOW, including for the time period of any stability study to be performed in accordance with any SOW. After the expiration of any minimum hold periods required by the Applicable Laws and/or any SOW, Lonza will notify Omeros in writing if it intends to dispose of specified samples, at Omeros’ reasonable cost, unless written instructions have been provided by Omeros to Lonza within thirty (30) days of Omeros’ receipt of such disposal notice to return samples to Omeros or a Third Party designee at Omeros’ reasonable cost. Lonza will return unused Omeros Materials to Omeros within ninety (90) days of the termination of the relevant SOW, at Omeros’ reasonable cost, unless prior written instructions have been provided by Omeros to dispose of such materials at Omeros’ reasonable cost. Lonza will store Omeros Materials free of charge during the term of the applicable SOW and for thirty (30) days thereafter.

	5.13
	If a Regulatory Authority orders or requires the recall of any Product supplied hereunder or if Omeros or Lonza believes a recall, field alert, biological product deviation, Product withdrawal or field correction (“Recall”) may be necessary with respect to any Product supplied under this Agreement, the Party receiving the notice from the Regulatory Authority or that holds such belief shall promptly notify the other Party in writing. With respect to any Recall, Lonza shall provide all necessary cooperation and assistance to Omeros. The cost of any Recall shall be borne by Omeros, and Omeros shall reimburse Lonza for reasonable expenses incurred in connection with any Recall, except to the extent such Recall is caused by (A) Lonza’s negligence in which case Lonza’s liability for such Recall costs and reasonable expenses is the Price charged for the recalled Product or (B) Lonza’s gross negligence or willful misconduct, in which case Lonza’s liability for such Recall costs and expenses shall not be limited. For purposes of clarification, Recall costs and reasonable expenses shall include, without limitation, notification to customers, Product retrieval, Product destruction, recall-related regulatory submissions, shipping and taxes. In the event that a Product is Recalled or Omeros is required to disseminate information relating to Product covered by this Agreement, Omeros shall so notify Lonza within a reasonable time so as to enable Lonza to provide Omeros with such assistance in connection with such Recall as may reasonably be requested by Omeros. Lonza will comply with all such reasonable requests from Omeros. Omeros shall handle exclusively the organization and implementation of all Recalls of Products. Any such Recall shall be implemented and administered in a manner that is appropriate and reasonable under the circumstances and in conformity with any requests or orders of the applicable Regulatory Authority and, to the extent consistent, accepted trade practices.

6. Minimum Order, Forecasting, Ordering, Rescheduling, Cancellation, and Supply Failure
	6.1
	Minimum Order

	6.1.1
	Minimum Campaign Size. The minimum Campaign size shall be [***] Batches (“Minimum Campaign”).

	6.1.2
	Minimum Order. Commencing from the [***] of the [***] following Launch, Omeros commits to order and Lonza commits to supply not less than [***] Batches per calendar year (“Minimum Order”).  For purposes of illustration only, the following is an example of the calculation for commencement of the Minimum Order: If Launch occurs on [***], then Omeros’ commitment to the Minimum Order begins for the calendar year commencing [***].

	6.2
	Forecasting for Batches

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	6.2.1
	Forecast. Omeros shall provide to Lonza, in writing, a rolling [***] forecast, based on desired Delivery date, of the number of Batches to be ordered in each calendar year. The forecast shall be updated [***] by Omeros (e.g., each [***]) and is non-binding (the “Forecast”).

	6.2.2
	Forecast Response. No later than [***] following Lonza’s receipt of a Forecast, Lonza shall respond to each Forecast (“Forecast Response”) with a written schedule to Omeros of whether it has (as of the date of receipt of the Forecast) capacity available to manufacture the number of Batches Forecasted therein, and shall provide Omeros with an estimated production schedule showing the estimated Commencement Date and Delivery date of such Batches. Lonza shall schedule all Batches for manufacture in each calendar year as [***], unless otherwise requested by Omeros in the Forecast; provided, however, that, at its option, Omeros shall have the right to split annual aggregate orders of [***] or more Batches into [***] Campaigns, each at least as large as the Minimum Campaign size. If [***] Batches during a calendar year are split into [***] Campaigns at Omeros’ request, the Batch Price shall be determined based on the size of the [***] Campaigns. If [***] Batches during a calendar year are split into [***] Campaigns by Lonza and not in response to a request by Omeros, the Batch Price shall be determined based on the aggregate number of Batches ordered in the Binding Order.

	6.2.3
	[***].

	6.3
	Purchase Orders

	6.3.1
	Omeros shall issue a Purchase Order for any Batches it wishes to order in accordance with the Lonza Forecast Response no later than [***] prior to the Commencement Date of each Campaign.

	6.3.2
	Lonza shall confirm the Commencement Date(s), Delivery date(s) and number of Batches to be Delivered to Omeros as set out in each Purchase Order within [***] of receipt from Omeros of the relevant Purchase Order. Upon acceptance of each Purchase Order from Lonza, it will then be regarded by the Parties as a binding order (“Binding Order”).  Any Commencement Date or Delivery date set forth in Lonza’s written confirmation of a Purchase Order shall be an estimated date only, provided that the estimated Commencement Date or Delivery date for a Batch by Lonza is no earlier or no later than [***] from Lonza’s most recent Forecast Response.

	6.3.3
	Omeros may request to add additional Batches into an existing Campaign under a Purchase Order with less than [***] prior notice and Lonza shall determine and notify Omeros within [***] of such request whether such additional Batches can be accommodated into that Campaign, creating a Binding Order if accepted by Lonza. For clarity, Lonza shall have no obligation to accept Purchase Orders for any requested additional Batches, or to reserve capacity prior to accepting such requested Purchase Orders.

	6.3.4
	Unless otherwise permitted by Lonza in its discretion, Omeros shall issue Purchase Orders for any Services other than Batch manufacture no later than [***] prior to the commencement of each of the Services or such earlier time as reasonably requested by Lonza.

	6.3.4
	Any additional or inconsistent terms or conditions of any Omeros-issued Purchase Orders, acknowledgement or similar standardized form given or received pursuant to this Agreement shall have no effect and such terms and conditions are hereby rejected, unless specifically acknowledged and accepted by Lonza.

	6.4
	Rescheduling

	6.4.1
	Lonza shall have the right to reschedule the Commencement Date and Delivery Date of any Batch or Campaign under Binding Order upon reasonable prior written notice to Omeros, delivered as soon as reasonably practicable following Lonza’s determination that it wishes to reschedule a Batch or Campaign; provided, that the rescheduled Commencement Date and Delivery Date is no earlier or no later than ninety (90) days from the Commencement Date and Release Date originally estimated at the time of Lonza’s confirmation of the Binding Order, and that any such Batches that are delayed by Lonza into a subsequent calendar year, shall count towards Omeros’ annual total for the originally scheduled calendar year for purposes of the Minimum Campaign or Minimum Order, as applicable.

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	6.4.2
	Omeros shall have the right to request to reschedule any Batch or Campaign upon prior written notice to Lonza. Lonza shall use commercially reasonable efforts to accommodate such reschedule request from Omeros wherever possible, but whilst observing its contractual commitments of other customers. [***] Omeros acknowledges that any such rescheduling request may not be fulfilled by Lonza.

	6.5
	Cancellation of a Batch under Binding Order

	6.5.1 
	Omeros shall notify Lonza of any Batches (the Binding Order for which has been confirmed) that it wishes to cancel. Lonza shall use commercially reasonable efforts to try and secure a replacement batch for a new project, whilst observing its contractual commitments of other customers.

	6.5.2 
	If Lonza is unable to resell the cancelled Batch(es), Omeros shall pay [***] of the Batch Price for each Batch cancelled in accordance with the previously agreed Batch Price payment schedule of [***] at scheduled Commencement Date and [***] at scheduled Release date.

	6.5.3
	If Lonza is able to resell any cancelled capacity to any Third Party then the cancellation fee provided for under Clause 6.5.2 for that Batch shall be waivered.

	6.5.4
	In addition, any Raw Materials that are irrevocably committed and shall expire before use in any other production Campaign shall be invoiced by Lonza and paid for by Omeros in accordance with the previously agreed scheduled Release date and the handling fee shall be paid for by Omeros. Such Raw Materials may be either shipped to Omeros, stored for future use for Omeros, or disposed of as requested by Omeros. All such Raw Materials paid for by Omeros shall be owned by Omeros.

	6.6 
	Supply Failure

	6.6.1
	Following Launch of the Product, If Lonza fails (where failure, for example, includes but is not limited to, failure to comply with the Master Batch Record during Processing of a Batch, failure of a Batch to meet Specifications, failure to Deliver a Batch, or failure due to reasons within Lonza’s control to Release a Batch) to produce [***] or more Batches within a [***] (“Supply Failure”), Lonza 's remediation plan for the Supply Failure shall be to Deliver replacement Batches within [***] (or any such timeframe as agreed between the Parties) of such Supply Failure. In the event that Lonza is unable to Deliver replacement Batches within the above timeframe, Omeros may terminate this Agreement by providing [***] advance written notice.

7. Price and Terms of Payment
	7.1
	Unless otherwise indicated in writing by Lonza, all prices and charges are exclusive of Value Added Tax or of any other applicable taxes, levies, imposts, duties and fees of whatever nature imposed by or under the authority of any government or public authority, which shall be paid by Omeros (other than taxes on Lonza’s income). All invoices are strictly net and payment must be made within thirty (30) days of receipt of invoice unless disputed. Payment shall be made without deduction, deferment, set-off, lien or counterclaim of any nature.

	7.2
	Any invoices that are disputed by Omeros must be notified to Lonza in writing and within thirty (30) days of issue of the invoice by Lonza. The Parties shall meet (in person or by telephone) within ten (10) days to resolve such dispute. Payment shall be made promptly after resolution of the dispute.

	7.3
	In case of any default of payment on the due date:

(a) interest shall accrue on any amount overdue of an undisputed invoice at the rate of [***] percent per month, interest to accrue on a day to day basis both before and after judgment and not exceeding more than [***] percent per annum; and
(b) Lonza shall, at its sole discretion, and without prejudice to any other of its accrued rights, be entitled to suspend the provision of the Services or to treat this Agreement as repudiated on not less than thirty (30) days’ prior notice in writing to Omeros given at any time thereafter unless such payment default is cured during or after such notice period and prior to repudiation.
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	7.4
	Price Adjustments

	7.4.1
	Not more than once per calendar year, to be effective after March 31 of that year, Lonza may increase the Price for Batches in accordance with the US Department of Labor’s Bureau of Labor Statistics Pharmaceutical Preparations Index, [***] (or any successor index) increase for the previous calendar year. Any new Price reflecting a Batch Price adjustment shall be effective only for Purchase Orders submitted in [***] and subsequent years and any Price increase shall not exceed [***% per annum]. Purchase Orders placed in a calendar year by Omeros for Delivery of Batch(es) in that same calendar year, and accepted by Lonza, shall not be subject to any Price increase.

	7.4.2
	In addition to the above, the Price may be changed by Lonza, upon reasonable prior written notice to Omeros (providing reasonable detail in support thereof), to reflect (i) any change in Process conditions that materially impact Lonza cost of manufacture and (ii)  any material change in an environmental, safety or regulatory standard to the extent such change materially impacts manufacturing costs exclusive of capital expenditures.

	7.4.3
	In the event Omeros awards a second product to Lonza the parties shall enter into good faith discussions to review the annual Price adjustments of Clause 7.

	7.5
	Invoicing

	7.5.1
	Invoices will not be provided to Omeros until the related activity is initiated or completed.

	7.5.2
	Lonza shall issue invoices to Omeros for [***] percent of the Price for Batches upon the Commencement Date of each Batch and [***] percent upon Release of each Batch, unless otherwise stated in the SOW or under a Binding Order, provided, however, that if a Batch is rejected the final [***] payment shall not become due until an investigation is completed and then payment responsibility will depend on the outcome of the investigation. Lonza shall (a) issue invoices for Services (other than the manufacture of Batches) in accordance with the schedule set forth in the applicable SOW. Omeros shall pay all undisputed invoices within 30 days of receipt or as otherwise set forth in the SOW.

	7.5.3
	Charges for Raw Materials and the Raw Materials Fee for each Batch shall be invoiced upon the Release of each Batch.

	7.5.4
	The cost of Resins will be invoiced by Lonza to Omeros upon purchase of the Resins by Lonza.

	7.5.5
	Any External Laboratory testing costs associated with testing will be invoiced upon Delivery of Batch.

8. Intellectual Property
	8.1
	Neither Party will, as a result of this Agreement, acquire any right, title, or interest in any Intellectual Property that the other Party owns or controls as of the Effective Date of this Agreement, or that the other Party obtains ownership or control of separate and apart from the performance of the Services under this Agreement.

	8.2
	Lonza shall own all right, title and interest in “New General Application Intellectual Property,” which as used in this Agreement means Intellectual Property that Lonza and/or its Affiliates, contractors or agents develops, conceives, invents, reduces to practice or makes in the course of performance of the Services and that [***].

	8.3
	Except for and not including the New General Application Intellectual Property, Omeros shall own all right, title, and interest in (a) any and all Intellectual Property that Lonza and/or its Affiliates conceives, invents, reduces to practice, develops or makes, solely or jointly with Omeros or others, [***] and (b)[***] (collectively, the “New Omeros Intellectual Property”). Omeros grants to Lonza a non-exclusive, non-transferable, royalty-free license to use the New Omeros Intellectual Property solely to the extent necessary for Lonza to perform its obligations under this Agreement. No other license to the New Omeros Intellectual Property is hereby granted. Lonza hereby assigns to Omeros and shall continue to assign to Omeros all of its right, title and interest in any New Omeros

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Intellectual Property. Lonza shall promptly disclose to Omeros in writing all New Omeros Intellectual Property. Lonza shall execute, and shall require Lonza’s personnel involved in the performance of the Services to execute, any documents required to confirm Omeros’ ownership of the New Omeros Intellectual Property, and any documents required to apply for, maintain and enforce any patent or other right in the New Omeros Intellectual Property. Upon Omeros’ request and at Omeros’ reasonable expense, and at no cost to Lonza, Lonza shall assist Omeros as may be necessary to apply for, maintain and enforce any patent or other right in the New Omeros Intellectual Property. For the avoidance of doubt, the parties agree that the term “New Omeros Intellectual Property” shall not under any circumstances be interpreted or defined to include any “New General Application Intellectual Property”.
	8.4
	[***]

9. Warranties and Indemnification
	9.1
	Lonza Warranty. Lonza warrants that:

(a) the Services shall be performed in accordance with Clauses 2.1, 2.2 and 2.5;
(b) unencumbered title (save for any Intellectual Property rights which may exist) to Product will be conveyed to Omeros upon Delivery;
(c) as of the date of this Agreement the Lonza Know How and Lonza Patent Rights are owned by Lonza or Lonza is otherwise entitled to use them for the purposes of providing Services under this Agreement and during the term of this Agreement Lonza shall not do or cause anything to be done that would adversely affect their ownership or entitlement to use the same for those purposes;
(d) Lonza has the necessary corporate authorisations to enter into this Agreement;
(e) as of the date of this Agreement to the best of Lonza’s knowledge and belief, the use by Lonza of the Process (excluding any modifications or steps made or developed by Omeros, Omeros Materials, Omeros Information and Omeros Patent Rights), and Lonza Patent Rights and Lonza Know How for the performance of the Services as provided herein will not infringe any rights (including without limitation any intellectual or industrial property rights) vested in any Third Party;
(f) Lonza will notify Omeros in writing immediately if it receives or is notified of a claim from a Third Party that the use by Lonza of the Process and/or the Lonza Know How or the Lonza Patent Rights for Services infringes any Intellectual Property rights vested in such Third Party;
(g) subject to Clause 2.2 and at the time of Delivery by Lonza, Product shall have been Processed in accordance with Applicable Laws and in conformance with the Specifications, and shall not be adulterated, misbranded or mislabelled within the meaning of Applicable Laws or misused, contaminated, tampered with or otherwise altered or mishandled while in the custody and control of Lonza, provided, that Lonza shall not be liable for defects attributable to Omeros Materials or a breach of representations and warranties made by Omeros under this Agreement;
(h) none of Lonza’s officers, directors, employees or, to Lonza’s knowledge, direct subcontractors, providing Services under this Agreement, or Affiliates has been debarred or, to Lonza’s knowledge, threatened with debarment under the United States Generic Drug Enforcement Act or convicted of a crime which could lead to debarment, and it has not utilized, and will not utilize, the services of any individual or entity in the performance of any SOW that has been debarred or threatened with debarment under the United States Generic Drug Enforcement Act, convicted of a crime that could lead to debarment by the FDA, and in the event that Lonza receives notice of the debarment or threatened debarment of any individual or entity utilized by Lonza in connection with the Services, Lonza shall notify Omeros in writing immediately, and Omeros shall have the right to terminate this Agreement upon written notice in accordance with Clause 12.2 of this Agreement, and make payments to Lonza of all accrued and unpaid obligations up to the date of termination without any further financial penalties;
(i) each Certificate of Analysis and Certificate of Compliance will be true and correct and accurately reflect the results of the tests conducted on the Batch of Product to which it relates, and the records
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Delivered to Omeros will accurately reflect in all material respects the processes and procedures followed by Lonza in Processing Product as set forth in the SOW, Master Batch Record and Specifications; and
(j) Lonza has obtained (or will obtain prior to Processing Product or performance of other Services), and will remain in compliance with during the term of this Agreement, all permits, licenses and other authorizations which are required under Applicable Laws for the provision of the Services under this Agreement.
	9.2
	Omeros Warranty. Omeros warrants that:

(a) Omeros has and shall at all times throughout the term of this Agreement have the right to supply the Omeros Cell Line, the other Omeros Materials and the Omeros Information to Lonza and the necessary rights to license or permit Lonza to use the same for the purpose of the Services;
(b) Omeros has the necessary corporate authorisations to enter into this Agreement;
(c) any of the Omeros Cell Line, the other Omeros Materials, Omeros Information and Omeros Patent Rights not owned by Omeros are licensed to Omeros under a license which will permit their use by Lonza to perform the Services;
(d) to the best of Omeros' knowledge and belief, the use by Lonza of the Omeros Cell Line, other Omeros Materials, Omeros Information and Omeros Patent Rights for the Services (including without limitation the Processing of the Product) will not infringe any Intellectual Property rights of any Third Party (provided, however, that Lonza shall waive any breach of this warranty that arises if a court of competent jurisdiction determines that the use by Lonza of the Omeros Cell Line, other Omeros Materials, Omeros Information or Omeros Patent Rights for the Services infringes the Intellectual Property rights of a Third Party, provided that and for so long as Omeros actually indemnifies Lonza pursuant to Clause 9.5 below); and
(e) Omeros will promptly notify Lonza in writing if it receives or is notified of a claim from a Third Party that the Omeros Cell Line, other Omeros Materials, Omeros Information or the Omeros Patent Rights or that the use by Lonza thereof for the provision of the Services infringes any Intellectual Property rights of such Third Party.
	9.3
	Disclaimer. THE WARRANTIES EXPRESSLY SET FORTH IN THIS AGREEMENT ARE IN LIEU OF ALL OTHER WARRANTIES, AND, EXCEPT FOR THE WARRANTIES EXPRESSLY SET FORTH IN THIS AGREEMENT, ALL OTHER WARRANTIES, BOTH EXPRESS AND IMPLIED, ARE EXPRESSLY DISCLAIMED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

	9.4
	Indemnification by Lonza. Subject to Clauses 9.6, 9.7 and 9.8 below, Lonza shall defend, indemnify and hold harmless each of Omeros (including Affiliates) and its directors, officers, and employees and the successors and assigns of any of the foregoing (each an “Omeros Indemnitee”) from and against (i) any Third Party claim, loss, damage, costs and expenses (including court costs and legal fees on a full indemnity basis) arising directly out of any breach of the warranties given by Lonza in Clause 9.1 above or (ii) any Third Party claims alleging that Lonza’s use of Lonza Know-How (excluding use of Lonza Know-How with Omeros Materials or Omeros Information if such use of the Lonza Know-How would not be infringing unless used specifically with Omeros Materials or Omeros Information) infringes any rights (including without limitation any intellectual property rights) vested in a Third Party (whether or not Lonza knows or ought to have known the same) provided that there shall be excluded from this indemnity all Omeros revenue, in each case, to the extent that such claims resulted from the negligence, intentional misconduct or breach of this Agreement by the Omeros Indemnitee. Lonza shall further indemnify and maintain Omeros promptly indemnified against all Third Party claims, actions, costs, expenses (including court costs and legal fees on a full indemnity basis) or other liabilities whatsoever caused by the negligent act or omission of Lonza in the Processing and/or supply of Product.

	9.5
	Indemnification by Omeros. Subject to Clauses 9.6 and 9.7 below, Omeros shall defend, indemnify and hold harmless each of Lonza (including Affiliates) and its directors, officers, and employees

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

and the successors and assigns of any of the foregoing (each a “Lonza Indemnitee”) from and against (i) any Third Party claim, loss, damage, costs and expenses of any nature (including court costs and legal fees on a full indemnity basis), arising directly out of any breach of the warranties given by Omeros in Clause 9.2 above or (ii) any Third Party claims alleging Lonza’s use of the Omeros Cell Line, the Omeros Materials or the Omeros Information infringes any rights (including, without limitation, any intellectual property rights) vested in any Third Party (whether or not Omeros knows or ought to have known about the same) provided that for purposes of clarity there shall be excluded from this indemnity all Lonza actual or potential revenues other than those which are an integral part of any Price or fees that Omeros is obliged to pay to Lonza under this Agreement, in each case, to the extent that such claims resulted from the negligence, intentional misconduct or breach of this Agreement by the Lonza Indemnitee. Omeros shall further indemnify and maintain Lonza promptly indemnified against all Third Party claims, actions, costs, expenses (including court costs and legal fees on a full indemnity basis) or other liabilities whatsoever in respect of:
(a) any product liability in respect of Product, unless such liability is caused by the negligent act or omission of Lonza in the Processing and/or supply of Product; and
(b) any negligent or wilful act or omission of Omeros in relation to the use, Processing, storage or sale of the Product.
	9.6
	Indemnification Procedure. If a Lonza Indemnitee or Omeros Indemnitee (the “Indemnitee”) intends to claim indemnification under this Clause 9, it shall promptly notify the other Party (the “Indemnitor”) in writing of such alleged liability. The Indemnitor shall have the right to control the defence thereof with counsel of its choice as long as such counsel is reasonably acceptable to Indemnitee; provided, however, that any Indemnitee shall have the right to retain its own counsel at its own expense, for any reason, including if representation of any Indemnitee by the counsel retained by the Indemnitor would be inappropriate due to actual or potential differing interests between such Indemnitee and any other party reasonably represented by such counsel in such proceeding and provided further that the Indemnitor may not admit to any unlawful act or infringement of a Third Party’s Intellectual Property by the Indemnitee or agree to any invalidity or unenforceability of an Indemnitee’s patent rights without the indemnitee’s written consent. The Indemnitee, its employees and agents, shall reasonably cooperate with the Indemnitor and its legal representatives in the investigation of any liability covered by this Clause 9. The obligations of this Clause 9.6 shall not apply to amounts paid in settlement of any claim, demand, action or other proceeding if such settlement is effected without the consent of the Indemnitor, which consent shall not be withheld or delayed unreasonably. The failure to deliver written notice to the Indemnitor within a reasonable time after the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve the Indemnitor of any obligation to the Indemnitee under this Clause 9. It is understood that only Lonza or Omeros may claim indemnity under this Clause 9 (on its own behalf or on behalf of its Indemnitees), and other Indemnitees may not directly claim indemnity hereunder.

	9.7
	Disclaimer of Consequential Damages. Subject to the second sentence of this Clause 9.7, in no event shall either Party be liable to the other Party for incidental, indirect, special, punitive or consequential damages arising from or related to breach of this Agreement. The foregoing disclaimer of damages shall not apply in the case of (a) breach of Clause 10 (Confidentiality), (b) personal injury or death, or (c) grossly negligent or intentionally wrongful acts or omissions.

	9.8
	Limitation of Liability. Except for Lonza’s indemnification obligations under Clause 9.4 and the exceptions set forth in the second sentence of Clause 9.7 and the second sentence of this Clause 9.8, in no event shall Lonza’s liability to Omeros for direct damages arising from or related to breach of this Agreement exceed [ ***] payable under this Agreement for Services, including under any Binding Orders not yet completed, by Omeros. The foregoing limitation of liability shall not apply in the case of (a) breach of Clause 10 (Confidentiality), (b) personal injury or death, or (c) grossly negligent or intentionally wrongful acts or omissions.

10. Confidentiality
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	10.1
	Omeros acknowledges that Lonza Know-How and Lonza acknowledges that Omeros Information with which it is supplied by the other pursuant to the Agreement, and Omeros Information that Lonza generates for Omeros during the course of performing Services under this Agreement, is supplied or generated, subject to Clause 10.5, in circumstances imparting an obligation of confidence and each agrees to keep such Lonza Know-How or such Omeros Information secret and confidential and to respect the other's proprietary rights therein and not at any time for any reason whatsoever to disclose or permit such Lonza Know-How or such Omeros Information to be disclosed to any Third Party save as expressly provided herein.

	10.2
	Omeros and Lonza shall each ensure that all their respective employees, consultants, contractors and persons for whom it is responsible having access to Lonza Know-How or Omeros Information shall be subject to the same obligations of confidence and non-use as the principals pursuant to Clauses 10.1 and 10.3 and shall be bound by secrecy and non-use agreements in support of such obligations, and Omeros and Lonza may share information with such employees, consultants, contractors and persons, in accordance with the foregoing obligations, on a need-to-know basis and solely for purposes of performance under this Agreement and to permit Omeros’ development and full use of the Product in conformance with the terms of this Agreement.

	10.3
	Lonza and Omeros each undertake not to disclose or permit to be disclosed to any Third Party (including, except as provided in Clause 10.2 above, any contractors or consultants not previously approved in writing by the Parties, such approval not to be unreasonably withheld or delayed), or otherwise make use of or permit to be made use of other than for purposes of performance under this Agreement (a) any trade secrets or confidential information relating to the technology, business affairs or finances of the other, any subsidiary, holding company or subsidiary or any such holding company of the other, or of any suppliers, agents, distributors, licensees or other customers of the other which comes into its possession under this Agreement or (b) the commercial terms of this Agreement except as required to be disclosed by applicable laws or regulations; provided, however, that, except for filings required under the United States Securities Exchange Act of 1934 and applicable rules promulgated thereunder, in each case to any extent that such information is required to be disclosed pursuant to subpoena, court order, judicial process or otherwise by law, provided the receiving Party provides prompt notice to the disclosing Party of such requirement in order to give the disclosing Party an opportunity to timely seek a protective order or other appropriate judicial relief. In the event the disclosing Party is unable to obtain a protective order or other appropriate judicial relief, the receiving Party shall disclose only that portion of the disclosing Party’s confidential information which is legally required to be disclosed, and ensure that all such confidential information of the disclosing Party shall be redacted to the fullest extent permitted by law prior to such disclosure and that the disclosing Party shall be given an opportunity to review the confidential information prior to its disclosure.

	10.4
	The obligations of confidence and non-use referred to in this Clause 10 shall not extend to any information which the Party seeking to disclose such information:

(a) is or becomes generally available to the public otherwise than by reason of a breach by the receiving Party of the provisions of this Clause 10;
(b) is known to the receiving Party and is at its free disposal prior to its receipt from the disclosing Party;
(c) is subsequently disclosed to the receiving Party without being made subject to an obligation of confidence by a third Party;
(d) Lonza or Omeros may be required to disclose under any statutory, regulatory or similar legislative requirement, subject to the imposition of obligations of secrecy wherever possible in that relation; or
(e) is developed by any servant or agent of the receiving Party without access to or use or knowledge of the information by the disclosing Party.
	10.5
	The Parties acknowledge that:

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

(a) without prejudice to any other rights and remedies that the Parties may have, the Parties agree that the Lonza Know-How and Omeros Information is valuable and that damages may not be an adequate remedy for any breach of the provisions of this Clause 10. The Parties agree that the relevant Party will be entitled without proof of special damage to seek the remedies of an injunction and other equitable relief for any actual or threatened breach by the other Party;
(b) save as provided herein Lonza shall not at any time have any right, title, license or interest in or to Omeros Information, Omeros Patent Rights or any other intellectual property rights vested in Omeros or to which Omeros is entitled; and
(c) Omeros shall not at any time have any right, title, license or interest in or to Lonza Know-How, the Lonza Patent Rights or any other intellectual property rights relating to the Process which are vested in Lonza or to which Lonza is otherwise entitled.
	10.6
	Following ten (10) years after the expiration or termination of this Agreement, the Parties shall have no affirmative obligations under Clauses 10.1, 10.2 and 10.3 except with respect to trade secrets and/or know-how, for which all affirmative obligations of this Clause 10 will continue for so long as such information remains a trade secret and/or know-how under applicable law. Notwithstanding any provision to the contrary, this Clause 10.6 shall not be construed as the grant of any license or any other right to either Party to use at any time the Intellectual Property, know-how, or confidential Information of the other Party except as set forth expressly in this Agreement or in connection with the ordinary course of performance under this Agreement.

11. Audits, Inspections and Records
	11.1
	Once annually during the term of this Agreement, and subject to Lonza’s obligations of confidentiality to Third Parties, Lonza will permit Omeros to conduct one quality assurance audit of those portions of the Facilities and Quality Systems where Services are being conducted upon reasonable advance notice and at reasonable times during regular business hours, provided, however, that Omeros may conduct additional “for cause” audits following issuance of Form FDA-483s, GMP inspection reports or similar reports delivered by Regulatory Authorities to Lonza pertaining to the Processing of Product, performance of other Services for Omeros, or the occurrence of other events which are likely to adversely affect the Processing of Product or other Services for Omeros as frequently as requested by Omeros, at reasonable times and for reasonable duration, until Lonza has corrected such deficiencies and as set out further in a separate Quality Agreement. Additionally, Lonza will permit Omeros to conduct a mock pre-approval inspection audit, not to exceed three (3) days in duration or as otherwise reasonably required, in support of Regulatory Applications or cGMP Qualified Person audit to support Qualified Person batch certification.

	11.2
	Each Party shall notify the other Party promptly of any inspection or inquiry by any Regulatory Authority concerning the Lonza Facilities to the extent pertaining to processing of cell banks, drug substance or drug product, any SOW or Processing of Product and as set out further in a separate Quality Agreement. Each Party shall cooperate with Regulatory Authorities in connection with any such inspection or inquiry and shall cooperate with the other Party in providing the information needed for any response. Each Party acknowledges that it may not direct the manner in which the other Party fulfils its obligations to permit inspection by a Regulatory Authority.

	11.3
	Unless the Parties otherwise agree in writing, Lonza shall maintain materially complete and accurate batch, laboratory and other technical records related to Product for the minimum period required by Applicable Laws, in accordance with Lonza’s standard operating procedures and as set out further in the Master Batch Record and the Quality Agreement.

	11.4
	Lonza and Omeros shall allocate responsibility for complying with cGMP (if applicable) between themselves as set forth in the Quality Agreement. Each Party shall provide the other with all reasonable assistance and take all actions reasonably requested by the other to enable the requesting Party to comply with any Applicable Laws relating to the performance by a Party of its obligations hereunder.

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	11.6
	Omeros shall be solely responsible for and will obtain all permits and licenses required by any Regulatory Authority with respect to the Product and any Services under this Agreement for which Omeros is responsible, including any product licenses, applications and amendments in connection therewith. Lonza will be responsible to maintain all permits and licenses required by any Regulatory Authorities in the United States, the EU and national and local jurisdictions in which the Lonza Facility is located, with respect to the Lonza Facility generally. During the Term, Lonza will assist Omeros with all regulatory matters relating to Services under this Agreement, at Omeros’ request and at Omeros’ expense. Each Party intends and commits to cooperate to satisfy all Applicable Laws relating to Services under this Agreement.

12. Term and Termination
	12.1
	Term. This Agreement shall commence on the Effective Date and shall expire five (5) years after Launch of Product in in either US or EU territory unless terminated earlier as provided herein, or by mutual written agreement of the Parties (the “Initial Term”).

	12.1.1
	Three (3) years prior to the end of the Initial Term, Omeros shall provide written notice to Lonza if it wishes not to extend the Agreement for a further four (4) years (an “Extension Term”) and absent such notice the Agreement shall automatically extend for the further four (4) years The Initial Term and any Extension Term are together referred to herein as the “Term”.

	12.2
	If it becomes apparent to either Lonza or Omeros at any stage in the provision of the Services that it will not be possible to obtain First Approval of the Product from the Facility and written notice of such has been provided to the other Party, following such written notice a[***] day period shall be allowed for good faith discussion and attempts to resolve such problems. If such problems are not resolved within such period, Lonza and Omeros shall each have the right to terminate the Agreement forthwith by notice in writing. In the event of such termination, Omeros shall pay to Lonza all amounts owed under Purchase Orders for Batches ordered that have been cancelled by Omeros and applicable SOWs for Services performed in accordance with the SOW and this Agreement by Lonza prior to such termination (including a pro rata proportion of the Price for any stage of the Services which is in process at the date of termination) and all expenses reasonably incurred by Lonza in giving effect to such termination, including the costs of terminating any commitments entered into and in accordance the Agreement, [***].

	12.3
	The obligation to make payment under Clause 12.2 shall be reduced (retrospectively, and hence Lonza shall make an appropriate refund to Omeros) to the extent that Lonza mitigates its loss in this regard (and Lonza shall use commercially reasonable efforts to mitigate its loss and shall promptly notify Omeros of any such mitigation). This provision shall not entitle Omeros to be refunded an amount greater than that paid by Omeros to Lonza pursuant to this Clause 12 and Lonza shall be entitled to deduct from the amount due to be refunded to Omeros its reasonable personnel and associated costs in attempting to mitigate its loss.

	12.4
	For the avoidance of doubt activities relating to cGMP fermentation shall be deemed to commence with the date of removal of the vial of cells from frozen storage for the performance of the fermentation.

	12.5
	The Parties may each terminate the Agreement for cause forthwith by notice in writing to the other Party upon the occurrence of any of the following events:

(a) if the other commits a material breach of the Agreement (which shall include a breach of the warranties set out in Clause 9 above) which in the case of a breach capable of remedy is not remedied within [***] days of the receipt by the other of notice identifying the breach and requiring its remedy (reasonable efforts to cure said breach shall be made within [***] days of receipt of notice); or
(b) if the other ceases for any reason to carry on business or compounds with or convenes a meeting of its creditors or has a receiver or manager appointed in respect of all or any part of its assets or is the subject of an application for an administration order or of any proposal for a
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

voluntary arrangement or enters into liquidation (whether compulsorily or voluntarily) or undergoes any analogous act or proceedings under foreign law; or
(c) if the Product is withdrawn from US and EU markets following First Approval, any Batches ordered at the time of termination may be cancelled by Omeros and shall be subject to the termination provisions herein and any Raw Materials received or irrevocably committed shall be paid to the extent specified in the termination provisions herein.
	12.6
	Consequences of termination.

	12.6.1
	In the event of termination of this Agreement without cause by Omeros, all Services and Batches ordered pursuant to a Purchase Order shall be deemed to have been cancelled and Omeros shall pay Lonza for:

(a) all Services rendered up to the date of termination, including in respect of any Product in-process;
(b) all costs incurred through the date of termination, including Raw Materials costs and Raw Materials Fees for Raw Materials used or purchased or to which Lonza is irrevocably committed for use in connection with the Services;
(c) all unused Raw Materials and Resins shall be paid for by Omeros within [***] days of invoice and at Omeros’ option will either be: (a) held by Lonza for future use for the production of Product; (b) delivered to Omeros; or (c) disposed of by Lonza.
	12.6.2
	Termination by Lonza under Clause 12.5(a) or 12.5(b). Upon termination of this Agreement by Lonza under Clause 12.5(a) or 12.5(b), subject to Lonza’s obligations under Clause 12.7, Omeros shall pay to Lonza: (a) Termination Fees of any unpaid portions of [***]% of all Binding Orders in effect on the notification date of such termination for which Services have commenced and/or at least partial payment has been made by Omeros, less the amount of any such slots that Lonza is able to resell, (b) Termination Fees of [***]% of all Binding Orders placed but for which Services have not yet commenced and for which Omeros has not yet made any payment, less the amount of any such slots that Lonza is able to resell, and (c)  for all Services provided but not paid as of the effective date of termination (including a pro-rata proportion of the Price for any stage of the Services which is in progress at the date of the termination).

	12.6.3
	Termination by Omeros under Clause 12.5(a) or 12.5(b).  Upon termination of this Agreement by Omeros under Clause 12.5(a) or 12.5(b) all Binding Orders shall be deemed cancelled without any Termination Fees and Omeros shall have no further obligation to Lonza under this Agreement, except that Customer shall pay to Lonza: (a) for all Services not under dispute provided but not paid as of the effective date of termination (including a pro-rata proportion of the Price for any stage of the Services which is in progress at the date of the termination); and (b) the costs of any non-cancellable commitments of subcontractors and External Laboratories; and (c) all expenses reasonably incurred by Lonza in giving effect to such termination, in each case after reasonable efforts to mitigate all such expenses, including the costs of terminating any non-cancellable commitments entered into under the Agreement that cannot be cancelled despite reasonable efforts to do so or cannot be re-purposed for other customers.

12.6.4. Termination due to Market Withdrawal. If Omeros withdraws the Product from the U.S. and European Union markets or is directed to do so by any regulatory agency and as a result, Omeros or Lonza terminates the Agreement in accordance with Clause 12.5(c), then Omeros shall pay a termination fee in the amount of [***]% of the Batch Price for all Batches under a Binding Order. Lonza shall use commercially reasonable efforts to try and secure a replacement reservation from a new project, whilst observing its contractual commitments of other customers, and if it is able to secure such replacement reservation Omeros shall be relieved proportionally of its obligation to pay a termination fee.
	12.7
	Upon the termination of the Agreement for whatever reason:

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

(a) Lonza shall promptly return to Omeros all Omeros Information and shall dispose of or return to Omeros the Omeros Materials (and where supplied by Omeros the Cell Line) and any materials therefrom, as directed by Omeros;
(b) Omeros shall promptly return to Lonza all Lonza Know-How it has received from Lonza, except for that included as part of license provided for in Clauses 2.8(a), and 2.8 (b), as applicable, or as part of the license to the New General Application Intellectual Property provided for in Clause 8.4;
(c) Omeros shall not thereafter use or exploit the Lonza Patent Rights or the Lonza Know-How in any way whatsoever, except for that included as part of license provided for in Clauses 2.8(a), and 2.8 (b), as applicable, or as part of the license to the New General Application Intellectual Property provided for in Clause 8.4; and
(d) Lonza and Omeros shall do all such acts and things and shall sign and execute all such deeds and documents as the other may reasonably require to evidence compliance with this Clause 12.7.
	12.8
	Omeros will have the right upon its request, during the term of or within [***] following expiration or termination of this Agreement, to transfer the Cell Line and Process, to itself and any Third Party for the manufacture of that Product (but no other product) that:

(a) is an IP-Respecting Entity;
(b) is listed on Schedule 3 hereto, as the same may be updated from time-to-time by written agreement of the Parties; or
(c) is consented to by Lonza in writing, such consent not to be unreasonably withheld or delayed, and Lonza shall not be considered to be unreasonably withholding its consent if (inter alia) Omeros wishes to transfer the Cell Line and the Process to any legal person or entity which is not an IP-Respecting Entity;
provided always, however, to the extent such technology transfer includes Lonza‘s Confidential Information, Lonza’s Intellectual Property and/or New General Application Intellectual Property such technology transfer shall be subject to a royalty and licensing fee for the purchase of media and feeds as provided for in Clauses 2.8(a) or 2.8(b), as applicable, and at all times shall also be subject to the outline technology transfer terms set forth in Schedule 2 hereto.
Lonza shall diligently provide reasonably necessary documents to complete such technology transfer and reasonable assistance to complete such technology transfer, provided that Omeros shall reimburse Lonza for any costs based on Lonza’s standard full-time employee rate for such support which is applicable at the date of such technology transfer and the outline technology transfer terms of Schedule 2.
For purposes of clarity, the outline technology transfer terms of Schedule 2 shall not apply if Omeros transfers the Cell Line to a Third Party without any transfer of the Process.
	12.9
	Termination of this Agreement for whatever reason shall not affect the accrued rights of either Lonza or Omeros arising under or out of this Agreement and all provisions which are expressed to survive the Agreement shall remain in full force and effect.

13. Force Majeure
	13.1
	If either Party is prevented or delayed in the performance of any of its obligations under the Agreement by Force Majeure it shall give written notice thereof to the other Party specifying the matters constituting Force Majeure together with such evidence as it reasonably can give and specifying the period for which it is estimated that such prevention or delay will continue, and it shall be excused from the performance or the punctual performance of such obligations as the case may be from the date of such notice for so long as such cause of prevention or delay shall continue. The Party that may invoke this clause shall use commercially reasonable efforts to reinstate its ongoing obligations to the other Party as soon as practicable. If the cause(s) shall continue unabated for 180 days, then both Parties shall meet to discuss and negotiate in good faith what

​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

modifications to this Agreement should result from such cause(s) and if not resolvable either Party shall have the right to terminate this Agreement.
	13.2
	The expression "Force Majeure" shall be deemed to include any cause affecting the performance by a Party of the Agreement arising from or attributable to acts, events, acts of God, omissions or accidents beyond the reasonable control of the Party.

14. Governing Law, Jurisdiction and Enforceability
	14.1
	The construction, validity and performance of the Agreement shall be governed by the laws of the State of New York, USA, and Lonza and Omeros submit to the non-exclusive jurisdiction of the US Federal Courts located in the State of New York, USA.

	14.2
	No failure or delay on the part of either Lonza or Omeros to exercise or enforce any rights conferred on it by the Agreement shall be construed or operate as a waiver thereof nor shall any single or partial exercise of any right, power or privilege or further exercise thereof operate so as to bar the exercise or enforcement thereof at any time or times thereafter.

	14.3
	Any disputes relating to issues arising from this Agreement shall, in the absence of resolution within thirty (30) days of the dispute arising, be referred to the Chief Executive Officers of Omeros and Lonza, who shall discuss the matter and attempt to resolve it by mutual consent. If the Chief Executive Officers of Omeros and Lonza cannot resolve the dispute within thirty (30) days of the matter being referred to them, either Party may, by written notice to the other Party, invoke the mediation procedure set out in Clause 14.4 below.

	14.4
	If a dispute arises between the Parties that the Parties cannot resolve pursuant to Clause 14.3 above, the Parties agree to attempt in good faith to resolve such dispute by mediation administered by the CPR Institute for Dispute Resolution, 366 Madison Avenue, New York, NY 10017, in New York, New York, USA. The Parties agree that they shall share equally the cost of any mediation fees, and the cost of the mediator. Each Party must bear its own attorneys’ fees and associated costs and expenses. The place of any mediation shall be New York, New York, USA. If efforts at mediation are unsuccessful within sixty (60) days of either Party referring the dispute to mediation, then either Party may require that the dispute shall be resolved by binding arbitration in accordance with the then existing commercial arbitration rules of CPR Institute for Dispute Resolution, 366 Madison Avenue, New York, NY 10017. Arbitration shall be conducted in New York, New York, USA.

	14.5
	Nothing in this Clause 14 shall prevent a Party from exercising any right under this Agreement, including the right of termination under Clause 12 above.

15. Notices
	15.1
	Any notice or other communication to be given under this Agreement shall be delivered personally or by international express courier with delivery confirmation addressed as follows:

(a) If to Lonza to:
	​
	LONZA BIOLOGICS TUAS PTE LTD
	​

	​
	35 Tuas South Ave 6,
	​

	​
	SG Singapore, 637377
	​

​
With a copy to:
	​
	Lonza Biologics plc
	​

	​
	228 Bath Road
	​

	​
	Slough
	​

	​
	Berkshire SL1 4DX
	​

	​
	England
	​

	​
	For the attention of: The Head of Legal Services
	​

​
(b) If to Omeros to:
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

	​
	Omeros Corporation
	​

	​
	201 Elliott Avenue West
	​

	​
	Seattle, WA 98119, USA
	​

	​
	For the attention of: General Counsel
	​

	​
	With a concurrent copy by e-mail (which shall not constitute notice) to
	​

	​
	generalcounsel@omeros.com,
	​

​
or to such other destination as either Party hereto may hereafter notify to the other in accordance with the provisions of this Clause 15.
	15.2
	All such notices or other communications shall be deemed to have been served as follows:

(a) if delivered personally, at the time of such delivery;
(b) if sent by first class pre-paid post, ten (10) business days (Saturdays, Sundays and Bank or other public holidays excluded) after being placed in the post.
16. Illegality
	16.1
	If any provision or term of this Agreement or any part thereof shall become or be declared illegal, invalid or unenforceable for any reason whatsoever:

(a) such provision shall, so far as it is illegal, invalid or unenforceable, be given no effect by the Parties and shall be deemed not to be included in this Agreement;
(b) the other provisions of this Agreement shall be binding on the Parties as if such provision was not included therein; and
(c) the Parties agree to negotiate in good faith to amend such provision to the extent possible for incorporation herein in such reasonable manner as most closely achieves the intention of the Parties without rending such provision invalid or unenforceable.
17. Miscellaneous
	17.1
	Lonza shall be entitled to instruct one of more of its Affiliates to perform any of Lonza’s obligations contained in this Agreement within the same Lonza Facility in which Product is Manufactured, subject to Omeros’ approval, which shall not be unreasonably withheld or delayed, of the use of such Affiliate at any other Facility or transfer of any aspect of Manufacturing to any other of Lonza’s or its Affiliates’ Facility, with no increase in costs, but Lonza shall remain fully responsible in respect of those obligations. Subject thereto, neither Party shall be entitled to assign, transfer, charge or in any way assign, sub-contract, transfer or delegate the benefit and/or the burden of this Agreement without the prior written consent of the other which consent shall not be unreasonably withheld or delayed, save that:

(a) Lonza shall be entitled without the prior written consent of the Omeros to assign, transfer, charge, sub-contract, deal with or in any other manner make over the benefit and/or burden of this Agreement (i) to an Affiliate or (ii) to any joint venture company of which Lonza, is the beneficial owner of at least fifty percent (50%) of the issued share capital thereof or (iii) to any company with which Lonza may merge or (iv) to any company to which Lonza may transfer its assets and undertaking; provided however in each case such assignee must be an IP Respecting Entity; and
(b) Omeros shall be entitled to assign this Agreement, including all rights and obligations arising thereunder, to any Third Party that:-
(i) is an IP-Respecting Entity and is not a Competing Contract Manufacturer,
(ii) is listed on Schedule 3 hereto other than [***], as the same may be updated from time-to-time by written agreement of the Parties,
(iii) is consented to by Lonza, such consent not to be unreasonably withheld or delayed, provided that Lonza shall not be considered to be unreasonably withholding its consent if (inter alia)
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Omeros wishes to assign this Agreement to any legal person or entity which is (i) a Competing Contract Manufacturer, or (ii) not an IP-Respecting Entity; or
(iv) is in connection with the sale or transfer (by whatever method) of all or substantially all of the business related to the subject matter of this agreement; provided, further, that such Affiliate or Third Party, as applicable, acknowledges and assumes in writing all of the assigning Party’s obligations under the Agreement. For purposes of this Clause 17.1, the terms “assign” and “assignment” shall include, without limitation (i) the sale, exchange, transfer or issuance of fifty percent (50%) or more of the outstanding stock of such Party to an Affiliate of such Party or an unrelated entity or natural person, (ii) the sale or transfer or other disposition of all or substantially all of the assets of the Party or the line of business or Product to which this Agreement relates, and (iii) a merger, consolidation, acquisition or other form of business combination. Any purported assignment in violation of the foregoing shall be void. No assignment shall relieve any Party of responsibility for the performance of any obligation that accrued prior to the effective date of such assignment. Subject to the foregoing, this Agreement shall bind and inure to the benefit of the respective Parties and their successors and permitted assigns.
	17.2
	The obligations of the Parties under Clauses 2.8 (Omeros Cell Line and Lonza Process and Omeros Cell Line and Omeros Process), 8 (Intellectual Property), 9 (Warranties and Indemnification), 10 (Confidentiality), 12.6 (consequences of termination), 12.7 (Technology Transfer), 14 (Governing Law, Jurisdiction and Enforceability) and 17 (Miscellaneous) shall survive the termination of this Agreement for any reason.

	17.3
	The text of any press release or other communication to be published by or in the media concerning the subject matter of the Agreement shall require the prior written approval of Lonza and Omeros.

	17.4
	The Agreement embodies the entire understanding of Lonza and Omeros and there are no promises, terms, conditions or obligations, oral or written, expressed or implied, other than those contained in the Agreement. The terms of the Agreement shall supersede all previous agreements (if any) which may exist or have existed between Lonza and Omeros relating to the Services, except that with respect to the process validation Batches ordered by Omeros under the Development Agreement and the commercial Batches ordered by Omeros under the Development Agreement, all terms of this Agreement shall apply to such Batches except for the price of such Batches, which shall be as set forth in the Development Agreement rather than in this Agreement.

	17.5
	The Parties to this Agreement do not intend that any term hereof should be enforceable by virtue of the Contracts (Rights of Third Parties) Act 1999 by any person who is not a Party to this Agreement.

	17.6
	The relationship of the Parties is that of independent contractors, and neither Party will incur any debts or make any commitments for the other Party except to the extent expressly provided in this Agreement. Nothing in this Agreement is intended to create or will be construed as creating between the Parties the relationship of joint ventures, co-partners, employer/employee or principal and agent. Neither Party shall have any responsibility for the hiring, termination or compensation of the other Party’s employees or contractors or for any employee benefits of any such employee or contractor.

	17.7
	No variation of or addition to this Agreement or any part thereof shall be effective unless in writing and signed on behalf of both Parties. Notwithstanding the above the Parties hereby confirm that amendments to the Specification shall be effective if reduced to writing and signed by the quality and/or regulatory representative of both Parties, which quality and/or regulatory representative shall be nominated from time to time by each Party.

[Remainder of Page Intentionally Blank]
​
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

AS WITNESS the hands of the duly authorised representatives of the Parties hereto the day and year first above written.
​
​
	​

	​

	​

	​

	​

	OMEROS CORPORATION
	    
	LONZA BIOLOGICS PTE LTD

	​
	​
	​

	Signature:
	/s/ Gregory A. Demopulos
	​
	Signature:
	/s/ [***]

	Printed Name:
	Gregory A. Demopulos, M.D.
	​
	Printed Name:
	[***]

	Title:
	Chairman & CEO
	​
	Title:
	General Manager, [***]

​
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

SCHEDULE 1
PRICING
​
[***]
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

SCHEDULE 2
OUTLINE TERMS FOR TECHNOLOGY TRANSFER FROM LONZA TO CUSTOMERS
[***]
​

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

SCHEDULE 3
APPROVED THIRD PARTIES
[***]

[***] CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (A) IS NOT MATERIAL AND (B) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSEDExhibit 4.1

    

     

     

    

     

     
      

                                                                                                                                                                                            

    

     

     

    

     

    

    BMW VEHICLE LEASE TRUST 20[__]-[__]

    [___]% Asset Backed Notes, Class A-1

    [____]% Asset Backed Notes, Class A-2a

    Benchmark [plus][minus] [___]% Asset Backed Notes, Class A-2b

    [___]% Asset Backed Notes, Class A-3

    [___]% Asset Backed Notes, Class A-4

    [___]% Asset Backed Notes, Class B

    

    

    

    

    

    

    

    

    

    

    [_______________],

    as Indenture Trustee,

     

    and

     

    BMW VEHICLE LEASE TRUST 20[__]-[__],

    as Issuer

     

    

     

    

     

    

     

    

     

    

     

    FORM OF INDENTURE

     

    Dated as of [__________], 20[__]

     

     

    

     

    

    
      
 

                                                                                                                                                                                            

    

    

    

    
      
        

    

    
    
      TABLE OF CONTENTS

      Page 

        

       

        

    

    	
            ARTICLE ONE DEFINITIONS

             

            

          	
            2

          
	
            Section 1.01

          	
            Definitions

          	
            2

          
	
            Section 1.02

             

            

          	
            Interpretive Provisions.

          	
            17

          
	
            ARTICLE TWO THE NOTES

             

            

          	
            17

          
	
            Section 2.01

          	
            Form

          	
            17

          
	
            Section 2.02

          	
            Execution, Authentication and Delivery

          	
            18

          
	
            Section 2.03

          	
            Temporary Notes

          	
            18

          
	
            Section 2.04

          	
            Registration; Registration of Transfer and Exchange

          	
            19

          
	
            Section 2.05

          	
            Mutilated, Destroyed, Lost or Stolen Notes

          	
            20

          
	
            Section 2.06

          	
            Persons Deemed Owners

          	
            21

          
	
            Section 2.07

          	
            Cancellation

          	
            21

          
	
            Section 2.08

          	
            Release of Collateral

          	
            22

          
	
            Section 2.09

          	
            Book-Entry Notes

          	
            22

          
	
            Section 2.10

          	
            Notices to Clearing Agency

          	
            22

          
	
            Section 2.11

          	
            Definitive Notes

          	
            23

          
	
            Section 2.12

          	
            Authenticating Agents

          	
            23

          
	
            Section 2.13

             

            

          	
            Tax Forms.

          	
            24

          
	
            ARTICLE THREE COVENANTS

             

            

          	
            24

          
	
            Section 3.01

          	
            Payment of Principal and Interest

          	
            24

          
	
            [Section 3.01A

          	
            [Interest Rate Cap Collateral Account

          	
            24

          
	
            Section 3.02

          	
            Maintenance of Office or Agency

          	
            25

          
	
            Section 3.03

          	
            Money for Payments to be Held in Trust

          	
            25

          
	
            Section 3.04

          	
            Existence

          	
            27

          
	
            Section 3.05

          	
            Protection of Trust Estate

          	
            27

          
	
            Section 3.06

          	
            Opinions as to Trust Estate.

          	
            27

          
	
            Section 3.07

          	
            Performance of Obligations; Administration of the 20[__]-[__] SUBI Assets.

          	
            28

          
	
            Section 3.08

          	
            Negative Covenants

          	
            29

          
	
            Section 3.09

          	
            Issuer and Indenture Trustee Certificates and Reports.

          	
            30

          
	
            Section 3.10

          	
            Restrictions on Certain Other Activities

          	
            31

          
	
            Section 3.11

          	
            Notice of Defaults

          	
            32

          
	
            Section 3.12

          	
            Further Instruments and Acts

          	
            32

          
	
            Section 3.13

          	
            Delivery of 20[__]-[__] SUBI Certificate

          	
            32

          
	
            Section 3.14

          	
            Compliance with Laws

          	
            32

          
	
            Section 3.15

          	
            Issuer May Consolidate, etc., Only on Certain Terms.

          	
            32

          
	
            Section 3.16

             

            

          	
            Perfection Representations.

          	
            34

          
	
            ARTICLE FOUR SATISFACTION AND DISCHARGE

             

            

          	
            34

          
	
            Section 4.01

          	
            Satisfaction and Discharge of Indenture

          	
            34

          
	
            Section 4.02

          	
            Application of Trust Money

          	
            35

          
	
            Section 4.03

              

            

          	
            Repayment of Monies Held by Paying Agent

          	
            35

          
	
            ARTICLE FIVE INDENTURE DEFAULT

              

            

          	 	
            36

          
	
            Section 5.01

          	
            Indenture Defaults

          	
            36

          
	
            Section 5.02

          	
            Acceleration of Maturity; Waiver of Indenture Default

          	
            37

          
	
            Section 5.03

          	
            Collection of Indebtedness and Suits for Enforcement by Indenture Trustee.

          	
            38

          
	
            Section 5.04

          	
            Remedies; Priorities.

          	
            40

          

    

    

    

    

    
      ii

      
        

    

    
      TABLE OF CONTENTS

      Page

       

        

    

    	
            Section 5.05

          	
            Optional Preservation of the 20[__]-[__] SUBI Assets

          	
            42

          
	
            Section 5.06

          	
            Limitation of Suits.

          	
            42

          
	
            Section 5.07

          	
            Unconditional Rights of Noteholders to Receive Principal and Interest

          	
            43

          
	
            Section 5.08

          	
            Restoration of Rights and Remedies

          	
            43

          
	
            Section 5.09

          	
            Rights and Remedies Cumulative

          	
            43

          
	
            Section 5.10

          	
            Delay or Omission Not a Waiver

          	
            43

          
	
            Section 5.11

          	
            Control by Noteholders

          	
            43

          
	
            Section 5.12

          	
            Waiver of Past Defaults

          	
            44

          
	
            Section 5.13

          	
            Undertaking for Costs

          	
            44

          
	
            Section 5.14

          	
            Waiver of Stay or Extension Laws

          	
            44

          
	
            Section 5.15

          	
            Action on Notes

          	
            45

          
	
            Section 5.16

          	
            Performance and Enforcement of Certain Obligations.

          	
            45

          
	
            Section 5.17

             

            

          	
            Sale of Trust Estate

          	
            45

          
	
            ARTICLE SIX THE INDENTURE TRUSTEE

             

            

          	
            46

          
	
            Section 6.01

          	
            Duties of Indenture Trustee.

          	
            46

          
	
            Section 6.02

          	
            Rights of Indenture Trustee.

          	
            47

          
	
            Section 6.03

          	
            Individual Rights of Indenture Trustee

          	
            50

          
	
            Section 6.04

          	
            Indenture Trustee’s Disclaimer

          	
            50

          
	
            Section 6.05

          	
            Notice of Defaults

          	
            50

          
	
            Section 6.06

          	
            Reports by Indenture Trustee to Noteholders

          	
            50

          
	
            Section 6.07

          	
            Compensation and Indemnity

          	
            50

          
	
            Section 6.08

          	
            Replacement of Indenture Trustee

          	
            51

          
	
            Section 6.09

          	
            Successor Indenture Trustee by Merger

          	
            53

          
	
            Section 6.10

          	
            Appointment of Co-Trustee or Separate Trustee.

          	
            53

          
	
            Section 6.11

          	
            Eligibility; Disqualification

          	
            54

          
	
            Section 6.12

          	
            Indenture Trustee as Holder of 20[__]-[__] SUBI Certificate

          	
            54

          
	
            Section 6.13

          	
            Representations and Warranties of Indenture Trustee

          	
            55

          
	
            Section 6.14

          	
            Furnishing of Documents

          	
            55

          
	
            Section 6.15

             

            

          	
            Preferential Collection of Claims Against the Issuer

          	
            55

          
	
            ARTICLE SEVEN NOTEHOLDERS’ LISTS AND REPORTS

             

            

          	
            55

          
	
            Section 7.01

          	
            Issuer to Furnish Indenture Trustee Noteholder Names and Addresses

          	
            55

          
	
            Section 7.02

          	
            Preservation of Information; Communications to Noteholders.

          	
            55

          
	
            Section 7.03

             

            

          	
            Reports by Indenture Trustee

          	
            56

          
	
            ARTICLE EIGHT ACCOUNTS, DISBURSEMENTS AND RELEASES

             

            

          	
            56

          
	
            Section 8.01

          	
            Collection of Money

          	
            56

          
	
            Section 8.02

          	
            Accounts.

          	
            56

          
	
            Section 8.03

          	
            Payment Date Certificate.

          	
            58

          
	
            Section 8.04

          	
            Disbursement of Funds.

          	
            60

          
	
            Section 8.05

          	
            General Provisions Regarding Accounts.

          	
            65

          
	
            Section 8.06

             

            

          	
            Release of Trust Estate.

          	
            66

          
	
            ARTICLE NINE SUPPLEMENTAL INDENTURES

             

            

          	
            67

          
	
            Section 9.01

          	
            Supplemental Indentures Without Consent of Noteholders.

          	
            67

          
	
            Section 9.02

          	
            Supplemental Indentures With Consent of Noteholders

          	
            68

          
	
            Section 9.03

          	
            Execution of Supplemental Indentures

          	
            70

          

    

    

    

    

    
      iii

      
        

    

    
      TABLE OF CONTENTS

      Page

       

        

    

    	
            Section 9.04

          	
            Effect of Supplemental Indenture

          	
            70

          
	
            Section 9.05

          	
            Reference in Notes to Supplemental Indentures

          	
            70

          
	
            Section 9.06

             

            

          	
            Conformity with Trust Indenture Act

          	
            70

          
	
            ARTICLE TEN REDEMPTION OF NOTES

             

            

          	
            70

          
	
            Section 10.01

          	
            Redemption.

          	
            70

          
	
            Section 10.02

          	
            Form of Redemption Notice

          	
            71

          
	
            Section 10.03

             

            

          	
            Notes Payable on Redemption Date

          	
            72

          
	
            ARTICLE ELEVEN MISCELLANEOUS

             

            

          	
            72

          
	
            Section 11.01

          	
            Compliance Certificates and Opinions.

          	
            72

          
	
            Section 11.02

          	
            Form of Documents Delivered to Indenture Trustee

          	
            74

          
	
            Section 11.03

          	
            Acts of Noteholders.

          	
            74

          
	
            Section 11.04

          	
            Notices

          	
            75

          
	
            Section 11.05

          	
            Notices to Noteholders; Waiver

          	
            75

          
	
            Section 11.06

          	
            Effect of Headings and Table of Contents

          	
            76

          
	
            Section 11.07

          	
            Successors and Assigns

          	
            76

          
	
            Section 11.08

          	
            Severability

          	
            76

          
	
            Section 11.09

          	
            Benefits of Indenture

          	
            76

          
	
            Section 11.10

          	
            Legal Holidays

          	
            76

          
	
            Section 11.11

          	
            Governing Law

          	
            76

          
	
            Section 11.12

          	
            Counterparts

          	
            76

          
	
            Section 11.13

          	
            Recording of Indenture

          	
            77

          
	
            Section 11.14

          	
            Trust Obligation

          	
            77

          
	
            Section 11.15

          	
            No Petition

          	
            77

          
	
            Section 11.16

          	
            No Recourse

          	
            77

          
	
            Section 11.17

          	
            Inspection

          	
            78

          
	
            Section 11.18

          	
            Limitation of Liability of Owner Trustee

          	
            78

          
	
            Section 11.19

          	
            TIA Incorporation and Conflicts

          	
            78

          
	
            Section 11.20

          	
            Intent

          	
            79

          
	
            Section 11.21

          	
            Intent of Parties; Reasonableness

          	
            79

          
	
            Section 11.22

             

            

          	
            Communications with Rating Agencies

          	
            79

          
	
            ARTICLE TWELVE ASSET REPRESENTATIONS REVIEW

              

            

          	
            80

          
	
            Section 12.01

          	
            Noteholder and Note Owner Requests for Vote on Asset Representations Review

          	
            80

          
	
            Section 12.02

          	
            Noteholder and Note Owner Vote on Asset Representations Review

          	
            80

          
	
            Section 12.03

          	
            Evaluation of Review Report

          	
            81

          
	
            Section 12.04

          	
            Dispute Resolution

          	
            81

          
	 	 	 

    

    

    	
            SCHEDULES

          
	
            Schedule I

             

            

          	
            Perfection Representations, Warranties and Covenants

          	
            I-1

          
	
            EXHIBITS

          	 	 
	
            Exhibit A

          	
            Form of Class A Note

          	
            A-1

          
	
            Exhibit B

          	
            Form of Class B Note

          	
            B-1

          
	
            Exhibit C

          	
            Servicing Criteria to be Addressed in the Indenture Trustee’s Assessment of Compliance

          	
            C-1

          

    

    

     

    
      iv

      
        

    

    INDENTURE

     

    This Indenture, dated as of [__________], 20[__], is between BMW Vehicle Lease Trust 20[__]-[__], a Delaware statutory trust (the “Issuer”), and
      [_________________], a [____________], as indenture trustee (the “Indenture Trustee”).

     

    Each party agrees as follows for the benefit of the other parties and for the equal and ratable benefit of the holders of the Issuer’s [____]% Asset
      Backed Notes, Class A-1 (the “Class A-1 Notes”), [____]% Asset Backed Notes, Class A-2a (the “Class A-2a Notes”), Benchmark [plus][minus] [____]% Asset Backed Notes, Class A-2b (the “Class A-2b Notes” and, together with the Class A-2a Notes, the
      “Class A-2 Notes”), [____]% Asset Backed Notes, Class A-3 (the “Class A-3 Notes”), [____]% Asset Backed Notes, Class A-4 (the “Class A-4 Notes” and, together with the Class A-1 Notes, the Class A-2 Notes and the Class A-3 Notes, the “Class A Notes”)
      and [____]% Asset Backed Notes, Class B (the “Class B Notes” and, together with the Class A Notes, the “Notes”):

     

    GRANTING CLAUSE

     

    The Issuer, to secure the payment of principal of and interest on, and any other amounts owing in respect of, the Notes, equally and ratably without
      prejudice, priority or distinction except as set forth herein, and to secure compliance with the provisions of this Indenture, hereby Grants in trust to the Indenture Trustee on the Closing Date, as trustee for the benefit of the Noteholders, all of
      the Issuer’s right, title and interest, whether now owned or hereafter acquired, in and to (i) the Trust Estate and (ii) all present and future claims, demands, causes and choses in action in respect of any or all of the foregoing and all payments on
      or under and all proceeds of every kind and nature whatsoever in respect of any or all of the foregoing, including all proceeds of the conversion, voluntary or involuntary, into cash or other liquid property, all cash proceeds, accounts, accounts
      receivable, notes, drafts, acceptances, chattel paper, checks, deposit accounts, insurance proceeds, condemnation awards, rights to payment of any and every kind and other forms of obligations and receivables, instruments, securities, financial
      assets and other property that at any time constitute all or part of or are included in the proceeds of any of the foregoing (collectively, the “Collateral”), in each case as such terms are defined herein.

     

    The foregoing Grant is made in trust to secure the payment of principal of and interest on, and any other amounts owing in respect of, the Notes, equally
      and ratably without prejudice, priority or distinction, [to secure amounts owing to each Swap Counterparty under the related Swap Agreement] and to secure compliance with the provisions of this Indenture, all as provided in this Indenture.

     

    The Indenture Trustee, as trustee on behalf of the Noteholders [and each Swap Counterparty], acknowledges the foregoing Grant, accepts the trusts under
      this Indenture in accordance with the provisions of this Indenture and agrees to perform its duties required in this Indenture in accordance with the terms set forth herein.

     

    
      
        

    

    
    

    

    ARTICLE ONE

      

      DEFINITIONS

     

    Section 1.01      Definitions.  Capitalized terms used herein that are not
      otherwise defined shall have the meanings ascribed thereto in the SUBI Trust Agreement or the Servicing Agreement, as the case may be.  Whenever used herein, unless the context otherwise requires, the following words and phrases have the following
      meanings:

     

    “Accounts” means the Note Distribution Account and the Reserve Fund.

     

    “Accrual Period” means, (i) with respect to any Payment Date and the Class
      A-1 Notes and Class A-2b Notes, the period from and including the previous Payment Date (or, in the case of the first Payment Date, from and including the Closing Date) to, but excluding, the related Payment Date, and (ii) with respect to any Payment
      Date and the Class A-2a Notes, Class A-3 Notes, Class A-4 Notes and Class B Notes, the period from and including the [_] day of the month in which the preceding Payment Date occurred (or, in the case of the first Payment Date, from and including the
      Closing Date) to but excluding the [_] day of the month in which such Payment Date occurs.

     

    “Act” has the meaning set forth in Section 11.03(a).

     

    “Administrator” means BMW FS, or any successor Administrator under the
      Issuer Administration Agreement.

     

    “Affiliate” means, for any specified Person, any other Person which,
      directly or indirectly, controls, is controlled by or is under common control with such specified Person and “affiliated” has a meaning correlative to the foregoing. For purposes of this definition, “control” means the power, directly or indirectly,
      to cause the direction of the management and policies of a Person.

     

    “Aggregate Securitization Value” means for any date the amount calculated as
      of the close of business on such date equal to the sum of the Securitization Values of all 20[__]-[__] Leases.

     

    “Asset Representations Reviewer Fee” means (i) an annual fee equal to
      $[_____], payable on the Payment Date occurring in [______] of each year, commencing in 20[__], and (ii) $[__] for each ARR Lease reviewed by it in accordance with the terms of the Asset Representations Review Agreement.

     

    “Authenticating Agent” means any Person authorized by the Indenture Trustee
      to act on behalf of the Indenture Trustee to authenticate and deliver the Notes.

     

    “Authorized Newspaper” means a newspaper of general circulation in The City
      of New York, printed in the English language and customarily published on each Business Day, whether or not published on Saturdays, Sundays and holidays.

     

    
      2

      
        

    

    

    

    “Authorized Officer” means, with respect to the Issuer, (i) any officer of
      the Owner Trustee who is authorized to act for the Owner Trustee in matters relating to the Issuer and who is identified on the list of Authorized Officers delivered by the Owner Trustee to the Indenture Trustee on the Closing Date and (ii) so long
      as the Issuer Administration Agreement is in effect, any of the following officers of the Administrator, each of whom is authorized to act for the Administrator in matters relating to the Issuer pursuant to the Issuer Administration Agreement: the
      President, any Vice President, the Treasurer, any Assistant Treasurer, the Secretary and any Assistant Secretary.

     

    “Available Funds” means, for any Payment Date and the related Collection
      Period, the sum of the following amounts: (i) SUBI Collections, (ii) Advances actually made by the Servicer, (iii) in the case of an Optional Purchase, the Optional Purchase Price and (iv) net investment earnings on amounts on deposit in the
      20[__]-[__] SUBI Collection Account.

     

    “Available Funds Shortfall Amount” means, for any Payment Date and the
      related Collection Period, the sum of (x) the amount by which Securityholder Available Funds is less than the amount necessary to make the distributions in clauses (i), (ii) and (iii) of Section 8.04(a) and (y) the amount by which Available Funds is
      less than the amount necessary to make the distributions in Sections 2.4(b)(i) and 2.4(b)(ii) of the Servicing Agreement.

     

     

    “Back-Up Security Agreement” means that certain back-up security agreement,
      dated as of [__________], 20[__], among the Vehicle Trust, the UTI Beneficiary, the Transferor, the Issuer and the Indenture Trustee, as amended or supplemented from time to time.

     

    “Basic Servicing Agreement” means that certain Servicing Agreement, dated as
      of August 30, 1995, between BMW FS, as servicer, BMW Manufacturing L.P. and Financial Services Vehicle Trust.

     

    [“Benchmark” means, initially, [insert floating rate benchmark applicable to
      any floating rate notes].  [Note: the Indenture with respect to any Series which includes floating rate notes will include additional defined terms, as applicable, with
        respect to the related benchmark and any benchmark replacement.]

     

    “BMW FS” means BMW Financial Services NA, LLC, and its successors.

     

    “Book-Entry Notes” means a beneficial interest in the Notes, ownership and
      transfers of which shall be made through book entries by a Clearing Agency as described in Section 2.09.

     

    “Business Day” means any day other than a Saturday, a Sunday or a day on
      which banking institutions in the states of Delaware, [___], [___], New Jersey, Ohio or New York are authorized or obligated by law, executive order or government decree to be closed.

     

    “Certificate Distribution Amount” means, as of any Payment Date, the amount
      being distributed to the Trust Certificateholders on such Payment Date.

     

     

    “Class” means a group of Notes whose form is identical except for variation
      in denomination, principal amount or owner, and references to “each Class” thus mean each of the

     

    
      3

      
        

    

    

    

     

    Class A-1 Notes, the Class A-2a Notes, the Class A-2b Notes, the Class A-3 Notes, the Class A-4 Notes and the Class B Notes.

     

     

    “Class A-1 Interest Rate” means [____]% per annum (computed on the basis of
      the actual number of days elapsed, but assuming a 360-day year).

     

    “Class A-2a Interest Rate” means [____]% per annum (computed on the basis of
      a 360-day year of twelve 30-day months).

     

    “Class A-2b Interest Rate” means, with respect to any Payment Date, the
      Benchmark for the related Payment Date, [plus][minus] [____]% per annum (computed on the basis of the actual number of days elapsed, but assuming a 360-day year).

     

     “Class A-3 Interest Rate” means [____]% per annum (computed on the basis of
      a 360-day year of twelve 30-day months).

     

    “Class A-4 Interest Rate” means [____]% per annum (computed on the basis of
      a 360-day year of twelve 30-day months).

     

    “Class B Interest Rate” means [____]% per annum (computed on the basis of a
      360-day year of twelve 30-day months).

     

    “Class A-1 Note Balance” means, as of any date, the Initial Class A-1 Note
      Balance reduced by all payments of principal made on or prior to such date on the Class A-1 Notes.

     

    “Class A-2a Note Balance” means, as of any date, the Initial Class A-2a Note
      Balance reduced by all payments of principal made on or prior to such date on the Class A-2a Notes.

     

    “Class A-2b Note Balance” means, as of any date, the Initial Class A-2b Note
      Balance reduced by all payments of principal made on or prior to such date on the Class A-2b Notes.

     

    “Class A-3 Note Balance” means, as of any date, the Initial Class A-3 Note
      Balance reduced by all payments of principal made on or prior to such date on the Class A-3 Notes.

     

    “Class A-4 Note Balance” means, as of any date, the Initial Class A-4 Note
      Balance reduced by all payments of principal made on or prior to such date on the Class A-4 Notes.

     

    “Class B Note Balance” means, as of any date, the Initial Class B Note
      Balance reduced by all payments of principal made on or prior to such date on the Class B Notes.

     

    “Clearing Agency” means an organization registered as a “clearing agency”
      pursuant to Section 17A of the Exchange Act and shall initially be DTC.

     

    “Clearing Agency Participant” means a broker, dealer, bank or other
      financial institution or other Person for which from time to time a Clearing Agency effects book-entry transfers and pledges of securities deposited with the Clearing Agency.

     

    “Closing Date” means [__________], 20[__].

     

    
      4

      
        

    

    

    

    “Code” means the Internal Revenue Code of 1986, as amended.

     

    “Collateral” has the meaning set forth in the Granting Clause.

     

    “Commission” means the U.S. Securities and Exchange Commission.

     

    “Corporate Trust Office” means the office of the Indenture Trustee at which
      at any particular time its corporate trust business shall be administered, which office at the date of the execution of this Indenture is located at (i) solely for the purposes of the transfer, surrender or exchange of the Notes,
      [________________________], and (ii) for all other purposes, [_______________________], Attention: [_________________];  or at such other address as the Indenture Trustee may designate from time to time by notice to the Noteholders and the Issuer, or
      the principal corporate trust office of any successor Indenture Trustee (the address of which the successor Indenture Trustee shall notify the Noteholders and the Issuer).

     

    “Daily Advance Reimbursements” means with respect to any Monthly Payment
      Advance made by the Servicer the amounts collected and netted on an ongoing basis from SUBI Collections by the Servicer to repay Monthly Payment Advance amounts where a Monthly Payment Advance amount has been recovered from a subsequent payment made
      by the related Lessee in respect of the Monthly Payment for which a Monthly Payment Advance was made.

     

    “Default” means any occurrence that is, or with notice or lapse of time or
      both would become, an Indenture Default.

     

    “Definitive Note” means a definitive fully registered Note.

     

    “Deposit Date” means the Business Day immediately preceding the related
      Payment Date.  So long as all the applicable accounts are held by [_________________], the Indenture Trustee may (but shall not be required to) treat the Deposit Date as the same day as the Payment Date for purposes of disbursing funds from the
      20[__]-[__] SUBI Collection Account to the applicable accounts in accordance with this Indenture.

     

    “Depository Agreement” means the representation letter delivered by the
      Issuer to DTC, as the initial Clearing Agency, dated as of the Closing Date.

     

    “Disposition Expenses” means expenses and other amounts reasonably incurred
      by the Servicer in connection with the sale or other disposition of a Matured Vehicle, a Defaulted Vehicle or a 20[__]-[__] Vehicle related to an Early Termination Lease, including but not limited to sales commissions, and expenses incurred in
      connection with making claims under any Contingent and Excess Liability Insurance Policy or other applicable insurance policies.  Disposition Expenses will be reimbursable to the Servicer from amounts otherwise included in Sales Proceeds, Insurance
      Proceeds and Termination Proceeds.

     

    “DTC” means The Depository Trust Company, and its successors.

     

    “Eligible Institution” means (a) a bank or depository institution organized
      under the laws of the United States or any state thereof or any United States branch or agency of a foreign bank or depository institution that (i) is subject to supervision and examination by federal or state

     

    
      5

      
        

    

    

    

    banking authorities, (ii) has a short-term unsecured debt rating or certificate of deposit rating of at least “[_]” from [___] and “[_]” from [___] (or any other ratings,
      subject to satisfaction of the Rating Agency Condition with respect thereto), (iii) if the institution holds the related account other than as segregated trust account and the deposits are to be held in the accounts more than 30 days, has a long-term
      unsecured debt rating or issuer rating of at least “[_]” from [___] (if rated by [___]) (or any other ratings, subject to satisfaction of the Rating Agency Condition with respect thereto) and (iv) if the institution is organized under the laws of the
      United States, whose deposits are insured by the Federal Deposit Insurance Corporation, or (b) the corporate trust department of any bank or depository institution organized under the laws of the United States or any state thereof or any United
      States branch or agency of a foreign bank or depository institution that is subject to supervision and examination by federal or state banking authorities that (i) is authorized under those laws to act as a trustee or in any other fiduciary capacity
      and (ii) has a long-term deposit rating of at least “[_]” from [___] and at least “[_]” from [___] (or any other ratings, subject to satisfaction of the Rating Agency Condition with respect thereto).

     

    “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     

    “Executive Officer” means, with respect to any (i) corporation or depository
      institution, the Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, President, Executive Vice President, any Vice President, the Secretary or the Treasurer of such corporation or depository institution, and (ii) any
      partnership, any general partner thereof.

     

    “FATCA” means Sections 1471 through to 1474 of the Code, any current or
      future regulations or official interpretations thereunder or thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code, any published intergovernmental agreement entered into in connection with the implementation the foregoing
      and any fiscal or regulatory legislation, rules or official practices adopted pursuant to such published intergovernmental agreement.

     

    “FATCA Withholding Tax” means any withholding or deduction required pursuant
      to FATCA.

     

    “FDIC” means Federal Deposit Insurance Corporation and any successor
      thereof.

     

    “First Priority Principal Distribution Amount” means, with respect to any
      Payment Date, an amount not less than zero, equal to (a) the aggregate principal amount of the Outstanding Notes as of the preceding Payment Date (after giving effect to any principal payments made on the Class A Notes on that preceding Payment
      Date), minus (b) the Aggregate Securitization Value at the end of the Collection Period preceding that Payment Date; provided, however, that the First Priority Principal Distribution Amount on and after the Final Scheduled Payment Date of any Class
      of the Class A Notes will not be less than the amount that is necessary to reduce the aggregate outstanding principal amount of that Class of Class A Notes to zero.

     

    “[______]” means [_________].

     

     “Force Majeure” means any delay or failure in performance caused by acts
      beyond the applicable party’s reasonable control, including, but not limited to, acts of God, war, epidemics or pandemics, vandalism, sabotage, accidents, fires, floods, strikes, labor disputes, mechanical breakdown, shortages or delays in obtaining
      suitable parts or equipment, material, labor, or

     

    
      6

      
        

    

    
    

    

    transportation, acts of subcontractors, interruption of utility services, acts of any unit of government or governmental agency, or any similar or dissimilar cause.

     

    “Grant” means mortgage, pledge, bargain, sell, warrant, alienate, remise,
      release, convey, assign, transfer, create and grant a lien upon and a security interest in and right of set-off against, deposit, set over and confirm pursuant to this Indenture, and, with respect to the Collateral or any other agreement or
      instrument, shall include all rights, powers and options (but none of the obligations) of the granting party thereunder, including the immediate and continuing right to claim for, collect, receive and give receipt for principal and interest payments
      in respect of the Collateral and all other monies payable thereunder, to give and receive notices and other communications, to make waivers or other agreements, to exercise all rights and options, to bring Proceedings in the name of the granting
      party or otherwise and generally to do and receive anything that the granting party is or may be entitled to do or receive thereunder or with respect thereto.

     

    “Hague Securities Convention” means The Convention on the Law Applicable to
      Certain Rights in Respect of Securities Held with an Intermediary (Concluded 5 July 2006), which became effective in the United States of America on April 1, 2017.

    

    

    “Indenture” means this Indenture, as amended or supplemented from time to
      time.

     

    “Indenture Default” has the meaning set forth in Section 5.01.

     

    “Indenture Trustee Fee” means an annual fee equal to $[_____], payable on
      the Payment Date occurring in [__________] of each year, commencing in 20[__].

     

    “Independent” means, when used with respect to any specified Person, that
      such Person (i) is in fact independent of the Issuer, any other obligor upon the Notes, the Administrator and any Affiliate of any of the foregoing Persons, (ii) does not have any direct financial interest or any material indirect financial interest
      in the Issuer, any such other obligor, the Administrator or any Affiliate of any of the foregoing Persons and (iii) is not connected with the Issuer, any such other obligor, the Administrator or any Affiliate of any of the foregoing Persons as an
      officer, employee, promoter, underwriter, trustee, partner, director or Person performing similar functions.

     

    “Independent Certificate” means a certificate or opinion to be delivered to
      the Indenture Trustee under the circumstances described in, and otherwise complying with, the applicable requirements of Section 11.01(b), made by an Independent appraiser or other expert appointed by an Issuer Order, and such opinion or certificate
      shall state that the signer has read the definition of “Independent” in this Indenture and that the signer is Independent within the meaning thereof.

     

    “Initial Class A-1 Note Balance” means $[___________].

     

    “Initial Class A-2a Note Balance” means $[___________].

     

    “Initial Class A-2b Note Balance” means $[___________].

     

    

    
      7

      
        

    

     

    “Initial Class A-3 Note Balance” means $[___________].

     

    “Initial Class A-4 Note Balance” means $[___________].

     

    “Initial Class B Note Balance” means $[___________].

     

    “Initial Deposit” has the meaning set forth in the Trust Agreement.

     

    “Initial Note Balance” means the sum of the Initial Class A-1 Note Balance,
      the Initial Class A-2a Note Balance, the Initial Class A-2b Note Balance, the Initial Class A-3 Note Balance, the Initial Class A-4 Note Balance and the Initial Class B Note Balance.

     

    “Interest Rate” means the Class A-1 Interest Rate, Class A-2a Interest Rate,
      Class A-2b Interest Rate, Class A-3 Interest Rate, Class A-4 Interest Rate or Class B Interest Rate, as applicable.

     

    “Issuer” means the BMW Vehicle Lease Trust 20[__]-[__], until a successor
      replaces it and, thereafter, means the successor and, for purposes of any provision contained herein, each other obligor on the Notes.

     

    “Issuer Administration Agreement” means that certain issuer administration
      agreement, dated as of the date hereof, among the Administrator, the Issuer, the Transferor and the Indenture Trustee, as amended or supplemented from time to time.

     

    “Issuer SUBI Certificate Transfer Agreement” means that certain issuer SUBI
      certificate transfer agreement, dated as of [__________], 20[__], between the Transferor, as transferor, and the Issuer, as transferee, as amended or supplemented from time to time.

     

    “Issuer Order” and “Issuer Request” means a written order or request of the Issuer signed in the name of the Issuer by any one of its Authorized Officers and delivered to the Indenture Trustee.

     

    “Lessee” means the lessee of a 20[__]-[__] Vehicle.

     

    “Monthly Payment Advance” means with respect to a 20[__]-[__] Lease, the
      amount advanced by the Servicer to the Issuer on the Business Day immediately preceding the related Payment Date equal to the unpaid Monthly Payment due from the related Lessee.

     

    “[_____]” means [_________].

     

     “Note” means a Class A-1 Note, Class A-2a Note, Class A-2b Note, Class A-3
      Note, Class A-4 Note or Class B Note, in each case substantially in the form of Exhibit A and Exhibit B hereto.

     

    “Note Balance” means the sum of the Class A-1 Note Balance, the Class A-2a
      Note Balance, the Class A-2b Note Balance, the Class A-3 Note Balance, the Class A-4 Note Balance and the Class B Note Balance.

     

    
      8

      
        

    

    

    

    “Note Distribution Account” means the trust account established by the
      Indenture Trustee on behalf of the Noteholders pursuant to Section 8.02, into which amounts released from the 20[__]-[__] SUBI Collection Account and the Reserve Fund for distribution to Noteholders shall be deposited and from which all distributions
      to Noteholders shall be made.

     

    “Note Distribution Amount” means, as of any Payment Date, the amount being
      distributed to the Noteholders on such Payment Date.

     

    “Note Final Scheduled Payment Date” means the Payment Date occurring, with
      respect to (i) a Class A-1 Note, in [_________] 20[__]; (ii) a Class A-2a Note, in [_________] 20[__]; (iii) a Class A-2b Note, in [_________] 20[__], (iv) a Class A-3 Note, in [_________] 20[__]; (v) a Class A-4 Note, in [_________] 20[__]; and (vi)
      a Class B Note, in [_________] 20[__].

     

    “Note Factor” means, with respect to each class of Notes on any Payment
      Date, the two digit decimal equivalent of a fraction the numerator of which is the remaining outstanding principal balance of that class of Notes on such Payment Date (after giving effect to any payment of principal on such Payment Date) and the
      denominator of which is the initial outstanding principal balance of that class of Notes.

     

    “Noteholder” means, as of any date, the Person in whose name a Note is
      registered on the Note Register on such date.

     

    “Note Owner” means, with respect to a Book-Entry Note, the Person who is the
      beneficial owner of such Book-Entry Note, as reflected on the books of the Clearing Agency or a Person maintaining an account with such Clearing Agency (directly as a Clearing Agency Participant or as an indirect participant, in each case in
      accordance with the rules of such Clearing Agency).

     

    “Note Register” and “Note Registrar” have the respective meanings set forth in Section 2.04.

     

    “Officer’s Certificate” means a certificate signed by an Authorized Officer
      of the Issuer, under the circumstances described in, and otherwise complying with, the applicable requirements of Section 11.01, and delivered to, the Indenture Trustee.

     

    “Opinion of Counsel” means one or more written opinions of counsel who may,
      except as otherwise expressly provided in this Indenture, be employees of or counsel to the Issuer or the Administrator, and who shall be satisfactory to the Indenture Trustee, and which opinion or opinions shall be addressed to the Indenture
      Trustee, comply with any applicable requirements of Section 11.01 and be in form and substance satisfactory to the Indenture Trustee.  Opinions of Counsel need address matters of law only, and may be based upon stated assumptions as to relevant
      matters of fact.

     

    “Optional Purchase” has the meaning set forth in Section 10.01(a).

     

    “Optional Purchase Price” has the meaning set forth in Section 10.01(a).

     

    
      9

      
        

    

    

    

    “Outstanding” means, as of any date, all Notes (or all Notes of an
      applicable Class) theretofore authenticated and delivered under this Indenture except:

     

    (i)            Notes (or Notes of an applicable Class) theretofore cancelled by the Note Registrar or delivered to the Note Registrar for cancellation;

     

    (ii)            Notes (or Notes of an applicable Class) or portions thereof the payment for which money in the necessary amount has been theretofore deposited with the Indenture Trustee or any Paying Agent
        in trust for the related Noteholders (provided, however, that if such Notes are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor, satisfactory to the Indenture Trustee, has been made);
        and

     

    (iii)            Notes (or Notes of an applicable Class) in exchange for or in lieu of other Notes (or Notes of such Class) that have been authenticated and delivered pursuant to this Indenture unless proof
        satisfactory to the Indenture Trustee is presented that any such Notes are held by a bona fide purchaser;

     

    provided, that in determining whether Noteholders holding the requisite Outstanding Amount have given any request, demand, authorization, direction, notice, consent or
      waiver hereunder or under any Basic Document, Notes owned by the Issuer, the Transferor, the Sponsor, the Servicer (so long as BMW FS or one of its affiliates is the Servicer) or any of their respective Affiliates shall be disregarded and deemed not
      to be Outstanding, except that, in determining whether the Indenture Trustee shall be protected in relying upon any such request, demand, authorization, direction, notice, consent or waiver, only Notes that a Responsible Officer knows to be so owned
      shall be so disregarded.  Notes so owned that have been pledged in good faith may be regarded as Outstanding if the pledgee thereof establishes to the satisfaction of the Indenture Trustee such pledgee’s right so to act with respect to such Notes and
      that such pledgee is not the Issuer, the Transferor, the Administrator or any of their respective Affiliates.

     

    “Outstanding Amount” means, as of any date, the aggregate initial principal
      amount of the applicable Notes Outstanding, reduced by all payments of principal made in respect thereof on or prior to such date.

     

    “Overcollateralization Target Amount” means an amount equal to [(i) for any
      Payment Date on or prior to the date on which the aggregate Outstanding Amount of the Class A-2a Notes and the Class A-2b Notes has been paid in full,] [____]% of the Aggregate Securitization Value of the 20[__]-[__] Leases as of the Cutoff Date[,
      and (ii) for any Payment Date after the date on which the aggregate Outstanding Amount of the Class A-2a Notes and the Class A-2b Notes has been paid in full, [____]% of the Aggregate Securitization Value of the 20[__]-[__] Leases as of the Cutoff
      Date].

     

    “Overdue Interest Rate” means, with respect to any Class, the Interest Rate
      applicable to such Class.

     

    “Owner Trustee Fee” means an annual fee equal to $[_______], payable on the
      Payment Date occurring in [__________] of each year, commencing in 20[__].

     

    
      10

      
        

    

    

    

    “Paying Agent” means the Indenture Trustee or any other Person that meets
      the eligibility standards for the Indenture Trustee set forth in Section 6.11 and is authorized by the Issuer to make the payments to and distributions from the Note Distribution Account, including the payment of principal of or interest on the Notes
      on behalf of the Issuer.

     

    “Payment Date” means the [__] day of each month or, if such day is not a
      Business Day, the next succeeding Business Day, beginning in [__________] 20[__].

     

    “Payment Date Certificate” has the meaning set forth in Section 8.03(a).

     

    “Permitted Investments” means, at any time, any one or more of the following
      instruments, obligations and securities, generally having original or remaining maturities of 30 days or less, but in no event occurring later than the Payment Date next occurring after the Indenture Trustee acquires the investments, which evidence:

     

    (a)            direct obligations of, and obligations fully guaranteed as to the full and timely payment by, the United States of America;

     

    (b)            demand deposits, time deposits or certificates of deposit of any depository institution, including the Indenture Trustee acting in its commercial capacity, or trust company incorporated under the laws of the United
        States of America or any state thereof (or any domestic branch of a foreign bank) and subject to supervision and examination by federal or state banking or depository institution authorities; provided, however, that at the time of the investment or
        contractual commitment to invest therein, the commercial paper or other short-term unsecured debt obligations (other than such obligations the rating of which is based on the credit of a person other than such depository institution or trust
        company) thereof shall have a short-term deposit rating of at least “[_]” from [___] and “[_]” from [___] (or any other ratings, subject to satisfaction of the Rating Agency Condition with respect thereto);

     

    (c)            repurchase obligations held by the Vehicle Trustee with respect to any security that is a direct obligation of, or fully guaranteed by, the United States of America or any agency or instrumentality thereof the
        obligations of which are backed by the full faith and credit of the United States of America, in either case entered into with a depository institution or trust company (acting as principal) described in clause (b) above;

     

    (d)            securities bearing interest or sold at a discount issued by any corporation incorporated under the laws of the United States or any state thereof, including the Indenture Trustee acting in its commercial capacity,
        so long as at the time of such investment or contractual commitment providing for such investment either (i) the long-term, unsecured debt of such corporation has a rating of at least “[_]” from [___] and at least “[_]” from [___] (or any other
        ratings, subject to satisfaction of the Rating Agency Condition with respect thereto) or (ii) the commercial paper or other short-term debt of such corporation has a rating of at least “[_]” from [___] and “[_]” from [___] (or any other ratings,
        subject to satisfaction of the Rating Agency Condition with respect thereto);

     

    (e)            investments of proceeds maintained in sweep accounts, short-term asset management accounts and the like utilized for the commingled investment, on an overnight

     

    
      11

      
        

    

    

    

    basis, of residual balances in investment accounts maintained at the Vehicle Trustee or any Affiliate thereof; and

     

    (f)            any other money market, common trust fund or obligation, or interest bearing or other security or investment (including those managed or advised by the Indenture Trustee or any Affiliate thereof) (A) rated in the
        highest rating category by each Rating Agency or (B) that has a long-term debt rating of at least (i) “[_]” from [___] [(or any other rating subject to receipt by the Indenture Trustee of written notification from S&P that investments of such
        type at such other minimum rating will not result in S&P reducing, withdrawing or qualifying its then existing rating of the Notes)] and (ii) “[_]” from [___].  Such investments in this subsection (f) may include money market mutual funds or
        common trust funds, including any fund for which [_________________], in its capacity other than as the Indenture Trustee, or an Affiliate thereof serves as an investment advisor, administrator, shareholder, servicing agent, and/or custodian or
        subcustodian, notwithstanding that (x) [_________________], the Indenture Trustee or any Affiliate thereof charges and collects fees and expenses from such funds for services rendered, (y) [_________________], the Indenture Trustee or any Affiliate
        thereof charges and collects fees and expenses for services rendered pursuant to the Indenture, and (z) services performed by the Indenture Trustee for such funds and pursuant to the Indenture may converge at any time.  [_________________] or an
        Affiliate thereof is hereby authorized to charge and collect from the Indenture Trustee such fees as are collected from all investors in such funds for such services rendered to such funds (but not to exceed investment earnings thereon).

     

    Each of the foregoing criteria may be amended, modified, or deleted and additional criteria may be added to this definition by the Depositor upon the satisfaction of the
      Rating Agency Condition with respect thereto.

     

    “Person” means any individual, corporation, estate, partnership, joint
      venture, association, joint stock company, trust (including any beneficiary thereof), unincorporated organization or government or any agency or political subdivision thereof.

     

    “Plan” has the meaning set forth in Section 2.04.

     

    “Predecessor Note” means, with respect to any particular Note, every
      previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purpose of this definition, any Note authenticated and delivered under Section 2.05 in lieu of a mutilated, destroyed, lost or stolen
      Note shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Note.

     

    “Principal Distribution Amount” means, for any Payment Date, to the extent
      of funds available for payment, the sum of the First Priority Principal Distribution Amount and the Regular Principal Distribution Amount not to exceed the outstanding Note Balance.

     

    “Proceeding” means any suit in equity, action at law or other judicial or
      administrative proceeding.

     

    “PTE” has the meaning set forth in Section 2.04.

     

    
      12

      
        

    

    

    

    “Rating Agency” means, for so long as such entity is rating a Class of
      Notes, each of [______] and [______].

     

    “Rating Agency Condition” means, with respect to each Rating Agency and any
      event or circumstance or proposed amendment or supplement to a Basic Document, the satisfaction of either of the following conditions, according to the then-current policies of such Rating Agency: (a) receipt of written confirmation from such Rating
      Agency (which, for the avoidance of doubt and without limitation, may be in the form of a letter, a press release or other publication, or a change in such Rating Agency’s published ratings criteria to this effect) that such event or circumstance or
      proposed amendment or supplement will not result in the qualification, reduction or withdrawal by such Rating Agency of its then-current rating of any Class of Notes; or (b) such Rating Agency shall have been given notice of such event or
      circumstance or proposed amendment or supplement at least ten (10) days (or such shorter period as is practicable or acceptable to such Rating Agency) prior to the occurrence of such event or circumstance or proposed amendment or supplement and such
      Rating Agency shall not have confirmed in writing that such   event or circumstance or proposed amendment or supplement would result in the qualification, reduction or withdrawal of its then-current rating of any Class of Notes.

     

    “Record Date” means, with respect to a Payment Date or Redemption Date, the
      close of business on the Business Day immediately preceding such Payment Date or Redemption Date; provided, however, that if Definitive Notes are issued, the Record Date will be the last Business Day of the month preceding the Payment Date or
      Redemption Date.

     

    “Redemption Date” means in the case of a redemption of the Notes pursuant to
      Section 10.01, the Payment Date specified by the Administrator or the Issuer pursuant to Section 10.01.

     

    “Redemption Price” means an amount equal to the unpaid principal amount of
      the Notes redeemed plus accrued and unpaid interest thereon at the applicable Interest Rate for the Notes being so redeemed, up to but excluding the Redemption Date, including, to the extent permitted under applicable law, interest on any overdue
      interest at the applicable Overdue Interest Rate.

     

    “Registered Holder” means the Person in whose name a Note is registered on
      the Note Register on the related Record Date.

     

    “Regular Principal Distribution Amount” means, with respect to any Payment
      Date, an amount not less than zero, equal to the difference between (a) the excess, if any, of (i) the aggregate principal amount of the Outstanding Notes as of the preceding Payment Date (after giving effect to any principal payments made on the
      Notes on that preceding Payment Date) over (ii) the Targeted Note Balance minus (b) the First Priority Principal Distribution Amount and the Second Priority Principal Distribution Amount, if any, with respect to that Payment Date.

     

    “Regulation AB” means Subpart 229.1100 – Asset Backed Securities (Regulation AB), 17 C.F.R. §§229.1100-229.1125, as such may be amended from time to time, and subject to such clarification and interpretation as have been provided by the
        Commission in the adopting releases (Asset-Backed Securities, Securities Act Release No. 33-8518, 70 Fed. Reg. 1,506,

     

    
      13

      
        

    

    

    

    1,531 (Jan. 7, 2005) and Asset-Backed Securities Disclosure and Registration, Securities Act Release No. 33-9638, 79 Fed. Reg. 57,184 (Sept. 24, 2014)) or by the staff of
      the Commission, or as may be provided by the Commission or its staff from time to time.

     

    “Regulation RR” means Regulation RR under the Exchange Act (17 C.F.R.
      §246.1, et seq.).

     

    “Reserve Fund” means the “securities account” (within the meaning of Section
      8-501 of the UCC) established by the Indenture Trustee on behalf of the Noteholders pursuant to Section 8.02.

     

    “Reserve Fund Deposit Amount” means, with respect to any Payment Date, an
      amount equal to the sum of (i) the Reserve Fund Requirement and (ii) net income realized on the investment of funds on deposit in the Reserve Fund.

     

    “Reserve Fund Draw Amount” means, for any Payment Date, the amount withdrawn
      from the Reserve Fund, equal to the lesser of (a) the Available Funds Shortfall Amount, if any, and (b) the amount on deposit in the Reserve Fund after giving effect to all deposits thereto on the related Deposit Date or such Payment Date.

     

    “Reserve Fund Property” means the Reserve Fund and all cash, investment
      property and other property from time to time deposited or credited to the Reserve Fund and all proceeds thereof, including without limitation the Initial Deposit.

     

    “Reserve Fund Requirement” means (i) on any Payment Date other than a
      Payment Date described in clause (ii), an amount equal to [_]% of the Aggregate Securitization Value of the 20[__]-[__] Leases as of the Cutoff Date or (ii) on any Payment Date occurring on or after the date on which the Note Balance has been reduced
      to zero, zero.

     

    “Residual Note” has the meaning set forth in Section 2.02.

     

    “Responsible Officer” means, with respect to the Indenture Trustee, any
      officer within Corporate Trust (or any successor group of the Indenture Trustee), including any Vice President, Assistant Secretary or other officer or assistant officer of the Indenture Trustee customarily performing functions similar to those
      performed by the people who at such time shall be officers, or to whom any corporate trust matter is referred within Corporate Trust because of his knowledge of and familiarity with the particular subject, in each case having direct responsibility
      for the administration of the Indenture.

     

    “Second Priority Principal Distribution Amount” means, with respect to any
      Payment Date, an amount not less than zero, equal to (a) (i) the aggregate principal amount of the Outstanding Notes as of the preceding Payment Date (after giving effect to any principal payments made on the Notes on that preceding Payment Date),
      minus (ii) the Aggregate Securitization Value at the end of the Collection Period preceding that Payment Date, minus (b) the First Priority Distribution Amount for such Payment Date; provided, however, that the Second Priority Principal Distribution
      Amount on and after the Final Scheduled Payment Date of the Class B Notes will not be less than the amount that is necessary to reduce the aggregate outstanding principal amount of the Class B Notes to zero.

     

    
      14

      
        

    

    

    

    “Securities” means the Trust Certificates and the Notes, collectively.

     

    “Securities Act” means the Securities Act of 1933, as amended.

     

    “Securityholder Available Funds” means on each Payment Date, all remaining
      Available Funds after giving effect to the payment to the Servicer pursuant to Section 2.4(b)(i) and (b)(ii) of the Servicing Supplement of (i) the related Payment Date Advance Reimbursement and (ii) the related Servicing Fee, together with any
      unpaid Servicing Fees for prior Collection Periods.

     

    “Servicing Agreement” means the Basic Servicing Agreement, as supplemented
      by the Servicing Supplement, as amended or supplemented from time to time with respect to the 20[__]-[__] SUBI.

     

    “Servicing Supplement” means that certain 20[__]-[__] Servicing Supplement,
      dated as of [__________], 20[__], among the Vehicle Trust, the UTI Beneficiary and the Servicer, as amended or supplemented from time to time with respect to the 20[__]-[__] SUBI.

     

    “Servicing Criteria” means the “servicing criteria” set forth in Item
      1122(d) of Regulation AB, as such may be amended from time to time.

     

    “Sponsor” means BMW FS, in its capacity as sponsor under the Servicing
      Agreement, and any successor Sponsor thereunder.

     

    “Subcontractor” means any vendor, subcontractor or other Person that is not
      responsible for the overall servicing (as “servicing” is commonly understood by participants in the asset-backed securities market) of the 20[__]-[__] Leases and 20[__]-[__] Vehicles but performs one or more discrete functions identified in Item
      1122(d) of Regulation AB with respect to the 20[__]-[__] Leases and 20[__]-[__] Vehicles under the direction or authority of the Servicer or a Subservicer.

     

    “SUBI Collections” means, with respect to any Collection Period, the net
      amount collected or received by the Servicer in respect of the 20[__]-[__] SUBI Assets during such Collection Period of: (i) Monthly Payments (net of any Daily Advance Reimbursements); (ii) Sales Proceeds; (iii) Reallocation Payments made by the
      Servicer; (iv) Termination Proceeds; (v) Pull-Ahead Amounts; (vi) Recovery Proceeds; and (vii) the price paid by the Servicer in connection with the Servicer’s purchase of certain 20[__]-[__] Leases pursuant to Section 2.3(f) of the Servicing
      Supplement and certain Matured Vehicles (to the extent not duplicative of any of clauses (i) through (v) of this definition).

     

    “SUBI Trust Agreement” means the Vehicle Trust Agreement as supplemented by
      that certain vehicle trust supplement, dated as of [__________], 20[__], among the parties to the Vehicle Trust Agreement, as amended or supplemented from time to time.

     

    “Subservicer” means any Person that services the 20[__]-[__] Leases and
      20[__]-[__] Vehicles on behalf of the Servicer or any Subservicer and is responsible for the performance (whether directly or through Subservicers or Subcontractors) of a substantial portion of the material servicing functions required to be
      performed by the Servicer under this Indenture that are identified in Item 1122(d) of Regulation AB.

     

    
      15

      
        

    

    

    

    [“Swap Agreement” means [______________________]]

     

    [“Swap Counterparty” means [______________________].]

     

    [“Swap Termination Event” means [______________________].]

     

    “Targeted Note Balance” means, for any Payment Date, the excess, if any, of
      (x) the Aggregate Securitization Value at the end of the Collection Period preceding such Payment Date over (y) the Overcollateralization Target Amount.

     

    “Tax Information” means information and/or properly completed and signed tax
      certifications sufficient to eliminate the imposition of or to determine the amount of any withholding of tax, including FATCA Withholding Tax.

     

    “TIA” means the Trust Indenture Act of 1939, as amended and as in force on
      the date hereof, unless otherwise specifically provided.

     

    “Trust Agreement” means that certain trust agreement, as amended and
      restated as of [__________], 20[__], between the Transferor and the Owner Trustee.

     

    “Trust Certificate” has the meaning set forth in the Trust Agreement.

     

    “Trust Certificateholder” has the meaning set forth in the Trust Agreement.

     

    “Trust Estate” means all right, title and interest whether now existing or
      hereafter acquired or arising in any money, accounts, chattel paper, general intangibles, goods, deposit accounts, instruments, investment property and all proceeds and products of the foregoing, including all of the Issuer’s right, title and
      interest whether now owned or existing or hereafter acquired or arising in (i) the 20[__]-[__] SUBI Certificate (transferred pursuant to the Issuer SUBI Certificate Transfer Agreement), evidencing the beneficial interest in the 20[__]-[__] SUBI
      Assets, including the right to payments thereunder from Sales Proceeds, Termination Proceeds and Recovery Proceeds and to amounts on deposit in the 20[__]-[__] SUBI Collection Account and investment earnings, net of losses and investment expenses, on
      amounts on deposit in the 20[__]-[__] SUBI Collection Account, (ii) the rights of the Issuer under the Back-Up Security Agreement, (iii) the rights of the Issuer to the funds on deposit from time to time in the 20[__]-[__] SUBI Collection Account,
      the Note Distribution Account, the Reserve Fund and any other account or accounts established pursuant to the Indenture and all cash, investment property and other property from time to time credited thereto and all proceeds thereof, (iv) the rights
      of the Transferor, as transferee under the SUBI Certificate Transfer Agreement, (v) the rights of the Issuer, as transferee under the Issuer SUBI Certificate Transfer Agreement, (vi) the rights of the Vehicle Trust under any related Dealer
      Agreements, (vii) the rights of the Issuer as third party beneficiary of the Servicing Agreement and SUBI Trust Agreement and (viii) all proceeds of the foregoing.

     

    “Trustee and Reviewer Fees” means, with respect to any Payment Date, the sum
      of any Indenture Trustee Fee, Owner Trustee Fee and Asset Representations Reviewer Fee then due and payable, or remaining unpaid as of such Payment Date.

     

    
      16

      
        

    

    

    

    “UCC” means, unless the context otherwise requires, the Uniform Commercial
      Code as in effect in the relevant jurisdiction, as amended from time to time.

     

    “Underwriter” means each of [___], [___], [___], [___] and [___].

     

    “United States” means the United States of America.

     

    “UTI Beneficiary” means BMW Manufacturing L.P., in its capacity as initial
      Beneficiary of the Vehicle Trust, and its permitted successors and assigns.

     

    “Vehicle Trust” means Financial Services Vehicle Trust, a Delaware statutory
      trust.

     

    “Vehicle Trust Agreement” means that certain trust agreement, dated as of
      August 30, 1995, as amended and restated as of September 27, 1996, as further amended as of May 25, 2000 and December 1, 2006, between BMW Manufacturing L.P., as grantor and initial beneficiary and BNY Mellon Trust of Delaware, formerly known as The
      Bank of New York (Delaware), as trustee, as amended.

     

    “Vehicle Trustee” means BNY Mellon Trust of Delaware, formerly known as The
      Bank of New York (Delaware), in its capacity as trustee of the Vehicle Trust.

     

    “Verified Note Owner” has the meaning set forth in Section 12.01.

     

    Section 1.02      Interpretive Provisions.

     

    (a)            For all purposes of this Indenture, except as otherwise expressly provided or unless the context otherwise requires, (i) terms used in this Indenture include, as appropriate, all genders and the plural as well as
        the singular, (ii) references to words such as “herein”, “hereof” and the like shall refer to this Indenture as a whole and not to any particular part, Article or Section within this Indenture, (iii) the term “include” and all variations thereof
        shall mean “include without limitation” and (iv) the term “proceeds” shall have the meaning set forth in the applicable UCC.

     

    (b)            As used in this Indenture and in any certificate or other document made or delivered pursuant hereto or thereto, accounting terms not defined in this Indenture or in any such certificate or other document, and
        accounting terms partly defined in this Indenture or in any such certificate or other document to the extent not defined, shall have the respective meanings given to them under generally accepted accounting principles.  To the extent that the
        definitions of accounting terms in this Indenture or in any such certificate or other document are inconsistent with the meanings of such terms under generally accepted accounting principles, the definitions contained in this Indenture or in any
        such certificate or other document shall control.

     

    ARTICLE TWO

      

      THE NOTES

     

    Section 2.01      Form.  The Notes, together with the Indenture Trustee’s
      certificate of authentication, shall be in substantially the form set forth as Exhibit A and Exhibit B hereto, with

     

    
      17

      
        

    

    

    

    such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture and may have such letters, numbers or other marks
      of identification and such legends or endorsements placed thereon as may, consistent herewith, be determined by the officers executing such Notes, as evidenced by their execution of such Notes.  Any portion of the text of any Note may be set forth on
      the reverse thereof, with an appropriate reference thereto on the face of such Note.

     

    The terms of the Notes set forth in Exhibit A and Exhibit B hereto are part of the terms of this Indenture.

     

    Section 2.02      Execution, Authentication and Delivery.  The Notes shall
      be executed by the Owner Trustee on behalf of the Issuer.  The signature of any authorized officer of the Owner Trustee on the Notes may be manual or by facsimile.  Notes bearing the manual or facsimile signature of individuals who were at any time
      authorized officers of the Owner Trustee shall bind the Issuer, notwithstanding that any such individuals have ceased to hold such offices prior to the authentication and delivery of such Notes or did not hold such offices at the date of such Notes.

     

    The Indenture Trustee shall, upon Issuer Order, authenticate and deliver for original issue the following aggregate principal amounts of the Notes: (i)
      $[__________] of Class A-1 Notes, (ii) $[__________] of Class A-2a Notes, (iii) $[__________] of Class A-2b Notes, (iv) $[__________] of Class A-3 Notes, (v) $[__________] of Class A-4 Notes and (vi) $[__________] of Class B Notes. The aggregate
      principal amount of Class A-1 Notes, Class A-2a Notes, Class A-2b Notes, Class A-3 Notes, Class A-4 Notes and Class B Notes outstanding at any time may not exceed such respective amounts, except as provided in Section 2.05.

     

    Each Note shall be dated the date of its authentication. The Notes shall be issuable as registered notes in book-entry form in minimum denominations of
      $1,000 and in integral multiples of $1,000 in excess thereof; provided, however, that on the Closing Date, one Class A‐1 Note, one Class A-2a Note, one Class A-2b Note, one Class A-3 Note, one Class A-4 Note and one Class B Note may be issued in a
      denomination that includes any remaining portion of the Initial Class A-1 Note Balance, the Initial Class A-2a Note Balance, the Initial Class A-2b Note Balance, the Initial Class A-3 Note Balance, the Initial Class A-4 Note Balance and the Initial
      Class B Note Balance (each, a “Residual Note”).

     

    No Note shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Note a certificate
      of authentication substantially in the form provided for herein executed by the Indenture Trustee by the manual signature of one of its authorized signatories, and such certificate upon any Note shall be conclusive evidence, and the only evidence,
      that such Note has been duly authenticated and delivered hereunder.

     

    Section 2.03      Temporary Notes.  Pending the preparation of Definitive
      Notes, the Owner Trustee may execute, on behalf of the Issuer, and upon receipt of an Issuer Order, the Indenture Trustee shall authenticate and deliver, temporary Notes that are printed, lithographed, typewritten, mimeographed or otherwise produced,
      substantially of the tenor of the Definitive Notes in lieu of which they are issued and with such variations not inconsistent with the terms of

     

    
      18

      
        

    

    

    

    this Indenture as the officers executing such Notes may determine, as evidenced by their execution of such Notes.

     

    If temporary Notes are issued, the Issuer shall cause Definitive Notes to be prepared without unreasonable delay.  After the preparation of Definitive
      Notes, the temporary Notes shall be exchangeable for Definitive Notes upon surrender of such temporary Notes at the office or agency of the Issuer to be maintained as provided in Section 3.02, without charge to the related Noteholder.  Upon surrender
      for cancellation of any one or more temporary Notes, the Owner Trustee shall execute, on behalf of the Issuer, and the Indenture Trustee shall authenticate and deliver in exchange therefor, a like principal amount of Definitive Notes of authorized
      denominations.  Until so exchanged, such temporary Notes shall in all respects be entitled to the same benefits under this Indenture as Definitive Notes.

     

    Section 2.04      Registration; Registration of Transfer and Exchange.  The
      Issuer shall cause to be kept a register (the “Note Register”) in which, subject to such reasonable regulations as it may prescribe, the Issuer shall provide for the
      registration of Notes and the registration of transfers of Notes.  The Indenture Trustee is hereby appointed the “Note Registrar” for the purpose of registering Notes and transfers of Notes as herein provided.  Upon any resignation of any Note
      Registrar, the Issuer shall promptly appoint a successor or, if it elects not to make such an appointment, assume the duties of Note Registrar.

     

    If a Person other than the Indenture Trustee is appointed by the Issuer as Note Registrar, the Issuer shall give the Indenture Trustee prompt written
      notice of such appointment and the location, and any change in such location, of the Note Register, and the Indenture Trustee shall have the right to inspect the Note Register at all reasonable times and to obtain copies thereof, and the Indenture
      Trustee shall have the right to rely upon a certificate executed on behalf of the Note Registrar by an Executive Officer as to the names and addresses of the Noteholders and the principal amounts and number of such Notes until a replacement
      certificate is provided to it by the Note Registrar.

     

    Upon surrender for registration of transfer of any Note at the office or agency of the Issuer to be maintained as provided in Section 3.02, if the
      requirements of Section 8-401 of the UCC are met, the Owner Trustee shall execute, on behalf of the Issuer, and the Indenture Trustee shall authenticate and the related Noteholder shall obtain from the Indenture Trustee, in the name of the designated
      transferee, one or more new Notes in any authorized denominations, of a like aggregate principal amount.

     

    At the option of the related Noteholder, Notes may be exchanged for other Notes in any authorized denominations, of a like aggregate principal amount,
      upon surrender of such Notes at such office or agency.  Whenever any Notes are so surrendered for exchange, if the requirements of Section 8-401 of the UCC are met, the Owner Trustee shall execute, on behalf of the Issuer, the Indenture Trustee shall
      authenticate and the Noteholder shall obtain from the Indenture Trustee the Notes that the Noteholder making such exchange is entitled to receive.

     

    Every Note presented or surrendered for registration of transfer or exchange shall (if so required by the Issuer or the Indenture Trustee) be duly
      endorsed, or be accompanied by a written instrument of transfer in form and substance satisfactory to the Issuer and the Indenture

     

    
      19

      
        

    

    

    

    Trustee, duly executed by the Noteholder thereof or its attorney-in-fact duly authorized in writing.

     

    All Notes issued upon any registration of transfer or exchange of Notes shall be the valid obligations of the Issuer, evidencing the same debt and
      entitled to the same benefits under this Indenture as the Notes surrendered upon such registration of transfer or exchange.

     

    No service charge shall be made to a Noteholder for any registration of transfer or exchange of Notes, but the Issuer may require payment of a sum
      sufficient to cover any tax or other governmental charge that may be imposed in connection therewith, other than exchanges pursuant to Sections 2.03 or 9.05 not involving any transfer.

     

    No Note, or any interest therein, may be transferred to an “employee benefit plan” within the meaning of Section 3(3) of ERISA that is subject to ERISA,
      a “plan” described in Section 4975(e)(1) of the Code, any entity that is deemed to hold “plan assets” of any of the foregoing by reason of an employee benefit plan’s or other plan’s investment in such entity, or any governmental or church plan
      subject to applicable law that is substantially similar to the fiduciary responsibility provisions of ERISA or Section 4975 of the Code (a “Plan”), unless such transferee
      represents, warrants and covenants that its purchase and holding of such note will not result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code because it will satisfy the requirements of an applicable
      prohibited transaction exemption (or in the case of such governmental or church plan, will not cause a non-exempt violation of any applicable law that is substantially similar to ERISA or Section 4975 of the Code).  By its acquisition of a Note in
      book-entry form or any interest therein, each transferee will be deemed to have represented, warranted and covenanted that it satisfies the foregoing requirements and the Indenture Trustee may rely conclusively on the same for purposes hereof.

     

    The preceding provisions of this Section notwithstanding, the Issuer shall not be required to make, and the Note Registrar need not register, transfers
      or exchanges of any Note (i) selected for redemption or (ii) for a period of 15 days preceding the due date for any payment with respect to such Note.

     

    All transfers or assignments of any Note or any interest in any Note shall be recorded in the Note Register.

     

    Section 2.05      Mutilated, Destroyed, Lost or Stolen Notes.  If (i) any
      mutilated Note is surrendered to the Indenture Trustee, or the Indenture Trustee receives evidence to its satisfaction of the destruction, loss or theft of any Note and (ii) there is delivered to the Indenture Trustee and the Issuer such security or
      indemnity as may be required by it to hold the Issuer and the Indenture Trustee harmless, then, in the absence of notice to the Issuer, the Note Registrar or a Responsible Officer of the Indenture Trustee that such Note has been acquired by a
      “protected purchaser” (as contemplated by Article Eight of the UCC), and provided that the requirements of Section 8-405 of the UCC are met, the Owner Trustee shall execute, on behalf of the Issuer, and upon Issuer Request the Indenture Trustee shall
      authenticate and deliver, in exchange for or in lieu of any such mutilated, destroyed, lost or stolen Note, a replacement Note; provided, however, that if any such destroyed, lost or stolen Note (but not a mutilated Note) shall have become or within
      seven days shall become due and payable, or shall have been called for

     

    
      20

      
        

    

    

    

    redemption, instead of issuing a replacement Note, the Issuer may pay such destroyed, lost or stolen Note when so due or payable or upon the Redemption Date without the
      surrender thereof.  If, after the delivery of such replacement Note or payment of a destroyed, lost or stolen Note pursuant to the proviso to the preceding sentence, a “protected purchaser” (as contemplated by Article Eight of the UCC) of the
      original Note in lieu of which such replacement Note was issued presents for payment such original Note, the Issuer and the Indenture Trustee shall be entitled to recover such replacement Note (or such payment) from the Person to whom it was
      delivered or any Person taking such replacement Note from such Person to whom such replacement Note was delivered or any assignee of such Person, except a “protected purchaser” (as contemplated by Article Eight of the UCC), and shall be entitled to
      recover upon the security or indemnity provided therefor to the extent of any loss, damage, cost or expense incurred by the Issuer or the Indenture Trustee in connection therewith.

     

    Upon the issuance of any replacement Note under this Section, the Issuer or the Indenture Trustee may require the payment by the related Noteholder of a
      sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other reasonable expenses (including the fees and expenses of the Indenture Trustee or the Note Registrar) connected therewith.

     

    Every replacement Note issued pursuant to this Section in replacement of any mutilated, destroyed, lost or stolen Note shall constitute an original
      additional contractual obligation of the Issuer, whether or not the mutilated, destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any
      and all other Notes duly issued hereunder.

     

    The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or
      payment of mutilated, destroyed, lost or stolen Notes.

     

    Section 2.06      Persons Deemed Owners.  Prior to due presentment for
      registration of transfer of any Note, the Issuer, the Indenture Trustee and their respective agents may treat the Person in whose name any Note is registered (as of the date of determination) as the owner of such Note for the purpose of receiving
      payments of principal of and interest, if any, on such Note and for all other purposes whatsoever, whether or not such Note be overdue, and neither the Issuer, the Indenture Trustee nor any of their respective agents shall be affected by notice to
      the contrary.

     

    Section 2.07      Cancellation.  All Notes surrendered for payment,
      registration of transfer, exchange or redemption shall, if surrendered to any Person other than the Indenture Trustee, be delivered to the Indenture Trustee and shall be promptly cancelled by the Indenture Trustee.  The Issuer may at any time deliver
      to the Indenture Trustee for cancellation any Notes previously authenticated and delivered hereunder that the Issuer may have acquired in any manner whatsoever, and all Notes so delivered shall be promptly cancelled by the Indenture Trustee.  No
      Notes shall be authenticated in lieu of or in exchange for any Notes cancelled as provided in this Section, except as expressly permitted by this Indenture.  All cancelled Notes may be held or disposed of by the Indenture Trustee in accordance with
      its standard retention or disposal policy as in effect at the time unless the Issuer shall direct by an Issuer Order that they be destroyed or

     

    
      21

      
        

    

    

    

    returned to it; provided, that such Issuer Order is timely and that such Notes have not been previously disposed of by the Indenture Trustee.

     

    Section 2.08      Release of Collateral.  Subject to Section 11.01 and the
      terms of the Basic Documents, the Indenture Trustee shall release property from the lien of this Indenture only upon receipt of an Issuer Request.

     

    Section 2.09      Book-Entry Notes.  Unless otherwise specified, the Notes,
      upon original issuance, will be issued in the form of one or more typewritten Notes representing the Book-Entry Notes, to be delivered to the Indenture Trustee, as custodian for DTC, the initial Clearing Agency, by, or on behalf of, the Issuer.  One
      fully registered Note shall be issued with respect to each $500 million in principal amount of each Class of Notes or such lesser amount as necessary.  Such Notes shall initially be registered on the Note Register in the name of Cede & Co., the
      nominee of the initial Clearing Agency, and no Note Owner shall receive a Definitive Note representing such Note Owner’s interest in such Note except as provided in Section 2.11.  Unless and until Definitive Notes have been issued to Note Owners
      pursuant to Section 2.11:

     

    (a)            the provisions of this Section shall be in full force and effect;

     

    (b)            the Note Registrar and the Indenture Trustee shall be entitled to deal with the Clearing Agency for all purposes of this Indenture (including the payment of principal of and interest on the Notes and the giving of
        instructions or directions hereunder) as the sole Noteholder, and shall have no obligation to Note Owners;

     

    (c)            to the extent that the provisions of this Section conflict with any other provisions of this Indenture, the provisions of this Section shall control;

     

    (d)            the rights of Note Owners shall be exercised only through the Clearing Agency and shall be limited to those established by law and agreements between or among such Note Owners and the Clearing Agency or Clearing
        Agency Participants pursuant to the Depository Agreement, unless and until Definitive Notes are issued pursuant to Section 2.11, the initial Clearing Agency will make book-entry transfers among the Clearing Agency Participants and receive and
        transmit payments of principal of and interest on the Notes to such Clearing Agency Participants; and

     

    (e)            whenever this Indenture requires or permits actions to be taken based upon instructions or directions of Noteholders evidencing a specified percentage of the Outstanding Amount, the Clearing Agency shall be deemed
        to represent such percentage only to the extent that it has received instructions to such effect from Note Owners or Clearing Agency Participants owning or representing, respectively, such required percentage of the beneficial interest in the Notes
        and has delivered such instructions to the Indenture Trustee.

     

    Section 2.10      Notices to Clearing Agency.  Whenever a notice or other
      communication to Noteholders is required under this Indenture, unless and until Definitive Notes shall have been issued to Note Owners pursuant to Section 2.11, the Indenture Trustee shall give all such notices and communications specified herein to
      be given to Noteholders to the Clearing Agency, and shall have no obligation to the Note Owners.

     

    
      22

      
        

    

    

    

    Section 2.11      Definitive Notes.  If (i) (A) the Administrator advises
      the Indenture Trustee in writing that the Clearing Agency is no longer willing or able to properly discharge its responsibilities as described in the Depository Agreement and (B) none of the Indenture Trustee, the Transferor or the Administrator is
      able to locate a qualified successor, (ii) the Administrator at its option, with the consent of the applicable Clearing Agency Participants, advises the Indenture Trustee in writing that it elects to terminate the book-entry system through the
      Clearing Agency or (iii) after an Indenture Default, Note Owners representing in the aggregate not less than 51% of the Outstanding Amount advise the Indenture Trustee through the Clearing Agency and its Participants in writing that the continuation
      of a book-entry system through the Clearing Agency or its successor is no longer in the best interest of Note Owners, the Indenture Trustee shall be required to notify all Note Owners, through the Clearing Agency, of the occurrence of such event and
      the availability through the Clearing Agency of Definitive Notes to Note Owners requesting the same.  Upon surrender to the Indenture Trustee by the Clearing Agency of the Note or Notes representing the Book-Entry Notes and the receipt of
      instructions for re-registration, the Indenture Trustee shall issue Definitive Notes to Note Owners, who thereupon shall become Noteholders for all purposes of this Indenture.  None of the Owner Trustee, the Note Registrar or the Indenture Trustee
      shall be liable for any delay in delivery of such instructions and may conclusively rely on, and shall be protected in relying on, such instructions.

     

    The Indenture Trustee shall not be liable if the Indenture Trustee or the Administrator is unable to locate a qualified successor Clearing Agency.  The
      Definitive Notes shall be typewritten, printed, lithographed or engraved or produced by any combination of such methods (with or without steel engraved borders), all as determined by the officers executing such Notes, as evidenced by their execution
      of such Notes.

     

    If Definitive Notes are issued and the Indenture Trustee is not the Note Registrar, the Owner Trustee shall furnish or cause to be furnished to the
      Indenture Trustee a list of the names and addresses of the Noteholders (i) as of each Record Date, within five days thereafter and (ii) as of not more than ten days prior to the time such list is furnished, within 30 days after receipt by the Owner
      Trustee of a written request therefor.

     

    Section 2.12      Authenticating Agents.  Upon the request of the Issuer,
      the Indenture Trustee shall, and if the Indenture Trustee so chooses the Indenture Trustee may, appoint one or more Authenticating Agents with power to act on its behalf and subject to its direction in the authentication of Notes in connection with
      issuance, transfers and exchanges under Sections 2.02, 2.04, 2.05 and 9.05, as fully to all intents and purposes as though each such Authenticating Agent had been expressly authorized by such Sections to authenticate such Notes.  For all purposes of
      this Indenture, the authentication of Notes by an Authenticating Agent pursuant to this Section shall be deemed to be the authentication of Notes by the Indenture Trustee.

     

    Any corporation into which any Authenticating Agent may be merged or converted or with which it may be consolidated, or any corporation resulting from
      any merger, consolidation or conversion to which any Authenticating Agent shall be a party, or any corporation succeeding to the corporate trust business of any Authenticating Agent, shall be the successor of such

     

    
      23

      
        

    

    

    

    Authenticating Agent hereunder, without the execution or filing of any further act on the part of the parties hereto or such Authenticating Agent or such successor
      corporation.

     

    Any Authenticating Agent may at any time resign by giving written notice of resignation to the Indenture Trustee and the Issuer.  The Indenture Trustee
      may at any time terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and the Issuer.  Upon receiving such notice of resignation or upon such termination, the Indenture Trustee shall
      promptly appoint a successor Authenticating Agent and shall give written notice of such appointment to the Issuer.

     

    The Issuer agrees to pay to each Authenticating Agent from time to time reasonable compensation for its services and reimbursement for its reasonable
      expenses relating thereto.  The provisions of Sections 2.07 and 6.04 shall be applicable to any Authenticating Agent.

     

    Section 2.13      Tax Forms. Prior to the first Payment Date and promptly upon request, each Noteholder shall provide to the Indenture Trustee and/or the Issuer (or other person responsible for withholding of taxes, including but not
        limited to FATCA Withholding Tax, or delivery of information under FATCA) the Tax Information; provided, however, the Indenture Trustee shall have no obligation to request such Tax Information or to determine what Tax Information is applicable for
        any Noteholder.

     

    ARTICLE THREE

      

      COVENANTS

     

    Section 3.01      Payment of Principal and Interest.  The Issuer shall duly
      and punctually pay the principal of and interest on the Notes in accordance with the terms of the Notes and this Indenture [and shall duly and punctually pay amounts, if any, owing to each Swap Counterparty in accordance with the terms of this
      Indenture and the related Swap Agreement].  Without limiting the foregoing, subject to Section 8.04, the Issuer shall cause to be distributed all amounts on deposit in the Note Distribution Account on each Payment Date that have been deposited
      therein for the benefit of the Notes [and each Swap Counterparty], as set forth in Section 8.04.  Amounts properly withheld under the Code by any Person from a payment to any Noteholder of interest or principal shall be considered to have been paid
      by the Issuer to such Noteholder for all purposes of this Indenture.

     

    [Section 3.01A      [Interest Rate Cap Collateral Account.  In the event
      that pursuant to the terms of the interest rate cap agreement, the cap counterparty is required to deposit cash or securities as collateral to secure its obligations (“Interest Rate
          Cap Collateral”), the Indenture Trustee at the written direction of the cap counterparty shall establish and maintain an Eligible Account in the name of the Indenture Trustee for the benefit of the Issuer and the cap counterparty (an “Interest Rate Cap Agreement Collateral Account”).  All sums on deposit and securities held in any Interest Rate Cap Agreement Collateral Account shall be used only for the
      purposes set forth in the related credit support agreement to be entered into between the Trust and the cap counterparty (the “Interest Rate Cap Credit Support Agreement”);
      provided, however, that the Indenture Trustee is not a party to the Interest Rate Cap Credit

     

    
      24

      
        

    

    

    

    Support Agreement and shall have no obligations or responsibilities under the Interest Rate Cap Credit Support Agreement, nor any obligation to monitor
      the Issuer’s or the cap counterparty’s compliance with the terms of the Interest Rate Cap Credit Support Agreement.  Amounts on deposit in any Interest Rate Cap Agreement Collateral Account may be invested in Eligible Investments at the written
      direction of the cap counterparty and on each Payment Date, all Investment Earnings actually received by the Indenture Trustee on amounts on deposit in the Interest Rate Cap Agreement Collateral Account or on securities held by the Indenture Trustee
      as Interest Rate Cap Collateral shall be paid directly to the cap counterparty and not become part of Available Funds in accordance with the terms of the Interest Rate Cap Credit Support Agreement.  The Indenture Trustee shall not be liable for any
      losses on investments made in accordance with the cap counterparty’s direction. All amounts deposited in the Interest Rate Cap Agreement Collateral Account shall be paid to the Issuer (and become part of Available Funds on the related Payment Date)
      or returned to the cap counterparty (in either case, upon receipt by the Indenture Trustee of written instructions from the Administrator to release the amounts on deposit) in accordance with the provisions set forth in the Interest Rate Cap Credit
      Support Agreement.]

     

    Section 3.02      Maintenance of Office or Agency.  The Note Registrar, on
      behalf of the Issuer, shall maintain at the Corporate Trust Office or at such other location in [___] or [___], chosen by the Note Registrar, acting for the Issuer, an office or agency where Notes may be surrendered for registration of transfer or
      exchange, and where notices to and demands upon the Issuer in respect of the Notes and this Indenture may be served.  The Issuer hereby appoints the Indenture Trustee as its agent to receive all such surrenders, notices and demands.  The Issuer shall
      give prompt written notice to the Indenture Trustee of the location, and of any change in the location, of any such office or agency.  If at any time the Issuer shall fail to maintain any such office or agency or shall fail to furnish the Indenture
      Trustee with the address thereof, such surrenders, notices and demands may be made or served at the Corporate Trust Office, and the Issuer hereby appoints the Indenture Trustee as its agent to receive all such surrenders, notices and demands.

     

    Section 3.03      Money for Payments to be Held in Trust.  As provided in
      Sections 8.04 and 5.04(b), all payments of amounts due and payable with respect to any Notes that are to be made from amounts withdrawn from the Note Distribution Account shall be made on behalf of the Issuer by the Indenture Trustee or by another
      Paying Agent, and no amounts so withdrawn therefrom for payments of Notes [or any Swap Counterparty] shall be paid over to the Issuer except as provided in this Section.

     

    On each Payment Date and Redemption Date, the Issuer shall deposit or cause to be deposited into the Note Distribution Account an aggregate sum
      sufficient to pay the amounts then becoming due under the Notes [or any Swap Agreement], and the Paying Agent shall hold such sum in trust for the benefit of the Persons entitled thereto and (unless the Paying Agent is the Indenture Trustee) shall
      promptly notify the Indenture Trustee of any failure by the Issuer to effect such deposit.

     

    The Issuer shall cause each Paying Agent other than the Indenture Trustee to execute and deliver to the Indenture Trustee an instrument in which such
      Paying Agent shall agree with the Indenture Trustee (and if the Indenture Trustee acts as Paying Agent, it hereby so agrees to the extent relevant), subject to the provisions of this Section, that such Paying Agent shall:

     

    
      25

      
        

    

    

    

    (a)            hold all sums held by it for the payment of amounts due with respect to the Notes [or any Swap Agreement] in trust for the benefit of the Persons entitled thereto until such sums shall be paid to such Persons or
        otherwise disposed of as herein provided and pay such sums to such Persons as herein provided;

     

    (b)            give the Indenture Trustee notice of any default by the Issuer of which it has actual knowledge (or any other obligor upon the Notes) in the making of any payment required to be made with respect to the Notes [or
        any Swap Agreement];

     

    (c)            at any time during the continuance of any such default, upon the written request of the Indenture Trustee, forthwith pay to the Indenture Trustee all sums so held in trust by such Paying Agent;

     

    (d)            immediately resign as a Paying Agent and forthwith pay to the Indenture Trustee all sums held by it in trust for the payment of Notes [or any Swap Agreement] if at any time it ceases to meet the standards required
        to be met by a Paying Agent at the time of its appointment; and

     

    (e)            comply with all requirements of the Code with respect to the withholding from any payments made by it on any Notes of any applicable withholding taxes imposed thereon and with respect to any applicable reporting
        requirements in connection therewith.

     

    The Issuer may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, by Issuer Order
      direct any Paying Agent to pay to the Indenture Trustee all sums held in trust by such Paying Agent, such sums to be held by the Indenture Trustee upon the same trusts as those upon which such sums were held by such Paying Agent; and upon such
      payment by any Paying Agent to the Indenture Trustee, such Paying Agent shall be released from all further liability with respect to such money.

     

    Subject to applicable laws with respect to escheat of funds, any money held by the Indenture Trustee or any Paying Agent in trust for the payment of any
      amount due with respect to any Note and remaining unclaimed for two years after such amount has become due and payable shall be discharged from such trust and deposited by the Indenture Trustee into the 20[__]-[__] SUBI Collection Account, and the
      related Noteholder shall thereafter, as an unsecured general creditor, look only to the Issuer for payment thereof, and all liability of the Indenture Trustee or such Paying Agent with respect to such trust money shall thereupon cease; provided,
      however, that the Indenture Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Issuer cause to be published once, in an Authorized Newspaper, notice that such money remains unclaimed and that,
      after a date specified therein, which date shall not be less than 30 days from the date of such publication, any unclaimed balance of such money then remaining shall be paid to the Administrator.  The Indenture Trustee shall also adopt and employ, at
      the expense of the Issuer, any other reasonable means of notification of such repayment (including mailing notice of such repayment to Noteholders the Notes of which have been called but not surrendered for redemption or whose right to or interest in
      monies due and payable but not claimed is determinable from the records of the Indenture Trustee or any Paying Agent at the last address of record for each such Noteholder).

     

    
      26

      
        

    

    

    

    Section 3.04      Existence.  The Issuer shall keep in full effect its
      existence, rights and franchises as a trust under the laws of the State of Delaware (unless it becomes, or any successor Issuer hereunder is or becomes, organized under the laws of any other state or of the United States, in which case the Issuer
      shall keep in full effect its existence, rights and franchises under the laws of such other jurisdiction) and shall obtain and preserve its qualification to do business in each jurisdiction in which such qualification is or shall be necessary to
      protect the validity and enforceability of this Indenture, the Notes, the Collateral and each other instrument or agreement included in the Trust Estate.

     

    Section 3.05      Protection of Trust Estate.  The Issuer intends the
      security interest Granted pursuant to this Indenture in favor of the Indenture Trustee on behalf of the Noteholders to be prior to all other liens in respect of the Trust Estate, and the Issuer shall take all actions necessary to obtain and maintain,
      for the benefit of the Indenture Trustee on behalf of the Noteholders, a first lien on and a first priority, perfected security interest in the Trust Estate.  The Issuer shall from time to time execute and deliver all such supplements and amendments
      hereto and all such financing statements, continuation statements, instruments of further assurance and other instruments, all as prepared by the Administrator and delivered to the Issuer, and shall take such other action necessary or advisable to:

     

    (a)            Grant more effectively all or any portion of the Trust Estate;

     

    (b)            maintain or preserve the lien and security interest (and the priority thereof) created by this Indenture or carry out more effectively the purposes hereof;

     

    (c)            perfect, publish notice of or protect the validity of any Grant made or to be made by this Indenture;

     

    (d)            enforce any of the Collateral;

     

    (e)            preserve and defend title to the Trust Estate and the rights of the Indenture Trustee and the Noteholders [and each Swap Counterparty] in the Trust Estate against the claims of all Persons; or

     

    (f)            pay all taxes or assessments levied or assessed upon the Trust Estate when due.

     

    The Issuer hereby designates the Indenture Trustee its agent and attorney-in-fact to file all financing statements, continuation statements or other
      instruments required to be filed pursuant to this Section.

     

    Section 3.06      Opinions as to Trust Estate.

     

    (a)            On the Closing Date, the Issuer shall furnish or cause to be furnished to the Indenture Trustee, an Opinion of Counsel to the effect that, in the opinion of such counsel, either (i) all financing statements and
        continuation statements have been executed and filed that are necessary to create and maintain the lien and security interest of the Indenture Trustee in the Trust Estate and reciting the details of such action, or (ii) no such action is necessary
        to create and maintain such lien and security interest.

     

    
      27

      
        

    

    

    

    (b)            On or before April 30th of each calendar year, beginning with April 30, 20[_], the Issuer shall furnish to the Indenture Trustee an Opinion of Counsel to the effect that in the opinion of such counsel, either (i)
        all financing statements and continuation statements have been executed and filed that are necessary to continue the lien and security interest of the Indenture Trustee in the Trust Estate and reciting the details of such filings or referring to
        prior Opinions of Counsel in which such details are given, or (ii) no such action is necessary to continue such lien and security interest.

     

    Section 3.07      Performance of Obligations; Administration of the 20[__]-[__] SUBI
          Assets.

     

    (a)            The Issuer shall not take any action and shall use its best efforts not to permit any action to be taken by others, including the Administrator, that would release any Person from any of such Person’s material
        covenants or obligations under any instrument or agreement included in the Trust Estate or that would result in the amendment, hypothecation, subordination, termination or discharge of, or impair the validity or effectiveness of, any such
        instrument or agreement, except as expressly provided in the Basic Documents or such other instrument or agreement.

     

    (b)            The Issuer may contract with other Persons, to assist it in performing its duties under this Indenture, and any performance of such duties by a Person identified to the Indenture Trustee in an Officer’s Certificate
        of the Issuer shall be deemed to be action taken by the Issuer. Initially, the Issuer has contracted with the Administrator, and the Administrator has agreed, to assist the Issuer in performing its duties under this Indenture.

     

    (c)            The Issuer shall, and, shall cause the Administrator and the Servicer to, punctually perform and observe all of its and their respective obligations and agreements contained in this Indenture, the other Basic
        Documents and the instruments and agreements included in the Trust Estate, including filing or causing to be filed all UCC financing statements and continuation statements required to be filed by the terms of this Indenture and the other Basic
        Documents in accordance with and within the time periods provided for herein and therein.  Except as otherwise expressly provided therein, the Issuer, as a party to the Basic Documents and as Holder of the 20[__]-[__] SUBI Certificate, shall not,
        and shall cause each of the Servicer and the Administrator not to, modify, amend, supplement, waive or terminate any Basic Document to which it is a party or any provision thereof without satisfying the Rating Agency Condition and satisfying each
        other condition as may be specified in the particular provision or Basic Document; [provided, for the avoidance of doubt, that a transfer or assignment by a Swap Counterparty or any of its interests or obligations in accordance with the related
        Swap Agreement (including the requirement, if applicable, that the Rating Agency Condition be satisfied) shall not constitute a waiver, amendment, modification, supplement or termination of the related Swap Agreement or any provisions thereof]. 
        Copies of any statements and certificates required to be provided to the Indenture Trustee pursuant to the Servicing Agreement or any other Basic Document may be obtained by Securityholders by a request in writing addressed to the Indenture
        Trustee.

     

    (d)            If the Issuer or a Responsible Officer of the Indenture Trustee shall have actual knowledge of the occurrence and continuation of a Servicer Default, such entity shall promptly

     

    
      28

      
        

    

    

    

    notify the other entity and the Administrator thereof, and shall specify in such notice the action, if any, the other entity is taking in respect of such default.  If a
      Servicer Default shall arise from the failure of the Servicer to perform any of its duties or obligations under the Servicing Agreement with respect to the 20[__]-[__] SUBI Assets, the Issuer shall take all reasonable steps available to it to remedy
      such failure.  Upon the occurrence and continuation of a Servicer Default with respect to the 20[__]-[__] SUBI, the Indenture Trustee may (and at the direction of Noteholders holding not less than 66 2⁄3% of the Outstanding Amount shall) terminate all
      of the rights and obligations of the Servicer with respect to the 20[__]-[__] SUBI only, and a successor Servicer shall be appointed pursuant to the Servicing Agreement.

     

    (e)            Upon any termination of the Servicer’s rights and powers or resignation of the Servicer pursuant to the Servicing Agreement, the Issuer or the Indenture Trustee shall promptly, but in any event within two Business
        Days of such termination or resignation, notify the other entity thereof.  As soon as a successor Servicer is appointed pursuant to the Servicing Agreement, the Issuer or the Indenture Trustee shall notify the other entity of such appointment,
        specifying in such notice the name and address of such successor Servicer.

     

    (f)            [As promptly as possible upon the occurrence of a Swap Termination Event or an Event of Default under the Swap Agreement, the Issuer shall hire or appoint a broker in order to obtain a Replacement Transaction
        according to the terms of the related Swap Agreement, and such broker shall accept its appointment by a written assumption in a form acceptable to the Issuer.  In connection with any such appointment, the Issuer may make such arrangements for the
        compensation of such broker as it and such broker shall agree, and the Issuer shall be entitled to reimbursement for such expenses from any Swap Termination Payments received upon the occurrence of any Swap Termination Event or Event of Default
        under the related Swap Agreement; provided, that any such Swap Termination Payments shall be applied, first, in payment of any upfront payment required to enter into any Replacement Transaction and, second, to the extent of remaining funds
        available therefor, to the Issuer for any such reimbursement.]

     

    Section 3.08      Negative Covenants.  So long as any Notes are
      Outstanding, the Issuer shall not:

     

    (a)            engage in any activities other than financing, acquiring, owning, leasing (subject to the lien of this Indenture), pledging and managing the 20[__]-[__] SUBI Certificate as contemplated by this Indenture and the
        other Basic Documents;

     

    (b)            [reserved];

     

    (c)            claim any credit on or make any deduction from the principal or interest payable in respect of the Notes (other than amounts properly withheld from such payments under the Code or applicable state law) or assert any
        claim against any present or former Noteholder by reason of the payment of the taxes levied or assessed upon any part of the Trust Estate;

     

    (d)            (i) permit the validity or effectiveness of this Indenture to be impaired, permit the lien of this Indenture to be amended, hypothecated, subordinated, terminated or discharged or permit any Person to be released
        from any covenants or obligations under this Indenture, except

     

    
      29

      
        

    

    

    

    as may be expressly permitted hereby, (ii) permit any lien, charge, excise, claim, security interest, mortgage or other encumbrance (other than the lien of this Indenture)
      to be created on or extend to or otherwise arise upon or burden the Trust Estate, any part thereof or any interest therein or the proceeds thereof (other than tax liens, mechanics’ liens and other liens that arise by operation of law, in each case on
      any 20[__]-[__] SUBI Asset and arising solely as a result of an action or omission of the related Lessee) or (iii) except as otherwise provided in the Basic Documents, permit the lien of this Indenture not to constitute a valid first priority (other
      than with respect to any such tax, mechanics’ or other lien) security interest in the Trust Estate;

     

    (e)            incur, assume or guarantee any indebtedness other than indebtedness incurred in accordance with the Basic Documents;

     

    (f)            except as otherwise permitted by the Basic Documents, dissolve or liquidate in whole or in part; or

     

    (g)            [enter into any amendment, modification or supplement to this Indenture or any other Basic Document without the consent of each Swap Counterparty that would materially adversely affect (i) any Swap Counterparty’s
        ability to enforce or protect its rights or remedies under the related Swap Agreement (including any security interest granted to such Swap Counterparty pursuant to this Indenture), (ii) the ability of the Issuer to timely and fully perform its
        obligations under each Swap Agreement or (iii) any of the Issuer’s obligations under each Swap Agreement or any Basic Document (including priority of payments under the Trust Agreement or this Indenture); or][unless an Indenture Default under this
        Indenture shall have occurred and be continuing, designate an “Early Termination Date” (as such term is defined in the related Swap Agreement”) under the related Swap Agreement without the consent of the Administrator].

     

    Section 3.09      Issuer and Indenture Trustee Certificates and Reports.

     

    (a)            The Issuer shall deliver to the Indenture Trustee and shall make available to each Rating Agency, within 90 days after the end of each calendar year (commencing with the year ending December 31, 20[__]), an
        Officer’s Certificate stating, as to the Authorized Officer signing such Officer’s Certificate, that:

     

    (i)            a review of the activities of the Issuer during such year and of its performance under this Indenture has been made under such Authorized Officer’s supervision; and

     

    (ii)            to the best of such Authorized Officer’s knowledge, based on such review, the Issuer has complied with all conditions and covenants under this Indenture throughout such year, or, if there has
        been a Default in the compliance of any such condition or covenant, specifying each such Default known to such Authorized Officer and the nature and status thereof.

     

    (b)            The Issuer shall supply to the Indenture Trustee such summaries of any information, documents and reports required to be filed by the Issuer pursuant to clauses (i) and (ii) of Section 3.09(a) as may be required
        pursuant to rules and regulations prescribed from time to time by the Commission.

     

    
      30

      
        

    

    

    

    (c)            On or before March [15th] of each calendar year in which a Form 10-K is required to be filed on behalf of the Issuer, commencing in 20[_], the Indenture Trustee shall deliver to the Issuer and the Administrator:

     

    (i)            a report regarding the Indenture Trustee’s assessment of compliance with the Servicing Criteria during the immediately preceding calendar year, as required under Rules 13a-18 and 15d-18 of
        the Exchange Act and Item 1122 of Regulation AB.  Such report shall be signed by an authorized officer of the Indenture Trustee, and shall address each of the Servicing Criteria specified on Exhibit C hereto or such criteria as mutually agreed upon
        by the Administrator, Transferor and Indenture Trustee; and

     

    (ii)            a report of a registered public accounting firm that attests to, and reports on, the assessment of compliance made by the Indenture Trustee and delivered pursuant to the preceding paragraph. 
        Such attestation shall be in accordance with Rules 13a-18 and 15d-18 of the Securities Act and the Exchange Act and Item 1122 of Regulation AB.

     

    (d)            The Issuer shall :

     

    (i)            file with the Commission copies of the monthly reports, the annual reports and such other information, documents and reports (or copies of such portions of any of the foregoing as the
        Commission may from time to time by rules and regulations prescribe) as the Issuer may be required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act, including reports on Form 10-K, Form 10-D and Form 8-K; and

     

    (ii)            file with the Commission in accordance with rules and regulations prescribed from time to time by the Commission such other information, documents and reports with respect to compliance by
        the Issuer with the conditions and covenants of this Indenture as may be required from time to time by such rules and regulations.

     

    (e)            Unless the Issuer otherwise determines, the fiscal year of the Issuer shall end on December 31 of each year.

     

    Section 3.10      Restrictions on Certain Other Activities.  Except as
      otherwise provided in the Basic Documents, the Issuer shall not: (i) engage in any activities other than financing, acquiring, owning, leasing (subject to the lien of this Indenture), pledging and managing the 20[__]-[__] SUBI Certificates in the
      manner contemplated by the Basic Documents; (ii) issue, incur, assume, guarantee or otherwise become liable, directly or indirectly, for any indebtedness; (iii) make any loan, advance or credit to, guarantee (directly or indirectly or by an
      instrument having the effect of assuring another’s payment or performance on any obligation or capability of so doing or otherwise), endorse or otherwise become contingently liable, directly or indirectly, in connection with the obligations, stocks
      or dividends of, own, purchase, repurchase or acquire (or agree contingently to do so) any stock, obligations, assets or securities of, or any other interest in, or make any capital contribution to, any other Person; or (iv) make any expenditure (by
      long-term or operating lease or otherwise) for capital assets (either realty or personalty).

     

    
      31

      
        

    

    

    

    Section 3.11      Notice of Defaults.  The Issuer agrees to give the
      Indenture Trustee, [each Swap Counterparty] and with respect to each Rating Agency make available, prompt written notice of each Indenture Default hereunder.

     

    Section 3.12      Further Instruments and Acts.  Upon request of the
      Indenture Trustee, the Issuer shall execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purposes of this Indenture.

     

    Section 3.13      Delivery of 20[__]-[__] SUBI Certificate.  On the Closing
      Date, the Issuer shall deliver or cause to be delivered to the Indenture Trustee as security for its obligations hereunder, the 20[__]-[__] SUBI Certificate.  The Indenture Trustee shall take possession of the 20[__]-[__] SUBI Certificate in New York
      and shall at all times during the period of this Indenture maintain custody of the 20[__]-[__] SUBI Certificate in New York.

     

    Section 3.14      Compliance with Laws.  The Issuer shall comply with the
      requirements of all applicable laws, the non-compliance with which would, individually or in the aggregate, materially and adversely affect the ability of the Issuer to perform its obligations under the Notes, this Indenture or any other Basic
      Document.

     

    Section 3.15      Issuer May Consolidate, etc., Only on Certain Terms.

     

    (a)            The Issuer shall not consolidate or merge with or into any other Person unless:

     

    (i)            the Person (if other than the Issuer) formed by or surviving such consolidation or merger shall be a Person organized and existing under the laws of the United States of America or any State
        or the District of Columbia and shall expressly assume, by an indenture supplemental hereto, executed and delivered to the Indenture Trustee, in form satisfactory to the Indenture Trustee, the duty to make due and punctual payment of the principal
        of and interest on all Notes and the performance or observance of every agreement and covenant of this Indenture on the part of the Issuer to be performed or observed, all as provided herein;

     

    (ii)            immediately after giving effect to such transaction, no Default or Indenture Default shall have occurred and be continuing;

     

    (iii)            the Rating Agency Condition shall have been satisfied in respect thereof;

     

    (iv)            the Issuer shall have received an Opinion of Counsel (and shall have delivered copies thereof to the Indenture Trustee) to the effect that such transaction will not (A) affect the treatment
        of the Notes as debt for U.S. federal income tax purposes, (B) be deemed to cause a taxable exchange of the Notes for U.S. federal income tax purposes or (C) cause the Issuer, the Transferor or the Vehicle Trust to be characterized as an
        association or publicly traded partnership, in either case taxable as a corporation for U.S. federal income tax purposes;

     

    (v)            any action that is necessary to maintain each lien and security interest created by this Indenture shall have been taken; and

     

    
      32

      
        

    

    

    

    (vi)            the Issuer shall have delivered to the Indenture Trustee an Officer’s Certificate and an Opinion of Counsel each stating that such consolidation or merger and any related supplemental
        indenture complies with this Article Three and that all conditions precedent provided in this Indenture relating to such transaction have been complied with (including any filing required by the Exchange Act).

     

    (b)            The Issuer shall not convey or transfer any of its properties or assets, including those included in the Trust Estate, to any Person other than pursuant to the terms of the Basic Documents, unless:

     

    (i)            the Person that acquires by conveyance or transfer such properties and assets of the Issuer shall (A) be a United States citizen or a Person organized and existing under the laws of the
        United States of America or any state or the District of Columbia, (B) expressly assume, by an indenture supplemental hereto, executed and delivered to the Indenture Trustee, in form satisfactory to the Indenture Trustee, the duty to make due and
        punctual payment of the principal of and interest on all Notes and the performance or observance of every agreement and covenant of this Indenture on the part of the Issuer to be performed or observed, all as provided herein, (c) expressly agrees
        by means of such supplemental indenture that all right, title and interest so conveyed or transferred shall be subject and subordinate to the rights of Holders of the Notes [and each Swap Counterparty], (D) unless otherwise provided in such
        supplemental indenture, expressly agrees to indemnify, defend and hold harmless the Issuer, the Owner Trustee and the Indenture Trustee against and from any loss, liability or expense arising under or related to this Indenture and the Notes and (E)
        expressly agrees by means of such supplemental indenture that such Person (or if a group of Persons, then one specified Person) shall make all filings that counsel satisfactory to such purchaser or transferee and the Indenture Trustee determines
        must be made with (1) the Commission (and any other appropriate Person) required by the Exchange Act or the appropriate authorities in any state in which the Notes have been sold pursuant to any qualification or exemption under the securities or
        “blue sky” laws of such state, in connection with the Notes or (2) the Internal Revenue Service or the relevant state or local taxing authorities of any jurisdiction;

     

    (ii)            immediately after giving effect to such transaction, no Default or Indenture Default shall have occurred and be continuing;

     

    (iii)            the Rating Agency Condition shall have been satisfied in respect thereof;

     

    (iv)            the Issuer shall have received an Opinion of Counsel (and shall have delivered copies thereof to the Indenture Trustee) to the effect that such transaction will not (A) affect the treatment
        of the Notes as debt for U.S. federal income tax purposes, (B) be deemed to cause a taxable exchange of the Notes for U.S. federal income tax purposes or (C) cause the Issuer, the Transferor or the Vehicle Trust to be characterized as an
        association or publicly traded partnership, in either case taxable as a corporation for U.S. federal income tax purposes;

     

    (v)            any action that is necessary to maintain each lien and security interest created by this Indenture shall have been taken; and

     

    
      33

      
        

    

    

    

    (vi)            the Issuer shall have delivered to the Indenture Trustee an Officer’s Certificate and an Opinion of Counsel each stating that such conveyance or transfer and such supplemental indenture
        comply with this Article Three and that all conditions precedent herein provided for relating to such transaction have been complied with (including any filing required by the Exchange Act).

     

    Section 3.16      Perfection Representations.

     

    (a)            The representations, warranties and covenants set forth in Schedule I hereto shall be a part of this Indenture for all purposes.

     

    (b)            Notwithstanding any other provision of this Indenture or any other Basic Document, the perfection representations contained in Schedule I hereto shall be continuing, and remain in full force and effect until such
        time as all obligations under this Indenture have been finally and fully paid and performed.

     

    (c)            The parties to this Indenture: (i) shall not waive any of the perfection representations contained in Schedule I hereto; (ii) shall provide notice to the Administrator (who shall make such notice available to the
        Rating Agencies) of any breach of perfection representations contained in Schedule I hereto and (iii) shall not waive a breach of any of the perfection representations contained in Schedule I hereto.

     

    ARTICLE FOUR

      

      SATISFACTION AND DISCHARGE

     

    Section 4.01      Satisfaction and Discharge of Indenture.  This Indenture
      shall discharge with respect to the Collateral securing the Notes except as to (a) rights of registration of transfer and exchange, (b) substitution of mutilated, destroyed, lost or stolen Notes, (c) rights of Noteholders to receive payments of
      principal thereof and interest thereon [and the rights of each Swap Counterparty to receive amounts due to it under the related Swap Agreement], (d) Sections 3.03, 3.04, 3.05, 3.08 and 3.10, (e) the rights, obligations and immunities of the Indenture
      Trustee hereunder (including the rights of the Indenture Trustee under Section 6.07 and the obligations of the Indenture Trustee under Section 4.02) and (f) the rights of Noteholders [and each Swap Counterparty] as beneficiaries hereof with respect
      to the property so deposited with the Indenture Trustee payable to all or any of them, and the Indenture Trustee, on demand and at the expense and on behalf of the Issuer, shall execute proper instruments acknowledging satisfaction and discharge of
      this Indenture, when [all amounts due and payable to each Swap Counterparty under the related Swap Agreement have been paid and],

     

    (i)            either (A) all Notes theretofore authenticated and delivered (other than (1) Notes that have been mutilated, destroyed, lost or stolen and that have been replaced or paid as provided in
        Section 2.05 and (2) Notes for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Issuer and thereafter paid to the Persons entitled thereto or discharged from such trust, as provided in Section
        3.03)) have been delivered to the Indenture Trustee for cancellation; or (B) all Notes not theretofore delivered to the Indenture Trustee for cancellation (1) have become due and

     

    
      34

      
        

    

    

    

    payable, (2) will become due and payable on the applicable Note Final Scheduled Payment Date within one year or (3) are to be called for redemption
      within one year under arrangements satisfactory to the Indenture Trustee for the giving of notice of redemption by the Indenture Trustee in the name, and at the expense, of the Issuer, and the Issuer, in the case of clauses (1), (2) or (3) above, has
      irrevocably deposited or caused to be irrevocably deposited with the Indenture Trustee cash or direct obligations of or obligations guaranteed by the United States (that will mature prior to the date such amounts are payable), in trust for such
      purpose, in an amount sufficient to pay and discharge the entire indebtedness on such Notes (including interest and any fees due and payable to the Servicer, the Owner Trustee, the Indenture Trustee or the Asset Representations Reviewer) not
      theretofore delivered to the Indenture Trustee for cancellation, when due, to the applicable Note Final Scheduled Payment Date for each Class, or to the Redemption Date (if Notes shall have been called for redemption pursuant to Section 10.01), as
      the case may be;

     

    (ii)            the Issuer has paid or caused to be paid all other sums payable hereunder by the Issuer including, but not limited to, fees and expenses due to the Indenture Trustee; and

     

    (iii)            the Issuer has delivered to the Indenture Trustee an Officer’s Certificate and an Opinion of Counsel, each meeting the applicable requirements of Section 11.01 and, subject to Section 11.02,
        each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with (and, in the case of an Officer’s Certificate, stating that the Rating Agency Condition has been
        satisfied); provided that with respect to an Optional Purchase, the satisfaction of the Rating Agency Condition shall not be required.

     

    Section 4.02      Application of Trust Money.  All monies deposited with
      the Indenture Trustee pursuant to Section 4.01 shall be held in trust and applied by it, in accordance with the provisions of the Notes and this Indenture, to the payment, either directly or through any Paying Agent, as the Indenture Trustee may
      determine, to the Noteholders of the particular Notes [or any Swap Counterparty pursuant to the related Swap Agreement, as applicable,] for the payment or redemption of which such monies have been deposited with the Indenture Trustee of all sums due
      and to become due thereon for principal and interest.  Such monies need not be segregated from other funds of the Indenture Trustee except to the extent required herein or in the Servicing Agreement or as required by law.

     

    Section 4.03      Repayment of Monies Held by Paying Agent.  In connection
      with the satisfaction and discharge of this Indenture with respect to the Notes, all monies then held by any Paying Agent other than the Indenture Trustee under the provisions of this Indenture with respect to such Notes shall, upon demand of the
      Issuer, be paid to the Indenture Trustee to be held and applied according to Section 3.03 and such Paying Agent shall thereupon be released from all further liability with respect to such monies.

     

    
      35

      
        

    

    

    

    ARTICLE FIVE

      

      INDENTURE DEFAULT

     

    Section 5.01      Indenture Defaults.  The occurrence and continuation of
      any one of the following events (whatever the reason for such Indenture Default and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or
      regulation of any administrative or governmental body) shall constitute a default under this Indenture (each, an “Indenture Default”):

     

    (a)            default in the payment of any interest on any Note when the same becomes due and payable, and such default shall continue for a period of five days or more; provided that, for the avoidance of doubt, failure to pay
        interest on the Class B Notes due to insufficient Available Funds shall not be an Indenture Default so long as the Class A Notes are then Outstanding;

     

    (b)            default in the payment of principal of any Note at the applicable Note Final Scheduled Payment Date or the Redemption Date;

     

    (c)            default in the observance or performance in any material respect of any covenant or agreement of the Issuer made in this Indenture (other than a covenant or agreement, a default in the observance or performance of
        which is elsewhere in this Section specifically dealt with), or any representation or warranty of the Issuer made in this Indenture or in any certificate or other writing delivered pursuant hereto or in connection herewith proving to have been
        incorrect in any material respect as of the time when the same shall have been made, and such default shall continue or not be cured, or the circumstance or condition in respect of which such misrepresentation or warranty was incorrect shall not
        have been eliminated or otherwise cured, for a period of 30 days after there shall have been given, by registered or certified mail, to the Issuer by the Indenture Trustee or to the Issuer and the Indenture Trustee by Noteholders representing at
        least 25% of the Outstanding Amount, voting together as a single class, a written notice specifying such default or incorrect representation or warranty and requiring it to be remedied and stating that such notice is a “Notice of Default”
        hereunder;

     

    (d)            the filing of a decree or order for relief by a court having jurisdiction in the premises in respect of the Issuer or any substantial part of the Trust Estate in an involuntary case under any applicable federal or
        state bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Issuer or for any substantial part of the Trust Estate, or
        ordering the winding up or liquidation of the Issuer’s affairs, and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days; or

     

    (e)            the commencement by the Issuer of a voluntary case under any applicable federal or state bankruptcy, insolvency or other similar law now or hereafter in effect or the consent by the Issuer to the entry of an order
        for relief in an involuntary case under any such law, the consent by the Issuer to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Issuer or for any
        substantial part of the Trust Estate, the making by the Issuer of any general assignment for the benefit of

     

    
      36

      
        

    

    

    

    creditors, the failure by the Issuer generally to pay its debts as such debts become due or the taking of action by the Issuer in furtherance of any of the foregoing.

     

    Notwithstanding the foregoing, a delay in or failure of performance referred to under clause (a) for a period of 45 days, under clause (b) for a period of 60 days or under
      clause (c) for a period of 120 days, will not constitute an Indenture Default if that failure or delay was caused by a Force Majeure.

     

    The Issuer shall promptly deliver to the Indenture Trustee, the Owner Trustee, the Vehicle Trustee, each Noteholder, and with respect to each Rating
      Agency shall make available, written notice in the form of an Officer’s Certificate of any Indenture Default, its status and what action the Issuer is taking or proposes to take with respect thereto.

     

    Subject to the provisions herein relating to the duties of the Indenture Trustee, if an Indenture Default occurs and is continuing, the Indenture Trustee
      shall be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of any Noteholder, if the Indenture Trustee reasonably believes that it will not be adequately indemnified against the costs,
      expenses and liabilities that might be incurred by it in complying with such request.  Subject to such provisions for indemnification and certain limitations contained herein, Noteholders holding not less than a majority of the Outstanding Amount
      shall have the right to direct the time, method and place of conducting any proceeding or any remedy available to the Indenture Trustee or exercising any trust power conferred on the Indenture Trustee, and Noteholders holding not less than a majority
      of the Outstanding Amount may, in certain cases, waive any default with respect thereto, except a default in the payment of principal or interest or a default in respect of a covenant or provision of the Indenture that cannot be modified without the
      waiver or consent of all of the Noteholders of the Outstanding Notes.

     

    Section 5.02      Acceleration of Maturity; Waiver of Indenture Default. 
      If an Indenture Default should occur and be continuing, the Indenture Trustee may (and, at the direction of the Noteholders holding not less than a majority of the Outstanding Amount of the Notes, shall) declare the principal of the Notes to be
      immediately due and payable.  Upon such declaration, the Indenture Trustee shall promptly provide written notice to the Administrator.  Such declaration may be rescinded by Noteholders holding a majority of the Outstanding Amount before a judgment or
      decree for payment of the amount due has been obtained by the Indenture Trustee if (a) the Issuer has deposited with the Indenture Trustee an amount sufficient to pay (i) all interest on and principal of the Notes as if the Indenture Default giving
      rise to such declaration had not occurred and (ii) all amounts advanced by the Indenture Trustee and its costs and expenses and (b) all Indenture Defaults (other than the nonpayment of principal of the Notes that has become due solely by such
      acceleration) have been cured or waived.

     

    At any time prior to the declaration of the acceleration of the maturity of the Notes, Noteholders holding not less than a majority of the Outstanding
      Amount may waive an Indenture Default as set forth in Section 5.12.

     

    If the Notes have been declared due and payable following an Indenture Default, the Indenture Trustee may institute proceedings to collect amounts due,
      exercise remedies as a secured party (including foreclosure or sale of the Trust Estate) or elect to maintain the Trust

     

    
      37

      
        

    

    

    

    Estate and continue to apply the proceeds from the Trust Estate as if there had been no declaration of acceleration.  Any sale of the Trust Estate by the Indenture Trustee
      will be subject to the terms and conditions of Section 5.04.

     

    Section 5.03      Collection of Indebtedness and Suits for Enforcement by Indenture
          Trustee.

     

    (a)            The Issuer covenants that if there is a default in the payment of (i) any interest on the Notes when the same becomes due and payable, and such default continues for a period of five days or (ii) the principal of
        the Notes at the Note Final Scheduled Payment Date or the Redemption Date, the Issuer shall, upon demand of the Indenture Trustee, pay to the Indenture Trustee, for the benefit of such Noteholders, the entire amount then due and payable on such
        Notes for principal and interest, with interest on the overdue principal, and, to the extent payment at such rate of interest shall be legally enforceable, upon overdue installments of interest, at the Overdue Interest Rate and in addition thereto,
        such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Indenture Trustee and its agents, attorneys and counsel.

     

    (b)            In case the Issuer shall fail forthwith to pay amounts described in Section 5.03(a) upon demand, the Indenture Trustee, in its own name and as trustee of an express trust, may institute a Proceeding for the
        collection of the sums so due and unpaid, and may prosecute such Proceeding to judgment or final decree, and may enforce the same against the Issuer or other obligor upon such Notes and collect in the manner provided by law out of the property of
        the Issuer or other obligor upon such Notes, wherever situated, the monies adjudged or decreed to be payable.

     

    (c)            If an Indenture Default occurs and is continuing, the Indenture Trustee may, in its discretion, proceed to protect and enforce its rights and the rights of the Noteholders [and each Swap Counterparty], by such
        appropriate Proceedings as the Indenture Trustee shall deem most effective to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted
        herein, or to enforce any other proper remedy or legal or equitable right vested in the Indenture Trustee by this Indenture or by law.

     

    (d)            In case there shall be pending, relative to the Issuer or any other obligor upon the Notes or any Person having or claiming an ownership interest in the Trust Estate, Proceedings under Title 11 of the Code or any
        other applicable federal or state bankruptcy, insolvency or other similar law, or in case a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed for or taken
        possession of the Issuer or its property or such other obligor or Person, or in case of any other comparable judicial Proceedings relative to the Issuer or other obligor upon the Notes, or to the property of the Issuer or such other obligor, the
        Indenture Trustee, irrespective of whether the principal of any Notes shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Indenture Trustee shall have made any demand pursuant to the
        provisions of this Section, shall be entitled and empowered, by intervention in such Proceedings or otherwise:

     

    
      38

      
        

    

    

    

    (i)            to file and prove a claim or claims for the whole amount of principal and interest owing and unpaid in respect of the Notes and to file such other papers or documents as may be necessary or
        advisable in order to have the claims of the Indenture Trustee (including any claim for reasonable compensation to the Indenture Trustee and each predecessor Indenture Trustee, and their respective agents, attorneys and counsel, and for
        reimbursement of all expenses and liabilities incurred, and all advances and disbursements made, by the Indenture Trustee and each predecessor Indenture Trustee, except as a result of negligence or bad faith) and of the Noteholders allowed in such
        Proceedings;

     

    (ii)            unless prohibited by applicable law and regulations, to vote on behalf of the Noteholders [and, if applicable, each Swap Counterparty] in any election of a trustee, a standby trustee or
        Person performing similar functions in any such Proceedings;

     

    (iii)            to collect and receive any monies or other property payable or deliverable on any such claims and to distribute all amounts received with respect to the claims of the Noteholders [, each Swap
        Counterparty] and the Indenture Trustee on their behalf; and

     

    (iv)            to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Indenture Trustee [, each Swap Counterparty] or the Noteholders
        allowed in any judicial proceedings relative to the Issuer, its creditors and its property;

     

    and any trustee, receiver, liquidator, custodian or other similar official in any such Proceeding is hereby authorized by each Noteholder [and each Swap Counterparty] to
      make payments to the Indenture Trustee and, in the event the Indenture Trustee shall consent to the making of payments directly to such Noteholders [and each Swap Counterparty], to pay to the Indenture Trustee such amounts as shall be sufficient to
      cover reasonable compensation to the Indenture Trustee, each predecessor Indenture Trustee and their respective agents, attorneys and counsel, and all other expenses and liabilities incurred and all advances and disbursements made by the Indenture
      Trustee and each predecessor Indenture Trustee except as a result of negligence or bad faith, and any other amounts due the Indenture Trustee under Section 6.07.

     

    (e)            Nothing herein contained shall be deemed to authorize the Indenture Trustee to authorize or consent to or vote for or accept or adopt on behalf of any Noteholder any plan of reorganization, arrangement, adjustment
        or composition affecting the Notes or the rights of any Noteholder or to vote in respect of the claim of any Noteholder in any such proceeding except, as aforesaid, to vote for the election of a trustee in bankruptcy or similar Person.

     

    (f)            All rights of action and of asserting claims under this Indenture, or under the Notes, may be enforced by the Indenture Trustee without the possession of the Notes or the production thereof in any trial or other
        Proceedings relative thereto, and any such action or Proceedings instituted by the Indenture Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment, subject to the payment of the expenses, advances,
        disbursements and compensation of the Indenture Trustee, each predecessor Indenture Trustee and their respective agents, attorneys and counsel shall be for the ratable benefit of the

     

    
      39

      
        

    

    

    

    Noteholders [and each Swap Counterparty] in respect of which such judgment has been recovered.

     

    (g)            In any Proceedings brought by the Indenture Trustee (and also any Proceedings involving the interpretation of any provision of this Indenture to which the Indenture Trustee shall be a party), the Indenture Trustee
        shall be held to represent all the Noteholders [and each Swap Counterparty], and it shall not be necessary to make any Noteholder [nor any Swap Counterparty] a party to any such Proceedings.

     

    Section 5.04      Remedies; Priorities.

     

    (a)            If an Indenture Default shall have occurred and be continuing, the Indenture Trustee may do one or more of the following (subject to Section 5.05):

     

    (i)            institute Proceedings in its own name and as trustee of an express trust for the collection of all amounts then payable on the Notes or under this Indenture with respect thereto, whether by
        declaration or otherwise, enforce any judgment obtained, and collect from the Issuer and any other obligor upon such Notes monies adjudged due;

     

    (ii)            institute Proceedings from time to time for the complete or partial foreclosure of this Indenture with respect to the Trust Estate;

     

    (iii)            exercise any remedies of a secured party under the UCC and take any other appropriate action to protect and enforce the rights and remedies of the Indenture Trustee [, each Swap Counterparty]
        and the Noteholders; and

     

    (iv)            subject to Section 5.17, after an acceleration of the maturity of the Notes pursuant to Section 5.02, sell the Trust Estate or any portion thereof or rights or interest therein, at one or
        more public or private sales called and conducted in any manner permitted by law;

     

    provided, however, the Indenture Trustee may not sell or otherwise liquidate the Trust Estate following an Indenture Default pursuant to clause (iv) above, other than an
      Indenture Default described in Section 5.01 (a) or (b), unless (A) Noteholders holding 100% of the Outstanding Amount consent thereto, (B) the proceeds of such sale are sufficient to discharge in full all amounts then due and unpaid upon all
      outstanding Notes or (C) the Indenture Trustee determines that the Trust Estate will not continue to provide sufficient funds for the payment of principal of and interest on the Notes as they would have become due if the Notes had not been declared
      due and payable and the Indenture Trustee obtains the consent of Noteholders holding not less than 66 2/3% of the Outstanding Amount; provided further, that the Indenture Trustee may not sell the Trust Estate unless it shall first have obtained an Opinion of Counsel that such sale will not cause the Vehicle Trust or an interest therein or
      portion thereof to be characterized as an association or a publicly traded partnership, in either case taxable as a corporation for U.S. federal income tax purposes.  In determining such sufficiency or insufficiency with respect to clauses (B) and
      (C) of the preceding sentence, the Indenture Trustee may but need not obtain (at the expense of the Issuer) and rely upon an opinion of an Independent investment banking or accounting firm of national reputation as to the feasibility of such proposed
      action and as to the sufficiency of the Trust Estate for such purpose.

     

    
      40

      
        

    

    

    

    (b)            If the Indenture Trustee collects any money or property pursuant to this Article Five after an acceleration of the maturity of the Notes pursuant to Section 5.02, it shall pay out such money or property held as
        Collateral (and other amounts including all amounts held on deposit in the Reserve Fund) for the benefit of the Noteholders, net of liquidation costs associated with the sale of the Trust Estate in the following order:[EACH INDENTURE WILL SPECIFY
        THAT TRUST’S PARTICULAR INDENTURE DEFAULT CASH FLOW PRIORITIES]

     

    (i)            to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent, the Owner Trustee and the Asset Representations Reviewer, pro rata, based on amounts due to each
        such party, for payment of any Trustee and Reviewer Fees and other amounts required to be paid and/or reimbursed to such party pursuant to Section 6.07 of this Indenture, Section 8.01 of the Trust Agreement or pursuant to the terms of the Asset
        Representations Review Agreement, respectively;

     

    (ii)            to the Servicer, for any Payment Date Advance Reimbursement;

     

    (iii)            to the Servicer, for amounts due in respect of accrued and unpaid Servicing Fees;

     

    (iv)            to the Noteholders of the Class A Notes, pro rata, based upon the aggregate amount of interest due to the Noteholders of each Class of Class A Notes, to pay due and unpaid interest, including
        any overdue interest and, to the extent permitted under applicable law, interest on any overdue interest at the applicable Overdue Interest Rate;

     

    (v)            to the Noteholders of the Class A-1 Notes, in payment of the principal amount due and unpaid on the Class A-1 Notes, until paid in full;

     

    (vi)            to the Noteholders of the Class A-2a Notes, Class A-2b Notes, Class A-3 Notes and Class A-4 Notes, pro rata, based on the aggregate outstanding principal amount of each such Class, in payment
        of the principal amount due and unpaid on such Notes until paid in full;

     

    (vii)            to the Noteholders of the Class B Notes, to pay due and unpaid interest, including any overdue interest and, to the extent permitted under applicable law, interest on any overdue interest at
        the applicable Overdue Interest Rate;

     

    (viii)            to the Noteholders of the Class B Notes, in payment of the principal amount due and unpaid on the Class B Notes, until paid in full; and

     

    (ix)            to the Certificateholder, any remaining amounts.

     

    (c)            The Indenture Trustee, pursuant to an Issuer Request may fix a record date and payment date for any payment to Noteholders pursuant to this Section as provided in the Issuer Request.  At least 15 days before such
        record date, the Issuer shall mail to each Noteholder and the Indenture Trustee a notice that states the record date, the payment date and the amount to be paid.

     

    
      41

      
        

    

    

    

    Section 5.05      Optional Preservation of the 20[__]-[__] SUBI Assets.  If
      the Notes have been declared to be due and payable under Section 5.02 following an Indenture Default and such declaration and its consequences have not been rescinded and annulled, the Indenture Trustee may, but need not, elect to maintain possession
      of the Trust Estate and continue to apply the proceeds thereof in accordance with Section 3.01 and 8.04.  It is the intent of the parties hereto and the Noteholders that there be at all times sufficient funds for the payment of principal of and
      interest on the Notes, and the Indenture Trustee shall take such intent into account when determining whether or not to maintain possession of the Trust Estate.  In determining whether to maintain possession of the Trust Estate, the Indenture Trustee
      may but need not obtain (at the expense of the Issuer) and rely upon an opinion of an Independent investment banking or accounting firm of national reputation as to the feasibility of such proposed action and as to the sufficiency of the Trust Estate
      for such purpose.

     

    Section 5.06      Limitation of Suits.

     

    (a)            No holder of any Note shall have any right to institute any Proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder,
        unless: (i) such Noteholder previously has given to the Indenture Trustee written notice of a continuing Indenture Default, (ii) Noteholders holding not less than 25% of the Outstanding Amount have made written request to the Indenture Trustee to
        institute such Proceeding in respect of such Indenture Default in its own name as Indenture Trustee, (iii) such Noteholder has offered the Indenture Trustee reasonable indemnity against the costs, expenses and liabilities to be incurred in
        complying with such request, (iv) the Indenture Trustee has for 60 days failed to institute such Proceedings and (v) no direction inconsistent with such written request has been given to the Indenture Trustee during such 60-day period by
        Noteholders holding a majority of the Outstanding Amount.

     

    No Noteholder or group of Noteholders shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to
      affect, disturb or prejudice the rights of any other Noteholders or to obtain or to seek to obtain priority or preference over any other Noteholder or to enforce any right under this Indenture, except in the manner herein provided.

     

    In the event the Indenture Trustee shall receive conflicting or inconsistent requests and indemnity from two or more groups of Noteholders, each
      representing less than a majority of the Outstanding Amount, the Indenture Trustee shall act in accordance with the request specified by the group of Noteholders with the greatest percentage of the Outstanding Amount, notwithstanding any other
      provisions of this Indenture.

     

    (b)            No Noteholder shall have any right to vote except as provided pursuant to this Indenture and the Notes, nor any right in any manner to otherwise control the operation and management of the Issuer.  However, in
        connection with any action as to which Noteholders are entitled to vote or consent under this Indenture and the Notes, the Issuer may set a record date for purposes of determining the identity of Noteholders entitled to vote or consent in
        accordance with TIA Section 316(c).

     

    
      42

      
        

    

    

    

    Section 5.07      Unconditional Rights of Noteholders to Receive Principal and
          Interest.  Notwithstanding any other provision in this Indenture, any Noteholder shall have the right, which is absolute and unconditional, to receive payment of the principal of and interest on, if any, such Note on or after the
      respective due dates thereof expressed in such Note or this Indenture (or, in the case of redemption, on or after the Redemption Date) and to institute suit for the enforcement of any such payment, and such right shall not be impaired without the
      consent of such Noteholder.

     

    Section 5.08      Restoration of Rights and Remedies.  If the Indenture
      Trustee or any Noteholder has instituted any Proceeding to enforce any right or remedy under this Indenture and such Proceeding has been discontinued or abandoned for any reason or has been determined adversely to the Indenture Trustee or such
      Noteholder, then and in every such case the Issuer, the Indenture Trustee and the Noteholders shall, subject to any determination in such Proceeding, be restored severally and respectively to their former positions hereunder, and thereafter all
      rights and remedies of the Indenture Trustee and the Noteholders shall continue as though no such Proceeding had been instituted.

     

    Section 5.09      Rights and Remedies Cumulative.  No right or remedy
      herein conferred upon or reserved to the Indenture Trustee [, each Swap Counterparty] or the Noteholders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in
      addition to every other right and remedy given hereunder or now or hereafter existing at law, in equity or otherwise.  The assertion or employment of any right or remedy hereunder or otherwise shall not prevent the concurrent assertion or employment
      of any other appropriate right or remedy.

     

    Section 5.10      Delay or Omission Not a Waiver.  No delay or omission of
      the Indenture Trustee [, any Swap Counterparty] or any Noteholder to exercise any right or remedy accruing upon any Default or Indenture Default shall impair any such right or remedy or constitute a waiver of any such Default or Indenture Default or
      an acquiescence therein.  Every right and remedy given by this Article or by law to the Indenture Trustee [, each Swap Counterparty] or the Noteholders may be exercised from time to time, and as often as may be deemed expedient, by the Indenture
      Trustee[, any Swap Counterparty] or by the Noteholders, as the case may be.

     

    Section 5.11      Control by Noteholders.  Subject to the provisions of
      Sections 5.06, 6.02(d) and 6.02(e), Noteholders holding not less than a majority of the Outstanding Amount shall have the right to direct the time, method and place of conducting any Proceeding for any remedy available to the Indenture Trustee with
      respect to the Notes or with respect to the exercise of any trust or power conferred on the Indenture Trustee, provided that:

     

    (a)            such direction shall not be in conflict with any rule of law or this Indenture;

     

    (b)            subject to Section 5.04, any direction to the Indenture Trustee to, sell or liquidate the Trust Estate shall be made by Noteholders holding not less than 100% of the Outstanding Amount;

     

    (c)            if the conditions set forth in Section 5.05 have been satisfied and the Indenture Trustee elects to retain the Trust Estate pursuant to such Section, and except in the case of a sale

     

    
      43

      
        

    

    

    

    of the Trust Estate pursuant to Section 2.19 of the Servicing Agreement, then any direction to the Indenture Trustee by Noteholders holding less than 100% of the
      Outstanding Amount to sell or liquidate the Trust Estate shall be of no force and effect; and

     

    (d)            the Indenture Trustee may take any other action deemed proper by the Indenture Trustee that is not inconsistent with such direction.

     

    Notwithstanding the rights of Noteholders set forth in this Section, subject to Section 6.01, the Indenture Trustee need not take any action it
      determines might expose it to personal liability or might materially adversely affect or unduly prejudice the rights of any Noteholders not consenting to such action, or is contrary to law or this Indenture.

     

    Section 5.12      Waiver of Past Defaults.  Prior to the acceleration of
      the maturity of the Notes as provided in Section 5.02, Noteholders holding not less than a majority of the Outstanding Amount, by written notice to the Issuer and the Indenture Trustee, may waive any such Indenture Default and its consequences except
      an Indenture Default (i) in payment of principal of or interest on the Notes or (ii) in respect of a covenant or provision hereof that cannot be modified or amended without the consent of each Noteholder.  In the case of any such waiver, the Issuer,
      the Indenture Trustee and the Noteholders shall be restored to their former positions and rights hereunder, respectively, but no such waiver shall extend to any subsequent or other Indenture Default or impair any right consequent thereto.

     

    Upon any such waiver, such Indenture Default shall cease to exist and be deemed to have been cured and not to have occurred, and any Indenture Default
      arising therefrom shall be deemed to have been cured and not to have occurred for every purpose of this Indenture, but no such waiver shall extend to any subsequent or other Indenture Default or impair any right consequent thereto.

     

    Section 5.13      Undertaking for Costs.  All parties to this Indenture
      agree, and each Noteholder by such Noteholder’s acceptance of a Note shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the
      Indenture Trustee for any action taken, suffered or omitted by it as Indenture Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs,
      including reasonable attorneys’ fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant, but the provisions of this Section shall not apply to (i) any suit
      instituted by the Indenture Trustee, (ii) any suit instituted by any Noteholder or group of Noteholders, in each case holding in the aggregate more than 10% of the Outstanding Amount or (iii) any suit instituted by any Noteholder for the enforcement
      of the payment of principal of or interest on any Note on or after the related due dates expressed in such Note and in this Indenture (or, in the case of redemption, on or after the Redemption Date).

     

    Section 5.14      Waiver of Stay or Extension Laws.  The Issuer covenants
      (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead or in any manner whatsoever, claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force,
      that may affect the covenants or the performance

     

    
      44

      
        

    

    

    

    of this Indenture, and the Issuer (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will
      not hinder, delay or impede the execution of any power herein granted to the Indenture Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.

     

    Section 5.15      Action on Notes.  The Indenture Trustee’s right to seek
      and recover judgment on the Notes or under this Indenture shall not be affected by the seeking, obtaining or application of any other relief under or with respect to this Indenture.  Neither the lien of this Indenture nor any rights or remedies of
      the Indenture Trustee or the Noteholders shall be impaired by the recovery of any judgment by the Indenture Trustee against the Issuer or by the levy of any execution under such judgment upon any portion of the Trust Estate or upon any of the assets
      of the Issuer.  Any money or property collected by the Indenture Trustee as a recovery of any judgment on the Notes or under this Indenture shall be applied in accordance with Section 5.04(b).

     

    Section 5.16      Performance and Enforcement of Certain Obligations.

     

    (a)            Promptly following a request from the Indenture Trustee to do so, the Issuer shall take all such lawful action as the Indenture Trustee may request to compel or secure the performance and observance by the Servicer
        of its obligations to the Issuer under or in connection with the Servicing Agreement in accordance with the terms thereof, and to exercise any and all rights, remedies, powers and privileges lawfully available to the Issuer under or in connection
        with each such agreement to the extent and in the manner directed by the Indenture Trustee, including the transmission of notices of default on the part of the Servicer thereunder and the institution of legal or administrative actions or
        proceedings to compel or secure performance by the Servicer of its obligations under the Servicing Agreement.

     

    (b)            If an Indenture Default has occurred and is continuing, the Indenture Trustee may, and at the direction (which direction shall be in writing) of Noteholders holding not less than a majority of the Outstanding
        Amount, shall, exercise all rights, remedies, powers, privileges and claims of the Issuer against the Vehicle Trustee or the Servicer under or in connection with the Servicing Agreement or the Servicing Supplement, as applicable, including the
        right or power to take any action to compel or secure performance or observance by the Servicer of its obligations to the Issuer thereunder and to give any consent, request, notice, direction, approval, extension or waiver under the Servicing
        Agreement, and any right of the Issuer to take such action shall be suspended.

     

    Section 5.17      Sale of Trust Estate.  If the Indenture Trustee acts to
      sell the Trust Estate or any part thereof, pursuant to Section 5.04(a), the Indenture Trustee shall publish a notice in an Authorized Newspaper stating that the Indenture Trustee intends to effect such a sale in a commercially reasonable manner and
      on commercially reasonable terms, which shall include the solicitation of competitive bids.  Following such publication, the Indenture Trustee shall, unless otherwise prohibited by applicable law from any such action, sell the Trust Estate or any
      part thereof, in such manner and on such terms as provided above to the highest bidder, provided, however, that the Indenture Trustee may from time to time postpone any sale by public announcement made at the time and place of such sale.  The
      Indenture Trustee shall give notice to the Transferor and Servicer of any proposed sale, and the Transferor and Servicer shall be

     

    
      45

      
        

    

    

    

    permitted to bid for the Trust Estate at any such sale.  The Indenture Trustee may obtain a prior determination from a conservator, receiver or trustee in bankruptcy of the
      Issuer that the terms and manner of any proposed sale are commercially reasonable.  The power to effect any sale of any portion of the Trust Estate pursuant to Section 5.04 and this Section 5.17 shall not be exhausted by any one or more sales as to
      any portion of the Trust Estate remaining unsold, but shall continue unimpaired until the entire Trust Estate shall have been sold or all amounts payable on the Notes shall have been paid.

     

    ARTICLE SIX

      

      THE INDENTURE TRUSTEE

     

    Section 6.01      Duties of Indenture Trustee.

     

    (a)            If a Responsible Officer of the Indenture Trustee has actual knowledge that an Indenture Default has occurred and is continuing, the Indenture Trustee shall exercise the rights and powers vested in it by this
        Indenture with the same degree of care and skill as a prudent Person would use in the conduct of such Person’s own affairs.

     

    (b)            Except during the continuance of an Indenture Default, the Indenture Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture, and no implied covenants or
        obligations shall be read into this Indenture against the Indenture Trustee.

     

    (c)            The Indenture Trustee shall not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:

     

    (i)            this paragraph does not limit the effect of paragraph (b);

     

    (ii)            the Indenture Trustee shall not be liable for any error of judgment made in good faith unless it is proved that the Indenture Trustee was negligent in ascertaining the pertinent facts; and

     

    (iii)            the Indenture Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 5.11.

     

    (d)            Every provision of this Indenture that in any way relates to the Indenture Trustee is subject to paragraphs (a), (b) and (c).

     

    (e)            The Indenture Trustee shall not be liable for interest on any money received by it except as the Indenture Trustee may agree in writing with the Issuer.

     

    (f)            Money held in trust by the Indenture Trustee need not be segregated from other funds of the Indenture Trustee except to the extent required by law or the terms of this Indenture.

     

    (g)            No provision of this Indenture shall require the Indenture Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties

     

    
      46

      
        

    

    

    

    hereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayments of such funds or indemnity satisfactory to it
      against such risk or liability is not reasonably assured to it.

     

    (h)            Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Indenture Trustee shall be subject to the provisions of this Section and to the provisions of
        the TIA.

     

    (i)            The Indenture Trustee shall not be deemed to have knowledge of any Indenture Default, Default, Servicer Default, breach of representation or warranty or other event unless a Responsible Officer has actual knowledge
        thereof or has received written notice thereof in accordance with the provisions of this Indenture.  For the avoidance of doubt, receipt by the Indenture Trustee of a Review Report under the Asset Representations Review Agreement shall not
        constitute knowledge of any such breach.

     

    (j)            The Indenture Trustee shall have no duty (A) to see to any recording, filing, or depositing of this Indenture or any agreement referred to herein or any financing statement or continuation statement evidencing a
        security interest, or to see to the maintenance of any such recording or filing or depositing or to any rerecording, refiling or redepositing of any thereof, (B) to see to any insurance, or (C) to see to the payment or discharge of any tax,
        assessment, or other governmental charge or any lien or encumbrance of any kind owing with respect to, assessed or levied against, any part of the Trust Estate.

     

    (k)            In no event shall the Indenture Trustee be required to perform, or be responsible for the manner of performance of, any of the obligations of the Servicer or any other party under the Servicing Agreement.

     

    (l)            The Indenture Trustee shall determine the Benchmark as of [___] for so long as the Class A-2b Notes are Outstanding.  All determinations of the Benchmark by the Indenture Trustee, in absence of manifest error, shall
        be conclusive for all purposes and binding on the Noteholders.

     

    (m)            The Indenture Trustee undertakes to perform the duties of Certificate Registrar and Paying Agent as specifically set forth in Sections 3.04, 3.09, 5.01, 5.02, 5.03, 9.01 and 12.08 of the Trust Agreement and no
        implied covenants or obligations shall be read into the Trust Agreement against the Indenture Trustee when acting as Certificate Registrar and Paying Agent thereunder.

     

    (n)            In the absence of bad faith on its part, the Indenture Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished
        to the Indenture Trustee and conforming to the requirements of this Indenture; provided, however, that the Indenture Trustee shall not be responsible for the accuracy or content of any such certificate or opinion; however, the Indenture Trustee
        shall examine the certificates and opinions to determine whether or not they conform on their face to the requirements of this Indenture and the other Basic Documents to which the Indenture Trustee is a party.

     

    Section 6.02      Rights of Indenture Trustee.

     

    
      47

      
        

    

    

    

    (a)            Except as provided by the second succeeding sentence, the Indenture Trustee may conclusively rely and shall be protected in acting upon or refraining from acting upon any resolution, certificate, statement,
        instrument, opinion, report, notice, request, consent, order, note, direction, demand, election or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper person.  The Indenture Trustee
        need not investigate any fact or matter stated in the document.  Notwithstanding the foregoing, the Indenture Trustee, upon receipt of all resolutions, certificates, statements, opinions, reports, documents, orders or other instruments furnished to
        the Indenture Trustee that shall be specifically required to be furnished pursuant to any provision of this Indenture, shall examine them to determine whether they comply as to form on their face to the requirements of this Indenture.

     

    (b)            Before the Indenture Trustee acts or refrains from acting, it may require an Officer’s Certificate (with respect to factual matters) or an Opinion of Counsel, as applicable.  The Indenture Trustee shall not be
        liable for any action it takes or omits to take in good faith in reliance on such Officer’s Certificate or Opinion of Counsel.

     

    (c)            The Indenture Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys or a custodian or nominee, and the Indenture Trustee shall
        not be responsible for any misconduct or negligence on the part of, or for the supervision of, the Administrator, any co-trustee or separate trustee appointed in accordance with the provisions of Section 6.10 or any other such agent, attorney,
        custodian or nominee appointed with due care by it hereunder.

     

    (d)            The Indenture Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within its rights or powers; provided, however, that the Indenture Trustee’s
        conduct does not constitute willful misconduct, negligence or bad faith.

     

    (e)            The Indenture Trustee may consult with counsel, and the advice of such counsel or any Opinion of Counsel with respect to legal matters relating to this Indenture and the Notes shall be full and complete
        authorization and protection from liability in respect to any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel.

     

    (f)            The Indenture Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture or to institute, conduct or defend any litigation under this Indenture or in relation to this
        Indenture at the request or direction of any of the Noteholders pursuant to this Indenture, other than requests, demands or directions explicitly required to be honored by the Indenture Trustee pursuant to Sections 12.01, 12.02 or 12.04 of this
        Indenture or Section 1.21 of the Issuer Administration Agreement, unless such Noteholders shall have offered to the Indenture Trustee security or indemnity satisfactory to it against the reasonable costs, expenses, disbursements, advances and
        liabilities that might be incurred by it, its agents and its counsel in compliance with such request or direction.

     

    (g)            The Indenture Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval,
        bond or other paper or document, unless requested in writing to

     

    
      48

      
        

    

    

    

    do so by Noteholders evidencing not less than 50% of the Outstanding Amount; provided, however, that if the payment within a reasonable time to the Indenture Trustee of the
      costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of the Indenture Trustee, not reasonably assured to the Indenture Trustee by the security afforded to it by the terms of this Indenture,
      the Indenture Trustee may require indemnity satisfactory to it against such cost, expense or liability as a condition to so proceeding.  The reasonable expense of each such investigation shall be paid by the Person making such request, or, if paid by
      the Indenture Trustee, shall be reimbursed by the Person making such request upon demand.

     

    (h)            Any request or direction of the Issuer mentioned herein shall be sufficiently evidenced by an Issuer Request.

     

    (i)            In the event that the Indenture Trustee is also acting as Paying Agent, Note Registrar, Certificate Registrar or Securities Intermediary under this Indenture or any of the Basic Documents, the rights and protections
        afforded the Indenture Trustee pursuant to this Indenture shall be afforded to such Paying Agent, Note Registrar, Certificate Registrar or Securities Intermediary.

     

    (j)            The right of the Indenture Trustee to perform any discretionary act enumerated in this Indenture shall not be construed as a duty, and the Indenture Trustee shall not be answerable for other than its negligence or
        willful misconduct in the performance of such act.

     

    (k)            The Indenture Trustee shall not be required to give any bond or surety in respect of the powers granted hereunder.

     

    (l)            For the avoidance of doubt, the Indenture Trustee shall not have any duty or obligation to monitor or enforce the Sponsor’s compliance with any applicable risk retention rules or regulations.  The Indenture Trustee
        shall not be charged with knowledge of any such rules or regulations, and it shall not be liable to any Noteholder or any other Person for any violation of any such rules or regulations.

     

    (m)            Subject to Sections 6.01(a) and (c), in no event shall the Indenture Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or
        indirectly, by a Force Majeure event, provided such failure or delay in performance could not have been prevented by the taking of commercially reasonable precautions such as the implementation and execution of disaster recovery plans.
        Notwithstanding the occurrence of a foregoing event, the Indenture Trustee shall perform its obligations hereunder to the extent it is able to do so under such event. The Indenture Trustee shall use reasonable efforts which are consistent with
        accepted practices in the banking industry to prevent any failure or delay in performance and to resume performance as soon as practicable under the circumstances.

     

    (n)            In no event shall the Indenture Trustee be liable for failure to perform its duties under this Indenture if (i) such failure is a direct or proximate result of another party’s failure to perform its obligations
        under this Indenture, (ii) such other party’s failure was not a direct or proximate result of the Indenture Trustee’s willful misconduct, bad faith or negligence and (iii)

     

    
      49

      
        

    

    

    

    such failure by the Indenture Trustee does not constitute willful misconduct, negligence or bad faith.

     

    Section 6.03      Individual Rights of Indenture Trustee.  The Indenture
      Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer or its Affiliates with the same rights it would have if it were not Indenture Trustee.  Any Paying Agent, Note Registrar,
      co-registrar, co-paying agent, co-trustee or separate trustee may do the same with like rights.  The Indenture Trustee must, however, comply with Section 6.11.

     

    Section 6.04      Indenture Trustee’s Disclaimer.  The Indenture Trustee
      shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture, the Trust Estate or the Notes, shall not be accountable for the Issuer’s use of the proceeds from the Notes sold to the Underwriters and shall
      not be responsible for any statement in the Indenture or in any document issued in connection with the sale of the Notes or in the Notes, all of which shall be taken as the statements of the Issuer, other than the Indenture Trustee’s certificate of
      authentication.

     

    Section 6.05      Notice of Defaults.  If an Indenture Default occurs and
      is continuing, and a Responsible Officer of the Indenture Trustee has actual knowledge thereof, the Indenture Trustee shall mail to each Noteholder [, each Swap Counterparty] and the Administrator notice of such Indenture Default within 90 days after
      it occurs.  Except in the case of an Indenture Default with respect to payment of principal of or interest on any Note (including payments pursuant to the redemption of Notes), the Indenture Trustee may withhold such notice if and so long as a
      committee of its Responsible Officers in good faith determines that withholding such notice is in the interests of the Noteholders [and each Swap Counterparty]; provided, however, that in the case of any Indenture Default of the character specified
      in Section 5.01(d), no such notice shall be given until at least 30 days after the occurrence thereof.

     

    Section 6.06      Reports by Indenture Trustee to Noteholders.  The
      Indenture Trustee, at the expense of the Issuer, shall deliver to each Noteholder, not later than the latest date permitted by law, such information as may be reasonably requested (and reasonably available to the Indenture Trustee) to enable such
      holder to prepare its federal and state income tax returns.  On each Payment Date, the Indenture Trustee shall make available to the Noteholders, via the Indenture Trustee’s internet website at https:[___] (or via such other internet website as may
      be designated by the Indenture Trustee for such purpose), the related Payment Date Certificate received by it from the Servicer pursuant to Section 8.03.  Noteholders with questions may direct them to the Indenture Trustee’s bondholder services group
      at [___].

     

    Section 6.07      Compensation and Indemnity.  The Indenture Trustee shall
      be entitled to the Indenture Trustee Fee as compensation for its services hereunder.  The Issuer shall (i) pay the Indenture Trustee Fee, (ii) reimburse the Indenture Trustee for all reasonable expenses (which shall include reasonable (and customary)
      out-of-pocket compensation and expenses (including extraordinary expenses), disbursements and advances of the Indenture Trustee’s agents, counsel, accountants and experts but shall exclude overhead), advances and disbursements reasonably incurred and
      (iii) indemnify the Indenture Trustee and any of its directors, officers, employees and agents (each, an “Indemnified Party”) for, and hold it harmless

     

    
      50

      
        

    

    

    

    against, any and all loss, liability or expense (including extraordinary expenses) (including reasonable attorneys’ fees and expenses, including those incurred by an
      Indemnified Party in defending against any claim relating to the actions or inactions of the Indemnified Party or in connection with the enforcement of any indemnification or other obligation of the Issuer) incurred by it in connection with the
      administration of the Issuer or the performance of its duties.  The fees, expenses and indemnities described in the immediately preceding sentence shall be paid and/or reimbursed by the Issuer pursuant to the terms of Sections 5.04 or 8.04 of this
      Indenture, as applicable.  The Indenture Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Indenture Trustee shall notify the Issuer and the Administrator promptly of any claim for which it
      may seek indemnity.  Failure by the Indenture Trustee to so notify the Issuer and the Administrator shall not relieve the Issuer of its obligations hereunder.  The Issuer shall, or shall cause the Administrator to, defend any such claim, and the
      Indenture Trustee may have separate counsel and the Issuer shall pay the fees and expenses of such counsel.  Notwithstanding the foregoing, the Indenture Trustee shall not be indemnified by the Issuer against any loss, liability or expense incurred
      by it through its own willful misconduct, negligence or bad faith, except that the Indenture Trustee shall not be liable (i) for any error of judgment made by it in good faith unless it is proved that the Indenture Trustee was negligent in
      ascertaining the pertinent facts, (ii) with respect to any action it takes or omits to take in good faith in accordance with a direction received by it from the Noteholders in accordance with the terms of this Indenture and (iii) for interest on any
      money received by it except as the Indenture Trustee and the Issuer may agree in writing.  The Indenture Trustee shall not be deemed to have knowledge of any event unless a Responsible Officer of the Indenture Trustee has actual knowledge thereof or
      has received written notice thereof.

     

    The Issuer’s payment obligations and indemnities to the Indenture Trustee pursuant to this Section shall survive the discharge of this Indenture or the
      earlier resignation or removal of the Indenture Trustee.  When the Indenture Trustee incurs expenses after the occurrence of a Default set forth in Section 5.01(e) or (f) with respect to the Issuer, the expenses are intended to constitute expenses of
      administration under Title 11 of the Code or any other applicable federal or state bankruptcy, insolvency or similar law.

     

    Section 6.08      Replacement of Indenture Trustee.  The Indenture Trustee
      may resign at any time with 30 days’ prior written notice to the Issuer, the Servicer and the Administrator. The Issuer shall remove the Indenture Trustee, with 30 days’ prior written notice, if:

     

    (i)            the Indenture Trustee fails to comply with Section 6.11;

     

    (ii)            a court having jurisdiction in the premises in respect of the Indenture Trustee in an involuntary case or proceeding under federal or state banking or bankruptcy laws, as now or hereafter
        constituted, or any other applicable federal or state bankruptcy, insolvency or other similar law, shall have entered a decree or order granting relief or appointing a receiver, liquidator, assignee, custodian, trustee, conservator, sequestrator
        (or similar official) for the Indenture Trustee or for any substantial part of the Indenture Trustee’s property, or ordering the winding-up or liquidation of the Indenture Trustee’s affairs, provided any such decree or order shall have continued
        unstayed and in effect for a period of 30 consecutive days;

     

    
      51

      
        

    

    

    

    (iii)            the Indenture Trustee commences a voluntary case under any federal or state banking or bankruptcy laws, as now or hereafter constituted, or any other applicable federal or state bankruptcy,
        insolvency or other similar law, or consents to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee, conservator, sequestrator or other similar official for the Indenture Trustee or for any substantial
        part of the Indenture Trustee’s property, or makes any assignment for the benefit of creditors or fails generally to pay its debts as such debts become due or takes any corporate action in furtherance of any of the foregoing; or

     

    (iv)            the Indenture Trustee otherwise becomes incapable of acting.

     

    Upon the resignation or required removal of the Indenture Trustee (the Indenture Trustee in any such event being referred to herein as the retiring
      Indenture Trustee), the Issuer shall be required promptly to appoint a successor Indenture Trustee.  Any successor Indenture Trustee must at all times have a combined capital and surplus of at least $50,000,000, a long-term debt rating of “[_]” or
      better by or is otherwise acceptable to, each Rating Agency and satisfy the requirements of Section 310(a) of the TIA. Additionally, prior to the appointment of any successor Indenture Trustee, the Rating Agency Condition must be satisfied with
      respect to such successor Indenture Trustee.

     

    A successor Indenture Trustee shall deliver a written acceptance of its appointment to the retiring Indenture Trustee and to the Issuer.  Thereupon the
      resignation or removal of the retiring Indenture Trustee shall become effective and the successor Indenture Trustee, without any further act, deed or conveyance, shall have all the rights, powers and duties of the Indenture Trustee under this
      Indenture, subject to satisfaction of the Rating Agency Condition.  The successor Indenture Trustee shall mail a notice of its succession to Noteholders.  The retiring Indenture Trustee shall promptly transfer all property held by it as Indenture
      Trustee to the successor Indenture Trustee.  The retiring Indenture Trustee shall not be responsible for any acts or omissions of any successor Indenture Trustee.

     

    If a successor Indenture Trustee does not take office within 45 days after the retiring Indenture Trustee resigns or is removed, the retiring Indenture
      Trustee, the Issuer or Noteholders holding not less than a majority of the Outstanding Amount may petition any court of competent jurisdiction for the appointment of a successor Indenture Trustee.

     

    If the Indenture Trustee fails to comply with Section 6.11, any Noteholder may petition any court of competent jurisdiction for the removal of the
      Indenture Trustee and the appointment of a successor Indenture Trustee.

     

    Any resignation or removal of the Indenture Trustee and appointment of a successor Indenture Trustee pursuant to any of the provisions of this Section
      shall not become effective until acceptance of appointment by the successor Indenture Trustee pursuant to this Section and payment of all fees and expenses owed to the outgoing Indenture Trustee.  Notwithstanding the replacement of the Indenture
      Trustee pursuant to this Section, the retiring Indenture Trustee shall be entitled to payment or reimbursement of such amounts as such Person is entitled pursuant to Section 6.07.  Any costs associated with the resignation or removal of the Indenture
      Trustee shall be paid by the Servicer, in its capacity as Administrator.

     

    
      52

      
        

    

    

    

    Section 6.09      Successor Indenture Trustee by Merger.  If the Indenture
      Trustee consolidates with, merges or converts into, or transfers all or substantially all its corporate trust business or assets to another corporation or depository institution the resulting, surviving or transferee corporation, without any further
      act, shall be the successor Indenture Trustee; provided, that such corporation or depository institution shall be otherwise qualified and eligible under Section 6.11.  The Indenture Trustee shall provide the Administrator written notice of any such
      transaction within 30 days of such consolidation or merger.

     

    In case at the time such successor or successors by merger, conversion or consolidation to the Indenture Trustee shall succeed to the trusts created by
      this Indenture, the Notes shall have been authenticated but not delivered, any such successor to the Indenture Trustee may adopt the certificate of authentication of any predecessor trustee and deliver such Notes so authenticated, and in case at that
      time the Notes shall not have been authenticated, any successor to the Indenture Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Indenture Trustee, and in all such cases such
      certificates shall have the full force that it is anywhere in the Notes or in this Indenture provided that the certificate of the Indenture Trustee shall have.

     

    Section 6.10      Appointment of Co-Trustee or Separate Trustee.

     

    (a)            Notwithstanding any other provisions of this Indenture, at any time, for the purpose of meeting any legal requirement of any jurisdiction in which any part of the Trust Estate may at the time be located, the
        Indenture Trustee shall have the power and may execute and deliver all instruments to appoint at its own expense one or more Persons to act as a co-trustee or co-trustees, or separate trustee or separate trustees, of all or any part of the
        Collateral, and to vest in such Person or Persons, in such capacity and for the benefit of the Noteholders, such title to the Trust Estate or any part hereof and, subject to the other provisions of this Section, such powers, duties, obligations,
        rights and trusts as the Indenture Trustee and the Administrator may consider necessary or desirable.  No co-trustee or separate trustee hereunder shall be required to meet the terms of eligibility as a successor trustee under Section 6.11 and no
        notice to Noteholders of the appointment of any co-trustee or separate trustee shall be required under Section 6.08.

     

    (b)            Every separate trustee and co-trustee shall, to the extent permitted by law, be appointed and act subject to the following provisions and conditions:

     

    (i)            all rights, powers, duties and obligations conferred or imposed upon the Indenture Trustee shall be conferred or imposed upon and exercised or performed by the Indenture Trustee and such
        separate trustee or co-trustee jointly (it being intended that such separate trustee or co-trustee is not authorized to act separately without the Indenture Trustee joining in such act), except to the extent that under any law of any jurisdiction
        in which any particular act or acts are to be performed, the Indenture Trustee shall be incompetent or unqualified to perform such act or acts, in which event such rights, powers, duties and obligations (including the holding of title to the
        Collateral or any portion thereof in any such jurisdiction) shall be exercised and performed singly by such separate trustee or co-trustee, but solely at the direction of the Indenture Trustee;

     

    
      53

      
        

    

    

    

    (ii)            no separate trustee or co-trustee hereunder shall be personally liable by reason of any act or omission of any other trustee hereunder; and

     

    (iii)            the Indenture Trustee may at any time accept the resignation of or remove any separate trustee or co-trustee.

     

    (c)            Any notice, request or other writing given to the Indenture Trustee shall be deemed to have been given to each of the then-separate trustees and co-trustees, as effectively as if given to each of them.  Every
        instrument appointing any separate trustee or co-trustee shall refer to this Indenture and the conditions of this Article.  Each separate trustee and co-trustee, upon its acceptance of the trusts conferred, shall be vested with the estates or
        property specified in its instrument of appointment, either jointly with the Indenture Trustee or separately, as may be provided therein, subject to all the provisions of this Indenture and specifically including every provision of this Indenture
        relating to the conduct of, affecting the liability of or affording protection to the Indenture Trustee.  Every such instrument shall be filed with the Indenture Trustee and a copy thereof given to the Administrator.

     

    (d)            Any separate trustee or co-trustee may at any time constitute the Indenture Trustee, its agent or attorney-in-fact with full power and authority, to the extent not prohibited by law, to do any lawful act under or in
        respect of this Indenture on its behalf and in its name.  If any separate trustee or co-trustee shall die, become incapable of acting, resign or be removed, then all of its estates, properties, rights, remedies and trusts shall vest in and be
        exercised by the Indenture Trustee to the extent permitted by law, without the appointment of a new or successor trustee.  Notwithstanding anything to the contrary in this Indenture, the appointment of any separate trustee or co-trustee shall not
        relieve the Indenture Trustee of its obligations and duties under this Indenture.

     

    Section 6.11      Eligibility; Disqualification.  The Indenture Trustee
      shall at all times satisfy the requirements of Section 310(a) of the TIA and shall in addition have a combined capital and surplus of at least $50,000,000 (as set forth in its most recent published annual report of condition) and a long-term debt
      rating of “[_]” or better by, or be otherwise acceptable to, each Rating Agency.  The Indenture Trustee shall satisfy the requirements of Section 310(b) of the TIA.  The Transferor, the Administrator, the Servicer and their respective Affiliates may
      maintain normal commercial banking relationships with the Indenture Trustee and its Affiliates, but neither the Issuer nor any Affiliate of the Issuer may serve as Indenture Trustee.

     

    Section 6.12      Indenture Trustee as Holder of 20[__]-[__] SUBI Certificate. 
      Following the occurrence and continuation of an Indenture Default, to the extent that the Owner Trustee or Issuer has rights as a Holder of the 20[__]-[__] SUBI Certificate, including rights to distributions and notice, or is entitled to consent to
      any actions taken by the Transferor, the Owner Trustee or Issuer may initiate such action or grant such consent only with consent of the Indenture Trustee at the direction of the Noteholders as provided in the following sentence.  Following the
      occurrence and continuation of an Indenture Default of which a Responsible Officer of the Indenture Trustee shall have actual knowledge, the Indenture Trustee shall exercise rights as a Holder of the 20[__]-[__] SUBI Certificate or the right to
      consent or withhold consent with respect to actions taken by the Transferor, the Owner Trustee or Issuer, upon the written direction of holders of Notes representing a majority of the Outstanding Amount, unless

     

    
      54

      
        

    

    

    

    otherwise provided in the Basic Documents, including the requirement that any direction to the Indenture Trustee to remove or replace the Servicer upon a Servicer Default
      shall be made by Noteholders holding not less than 66 2/3% of the Outstanding Amount.

     

    Section 6.13      Representations and Warranties of Indenture Trustee.  The
      Indenture Trustee hereby makes the following representations and warranties as of the Closing Date, on which the Issuer and Noteholders shall rely, and which shall survive the Closing Date:

     

    (i)            the Indenture Trustee is a [______] duly organized and validly existing under the laws of [____];

     

    (ii)            the Indenture Trustee has full power, authority and legal right to execute, deliver, and, perform this Indenture and shall have taken all necessary action to authorize the execution, delivery
        and performance by it of this Indenture; and

     

    (iii)            no consent, license, approval or authorization of, or filing or registration with, any governmental authority, bureau or agency is required to be obtained that has not been obtained by the
        Indenture Trustee in connection with the execution, delivery or performance by the Indenture Trustee of the Basic Documents.

     

    Section 6.14      Furnishing of Documents.  The Indenture Trustee shall
      furnish to any Noteholder promptly upon receipt of a written request by such Noteholder (at the expense of the requesting Noteholder) therefor, duplicates or copies of all reports, notices, requests, demands, certificates and any other instruments
      furnished to the Indenture Trustee under the Basic Documents.

     

    Section 6.15      Preferential Collection of Claims Against the Issuer. 
      The Indenture Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b).  Any Indenture Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated
      therein.

     

    ARTICLE SEVEN

      

      NOTEHOLDERS’ LISTS AND REPORTS

     

    Section 7.01      Issuer to Furnish Indenture Trustee Noteholder Names and Addresses. 
      The Issuer shall furnish or cause to be furnished to the Indenture Trustee (i) not more than five days after each Record Date a list, in such form as the Indenture Trustee may reasonably require, of the names and addresses of the Noteholders as of
      such Record Date and (ii) at such other times as the Indenture Trustee may request in writing, within 30 days after receipt by the Issuer of any such request, a list of similar form and content as of a date not more than ten days prior to the time
      such list is furnished; provided, however, that so long as the Indenture Trustee is the Note Registrar or the Notes are issued as Book-Entry Notes, no such list shall be required to be furnished to the Indenture Trustee.

     

    Section 7.02      Preservation of Information; Communications to Noteholders.

     

    
      55

      
        

    

    

    

    (a)            The Indenture Trustee shall preserve in as current a form as is reasonably practicable the names and addresses of the Noteholders contained in the most recent list furnished to the Indenture Trustee as provided in
        Section 7.01 and the names and addresses of Noteholders received by the Indenture Trustee in its capacity as Note Registrar.  The Indenture Trustee may destroy any list furnished to it as provided in Section 7.01 upon receipt of a new list so
        furnished; provided, however, that so long as the Indenture Trustee is the Note Registrar or the Notes are issued as Book-Entry Notes, no such list shall be required to be preserved or maintained.

     

    (b)            The Noteholders may communicate pursuant to TIA Section 312(b) with other Noteholders regarding their rights under this Indenture or under the Notes.

     

    (c)            The Issuer, the Indenture Trustee and the Note Registrar shall have the protection of TIA Section 312(c).

     

    Section 7.03      Reports by Indenture Trustee.  If required by TIA §
      313(a), within 60 days after each [_________], beginning with [_________], 20[__], the Indenture Trustee shall mail to each Noteholder as required by TIA § 313(c) a brief report dated as of such date that complies with TIA § 313(a).  The Indenture
      Trustee also shall comply with TIA § 313(b).

     

    ARTICLE EIGHT

      

      ACCOUNTS, DISBURSEMENTS AND RELEASES

     

    Section 8.01      Collection of Money.  Except as otherwise expressly
      provided herein, the Indenture Trustee may demand payment or delivery of, and shall receive and collect, directly and without intervention or assistance of any fiscal agent or other intermediary, all money and other property payable to or receivable
      by the Indenture Trustee pursuant to this Indenture.  The Indenture Trustee shall apply all such money received by it as provided in this Indenture.  Except as otherwise expressly provided in this Indenture, if any default occurs in the making of any
      payment or performance under any agreement or instrument that is part of the Trust Estate, the Indenture Trustee may take such action as may be appropriate to enforce such payment or performance, including the institution and prosecution of
      appropriate Proceedings.  Any such action shall be without prejudice to any right to claim an Indenture Default under this Indenture and any right to proceed thereafter as provided in Article Five.

     

    Section 8.02      Accounts.

     

    (a)            The Issuer shall cause the Indenture Trustee to establish and maintain with the Securities Intermediary a segregated securities account in the name of the Indenture Trustee on behalf of the Noteholders, which shall
        be designated as the “Reserve Fund.” The Reserve Fund shall be held for the benefit of the Noteholders [and each Swap Counterparty], and shall bear a designation clearly indicating that the funds on deposit therein are held for the benefit of the
        Noteholders [and each Swap Counterparty].  The Reserve Fund shall be under the sole dominion and control of the Indenture Trustee.  The Reserve Fund initially shall be established with the corporate trust department of [_________________].  If at
        any time the Reserve Fund ceases to be held at an Eligible Institution, the Indenture Trustee shall, within thirty (30) days (or such

     

    
      56

      
        

    

    

    

    longer period in respect of which the Rating Agency Condition shall have been satisfied) following notification of such occurrence, establish a new Reserve Fund at an
      Eligible Institution and shall transfer any cash or investments to such new Reserve Fund.  All deposits to and withdrawals from the Reserve Fund shall be made only upon the terms and conditions of the Basic Documents.

     

    (b)            The Issuer shall establish and maintain with the Indenture Trustee, prior to the Closing Date, a segregated trust account in the name of the Indenture Trustee on behalf of the Noteholders, which shall be designated
        as the “Note Distribution Account”.  The Note Distribution Account shall be held in trust for the benefit of the Noteholders.  The Note Distribution Account shall be under the sole dominion and control of the Indenture Trustee.  The Note
        Distribution Account initially shall be established with the corporate trust department of [_________________].  If at any time the Note Distribution Account ceases to be held at an Eligible Institution, the Indenture Trustee shall, within thirty
        (30) days (or such longer period in respect of which the Rating Agency Condition shall have been satisfied) following notification of such occurrence, establish a new Note Distribution Account at an Eligible Institution and shall transfer any cash
        or investments to such new Note Distribution Account.

     

    (c)            The Issuer shall establish and the Indenture Trustee shall maintain with the Securities Intermediary a segregated trust account in the name of the Issuer, for the exclusive benefit of the holders of interests in the
        20[__]-[__] SUBI, the 20[__]-[__] SUBI Collection Account, which shall be designated as the “20[__]-[__] SUBI Collection Account,” at an Eligible Institution.  The 20[__]-[__] SUBI Collection Account initially shall be established with the
        corporate trust department of [_________________].  If at any time the 20[__]-[__] SUBI Collection Account ceases to be held at an Eligible Institution, the Indenture Trustee shall, within thirty (30) days (or such longer period in respect of which
        the Rating Agency Condition shall have been satisfied) following notification of such occurrence, and with the assistance of the Servicer, as necessary, establish a new 20[__]-[__] SUBI Collection Account at an Eligible Institution and transfer any
        cash or investments to such new 20[__]-[__] SUBI Collection Account.  The 20[__]-[__] SUBI Collection Account shall relate solely to the 20[__]-[__] SUBI and the 20[__]-[__] SUBI Assets, and funds therein shall not be commingled with any other
        monies, except as otherwise provided for in or contemplated by the Servicing Agreement.  All deposits into the 20[__]-[__] SUBI Collection Account shall be made as described in Section 2.2 of the Servicing Agreement.  On each Deposit Date and
        Payment Date, pursuant to the instructions from the Servicer, the Indenture Trustee shall make such deposits to and withdrawals from the 20[__]-[__] SUBI Collection Account as set forth in the Servicing Supplement and in Section 8.04(a) of this
        Indenture.  Any transfer of funds to a Holder of the 20[__]-[__] SUBI Certificate shall be made as directed pursuant to the Basic Documents.

     

    (d)            Pursuant to Section 5.01 of the Trust Agreement, the Owner Trustee will establish (or will cause the Indenture Trustee to establish) a segregated trust account at an Eligible Institution in the name of the Issuer
        which shall be designated the “Certificate Distribution Account”.  The Certificate Distribution Account shall be held in trust for the benefit of the Trust Certificateholders, and shall bear a designation clearly indicating that the funds deposited
        therein are held for the benefit of the Trust Certificateholders.  The Certificate Distribution Account initially shall be established with the corporate trust department of [_________________].

     

    
      57

      
        

    

    

    

    (e)            All monies deposited from time to time in the 20[__]-[__] SUBI Collection Account and the Accounts pursuant to this Indenture or the Servicing Supplement shall be held by the Indenture Trustee as part of the
        Collateral and shall be applied to the purposes herein provided.  All of the Accounts shall be non-interest bearing.

     

    Section 8.03      Payment Date Certificate.

     

    (a)            On the second Business Day preceding each Payment Date prior to [11:00 a.m.], New York City time, the Issuer shall cause the Servicer, to deliver to the Vehicle Trustee, the Indenture Trustee, the Owner Trustee and
        each Paying Agent hereunder or under the Trust Agreement, a certificate (the “Payment Date Certificate”) including, among other things, the following information with
        respect to such Payment Date and the related Collection Period and Accrual Period:

     

    (i)            SUBI Collections for such Collection Period and the amounts allocable to the interest represented by the 20[__]-[__] SUBI Certificate;

     

    (ii)            Available Funds, including amounts with respect to each of items (i) through (iv) of the definition thereof;

     

    (iii)            the amount of interest accrued during such Accrual Period on each Class of the Notes, including the Benchmark (as determined by the Indenture Trustee) for such Accrual Period;

     

    (iv)            the Class A-1 Note Balance, the Class A-2a Note Balance, the Class A-2b Note Balance, the Class A-3 Note Balance, the Class A-4 Note Balance and the Class B Note Balance, in each case before
        and after giving effect to distributions on such Payment Date;

     

    (v)            the aggregate amount of SUBI Collections deposited into the Note Distribution Account and the Certificate Distribution Account, respectively;

     

    (vi)            (A) the amount on deposit in the Reserve Fund before and after giving effect to withdrawals therefrom and deposits thereto in respect of such Payment Date, (B) the Reserve Fund Requirement
        for such Payment Date, (C) the Reserve Fund Deposit Amount, if any, for such Payment Date and (D) the Reserve Fund Draw Amount, if any, for such Payment Date;

     

    (vii)            the Note Distribution Amount for such Payment Date;

     

    (viii)            the amount of the Note Distribution Amount allocable to each Class of the Notes;

     

    (ix)            the First Priority Principal Distribution Amount, the Second Priority Principal Distribution Amount and the Regular Principal Distribution Amount for such Payment Date;

     

    
      58

      
        

    

    

    

    (x)            the Note Factor for each Class of the Notes, after giving effect to the distribution of the Note Distribution Amount;

     

    (xi)            the aggregate amount of Residual Value Losses for such Collection Period;

     

    (xii)            the amount of Sales Proceeds Advances and Monthly Payment Advances included in Available Funds;

     

    (xiii)            any Payment Date Advance Reimbursement for such Payment Date and the amount of Daily Advance Reimbursements included therein;

     

    (xiv)            the Certificate Distribution Amount for such Payment Date;

     

    (xv)            the Servicing Fee for such Payment Date; and

     

    (xvi)            amounts due and payable to each of the Indenture Trustee, the Owner Trustee and the Asset Representations Reviewer, before and after giving effect to distributions from the 20[__]-[__] SUBI
        Collection Account on such Payment Date.

     

    Each amount set forth pursuant to clauses (iii) and (viii) above shall be expressed in the aggregate and as a dollar amount per $1,000 of original
      principal balance of a Note.

     

    The Payment Date Certificate related to the first Collection Period will also include the disclosure required by Rule [4(c)(1)(ii)][4(c)(2)(ii)] of
      Regulation RR.

     

    On each Payment Date, the Indenture Trustee will make such Payment Date Certificate (and, at its option, any additional files containing the same
      information in an alternative format) available to each Person that was a Noteholder as of the close of business on the related Record Date (which shall be Cede & Co. as the nominee of DTC unless Definitive Notes are issued under the limited
      circumstances described herein), and the Administrator via the Indenture Trustee’s internet website. The Indenture Trustee’s internet website shall initially be located at “[____________]”.  Assistance in using the website can be obtained by calling
      the Indenture Trustee’s customer service desk at [___________].  Such parties that are unable to use the website are entitled to have a paper copy mailed to them via first class mail by calling the customer service desk and indicating such. The
      Indenture Trustee shall have the right to change the way such statements are distributed in order to make such distribution more convenient or more accessible to the above parties and the Indenture Trustee shall provide timely and adequate
      notification to all above parties regarding any such changes.  As a condition to access to the Indenture Trustee’s internet website, the Indenture Trustee may require registration and the acceptance of a disclaimer. The Indenture Trustee will not be
      liable for the dissemination of information in accordance with this Indenture. The Indenture Trustee shall be entitled to rely on but shall not be responsible for the content or accuracy of any information provided in the information set forth in the
      Payment Date Certificate and may affix thereto any disclaimer it deems appropriate in its reasonable discretion.

     

    (b)            Neither the Indenture Trustee nor the Paying Agent shall have any duty or obligation to verify or confirm the accuracy of any of the information or numbers set forth in the

     

    
      59

      
        

    

    

    

    Payment Date Certificate delivered to the Indenture Trustee and the Paying Agent in accordance with this Section, and each of the Indenture Trustee and the Paying Agent
      shall be fully protected in relying upon such Payment Date Certificate.

     

    Section 8.04      Disbursement of Funds.

     

    (a)            On the Deposit Date, prior to [3:00 p.m.]., New York City time, the Paying Agent shall, in accordance with the related Payment Date Certificate and pursuant to the instructions of the Servicer, transfer from
        the 20[__]-[__] SUBI Collection Account all Securityholder Available Funds and apply such amount, in accordance with the following priorities:

     

    (i)            to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent, the Owner Trustee and the Asset Representations Reviewer, pro rata, based on amounts due to each
        such party, for payment of any Trustee and Reviewer Fees and other amounts required to be paid and/or reimbursed to such party pursuant to Section 6.07 of this Indenture, Section 8.01 of the Trust Agreement or pursuant to the terms of the Asset
        Representations Review Agreement, respectively, in an aggregate amount not to exceed $[___] in any calendar year;

     

    (ii)            to the Note Distribution Account [and the Swap Counterparty], [pro rata, based on the aggregate Outstanding Amount of the Class A Notes and the amount of any swap termination payment and swap
        payment due and payable by the Issuer to the Swap Counterparty under this clause (ii): (x)] for payment to the Noteholders of each Class of Class A Notes, on a pro rata basis, an amount equal to the interest accrued at the applicable Interest Rate
        for such Class of Class A Notes during the related Accrual Period on the applicable Outstanding Amount for such Class (and, to the extent permitted by applicable law, interest on any overdue interest at the Overdue Interest Rate)[, (y) to the Swap
        Counterparty, the amount of any termination payment due to the Swap Counterparty under the Swap Agreement due to a Swap Termination resulting from a payment default by the Issuer or the insolvency of the Issuer; provided, that if any amounts
        allocable to the Class A Notes are not needed to pay the Class A Noteholders’ accrued and unpaid interest as of such Payment Date, such amounts will be applied to pay the portion, if any, of any Swap Termination payment referred to above remaining
        unpaid, and (z) to the Swap Counterparty, the amount of interest at [____]% due to the Swap Counterparty under the Swap Agreement];

     

    (iii)            to the Note Distribution Account, as payments of principal, an amount equal to the First Priority Principal Distribution Amount attributable to the Notes, in the following order of priority:

     

    (A)            on any Payment Date (so long as the maturity of the Notes has not been accelerated pursuant to Section 5.02):

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to the Class A-2a Noteholders and the Class A-2b Noteholders, pro rata based on their respective Outstanding Amounts on

     

    
      60

      
        

    

    

    

    such Payment Date (until the Class A-2a Note Balance and Class A-2b Note Balance have each been reduced to zero);

     

    3)            third, to the Class A-3 Noteholders (until the Class A-3 Note Balance has been reduced to zero);

     

    4)            fourth, to the Class A-4 Noteholders (until the Class A-4 Note Balance has been reduced to zero); and

     

    5)            fifth, to the Class B Noteholders (until Class B Note Balance has been reduced to zero).

     

     (B)            on any Payment Date after the maturity of the Notes has been accelerated pursuant to Section 5.02:

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to each other Class of Class A Notes pro rata (based on the Outstanding Amount of each such Class on such Payment Date), until the Note Balance of each such Class of Class A Notes has
        been reduced to zero; and

     

    3)            third, to the Class B Noteholders (until the Class B Note Balance has been reduced to zero);

     

    (iv)            to the Note Distribution Account, for payment to the Noteholders of the Class B Notes, an amount equal to the interest accrued at the Class B Interest Rate during the related Accrual Period
        on the applicable Outstanding Amount for the Class B Notes (and, to the extent permitted by applicable law, interest on any overdue interest at the Overdue Interest Rate);

     

    (v)            to the Note Distribution Account, as payments of principal, an amount equal to the Second Priority Principal Distribution Amount attributable to the Notes, in the following order of priority:

     

    (A)            on any Payment Date (so long as the maturity of the Notes has not been accelerated pursuant to Section 5.02):

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to the Class A-2a Noteholders and the Class A-2b Noteholders, pro rata based on their respective Outstanding Amounts on such Payment Date (until the Class A-2a Note Balance and Class
        A-2b Note Balance have each been reduced to zero);

     

    
      61

      
        

    

    

    

    3)            third, to the Class A-3 Noteholders (until the Class A-3 Note Balance has been reduced to zero);

     

    4)            fourth, to the Class A-4 Noteholders (until the Class A-4 Note Balance has been reduced to zero); and

     

    5)            fifth, to the Class B Noteholders (until Class B Note Balance has been reduced to zero).

     

     (B)            on any Payment Date after the maturity of the Notes has been accelerated pursuant to Section 5.02:

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to each other Class of Class A Notes pro rata (based on the Outstanding Amount of each such Class on such Payment Date), until the Note Balance of each such Class of Class A Notes has
        been reduced to zero; and

     

    3)            third, to the Class B Noteholders (until the Class B Note Balance has been reduced to zero);

     

    (vi)            to the Reserve Fund, until the amount on deposit therein equals the Reserve Fund Requirement;

     

    (vii)            to the Note Distribution Account, as payments of principal, an amount equal to the Regular Principal Distribution Amount attributable to each Class of the Notes, in the following order of
        priority:

     

    (A)            on any Payment Date (so long as the maturity of the Notes has not been accelerated pursuant to Section 5.02),

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to the Class A-2a Noteholders and the Class A-2b Noteholders, pro rata based on their respective Outstanding Amounts on such Payment Date (until the Class A-2a Note Balance and Class
        A-2b Note Balance have each been reduced to zero);

     

    3)            third, to the Class A-3 Noteholders (until the Class A-3 Note Balance has been reduced to zero);

     

    4)            fourth, to the Class A-4 Noteholders (until the Class A-4 Note Balance has been reduced to zero); and

     

    
      62

      
        

    

    

    

    5)            fifth, to the Class B Noteholders (until the Class B Note Balance has been reduced to zero).

     

    (B)            on any Payment Date after the maturity of the Notes has been accelerated pursuant to Section 5.02:

     

    1)            first, to the Class A-1 Noteholders (until the Class A-1 Note Balance has been reduced to zero);

     

    2)            second, to each other Class of Class A Notes pro rata (based on the Outstanding Amount of each such Class on such Payment Date), until the Note Balance of each such Class of Class A Notes has
        been reduced to zero; and

     

    3)            third, to the Class B Noteholders (until the Class B Note Balance has been reduced to zero);

     

    (viii)            [(x)] to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent, the Owner Trustee and the Asset Representations Reviewer, pro rata, based on amounts due to
        each such party, for payment of any Trustee and Reviewer Fees and other amounts required to be paid and/or reimbursed to such party pursuant to Section 6.07 of this Indenture, Section 8.01 of the Trust Agreement or pursuant to the terms of the
        Asset Representations Review Agreement, respectively, to the extent any such amounts remain unpaid after application of clause (i) above [and
            (y) any termination payments due to the Swap Counterparty not paid in clause (y) of clause (ii) above]; and

     

    (ix)            to the Certificate Distribution Account, any remaining funds.

     

    (b)            On each Payment Date, after taking into account amounts to be distributed to Noteholders from the 20[__]-[__] SUBI Collection Account, the Servicer will allocate the Reserve Fund Draw Amount, if any, reflected in
        the Payment Date Certificate, with respect to the related Collection Period and will instruct the Indenture Trustee, in writing, to make the following deposits and distributions in the following amounts and order of priority, prior to [3:00 p.m.],
        New York City time:

     

    (i)            to the Servicer, the amount, if any, of the related Payment Date Advance Reimbursement to the extent remaining unpaid;

     

    (ii)            to the Servicer, the amount, if any, of the related Servicing Fee and any unpaid Servicing Fees from prior Collection Periods, in each case to the extent remaining unpaid;

     

    (iii)            to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent, the Owner Trustee and the Asset Representations Reviewer, pro rata, based on amounts due to each
        such party and to the extent remaining unpaid, for payment of any Trustee and Reviewer Fees and other amounts required to be paid and/or reimbursed  to such party pursuant to Section 6.07 of this Indenture, Section 8.01 of the Trust Agreement or
        pursuant to the terms of the Asset Representations Review

     

    
      63

      
        

    

    

    

    Agreement, respectively; provided, that the aggregate amount of any such payments to such parties pursuant to this clause (iii), together with the
      aggregate amount of any payments to such parties pursuant to Section 8.04(a)(i) above, shall not exceed $250,000 in any calendar year;

     

    (iv)            to the Note Distribution Account [and the Swap Counterparty], [pro rata, based on the aggregate Outstanding Amount of the Class A Notes and the amount of any swap termination payment and swap
        payment due and payable by the Issuer to the Swap Counterparty under this clause (ii): (x)] for payment to the Noteholders of each Class of Class A Notes, on a pro rata basis, an amount equal to the interest accrued at the applicable Interest Rate
        for such Class of Class A Notes during the related Accrual Period on the applicable Outstanding Amount for such Class (and, to the extent permitted by applicable law, interest on any overdue interest at the Overdue Interest Rate)[, (y) to the Swap
        Counterparty, the amount of any termination payment due to the Swap Counterparty under the Swap Agreement due to a Swap Termination resulting from a payment default by the Issuer or the insolvency of the Issuer; provided, that if any amounts
        allocable to the Class A Notes are not needed to pay the Class A Noteholders’ accrued and unpaid interest as of such Payment Date, such amounts will be applied to pay the portion, if any, of any Swap Termination payment referred to above remaining
        unpaid, and (z) to the Swap Counterparty, the amount of interest at [____]% due to the Swap Counterparty under the Swap Agreement];

     

    (v)            to the Note Distribution Account, the remaining First Priority Principal Distribution Amount, which will be allocated to pay principal on the Notes in the amounts and order of priority set
        forth in Section 8.04(a)(iii);

     

    (vi)            to the Note Distribution Account, for payment to the Noteholders of the Class B Notes, an amount equal to the interest accrued at the applicable Interest Rate for such Class of Notes during
        the related Accrual Period on the applicable Outstanding Amount for such Class (and, to the extent permitted by applicable law, interest on any overdue interest at the Overdue Interest Rate), in each case to the extent remaining unpaid;

     

    (vii)            to the Note Distribution Account, the remaining Second Priority Principal Distribution Amount, which will be allocated to pay principal on the Notes in the amounts and order of priority set
        forth in Section 8.04(a)(v); and

     

    (viii)            to the Certificate Distribution Account, any remaining amounts.

     

    (c)            If on any Payment Date, after giving effect to all deposits to and withdrawals from the Reserve Fund, the amount on deposit in the Reserve Fund exceeds the Reserve Fund Requirement, each as set forth in the Payment
        Date Certificate, the Indenture Trustee shall deposit any such excess into the Certificate Distribution Account, for distribution to the Trust Certificateholder.  Upon any such distributions to the Trust Certificateholder, the Noteholders will have
        no further rights in, or claims to such amounts, except for such amounts that have been distributed to the Trust Certificateholder in error.  Following the payment in full of the Outstanding Amount of the Notes and of all other amounts owing or to
        be distributed hereunder

     

    
      64

      
        

    

    

    

    to Noteholders or any other Person and the termination of the Issuer, any amount then allocated to the Reserve Fund shall be deposited into the Certificate Distribution
      Account, for distribution to the Trust Certificateholder.

     

    (d)            On each Payment Date or Redemption Date, from the amounts on deposit in the Note Distribution Account, the Indenture Trustee shall duly and punctually distribute payments of principal and interest on the Notes due
        and by check mailed to the Person whose name appears as the registered holder of a Note (or one or more Predecessor Notes) on the Note Register as of the close of business on the related Record Date, except that with respect to Notes registered on
        the Record Date in the name of the nominee of DTC (initially, such nominee to be Cede & Co.), payments will be made by wire transfer in immediately available funds to the account designated by such nominee.  Such checks shall be mailed to the
        Person entitled thereto at the address of such Person as it appears on the Note Register as of the applicable Record Date without requiring that the Note be submitted for notation of payment.  Any reduction in the principal amount of any Note (or
        any one or more Predecessor Notes) affected by any payments made on any Payment Date or Redemption Date shall be binding upon all future holders of any Note issued upon the registration of transfer thereof or in exchange thereof or in lieu thereof,
        whether or not noted thereon.  Amounts properly withheld under the Code by any Person from payment to any Noteholder of interest or principal shall be considered to have been paid by the Indenture Trustee to such Noteholder for purposes of this
        Indenture.  If funds are expected to be available, pursuant to the notice delivered to the Indenture Trustee, for payment in full of the remaining unpaid principal amount of the Notes on a Payment Date or Redemption Date, then the Indenture
        Trustee, in the name of and on behalf of the Issuer, will notify each Person who was the registered holder of a Note as of the Record Date preceding the most recent Payment Date or Redemption Date by notice mailed within 30 days of such Payment
        Date or Redemption Date and the amount then due and payable shall be payable only upon presentation and surrender of the Note at the Corporate Trust Office of the Indenture Trustee or at the office of the Indenture Trustee’s agent appointed for
        such purposes located in The City of New York.

     

    Section 8.05      General Provisions Regarding Accounts.

     

    (a)            For so long as no Default or Indenture Default of which a Responsible Officer of the Indenture Trustee shall have actual knowledge shall have occurred and be continuing, all of the funds in the Reserve Fund shall be
        invested and reinvested by the Indenture Trustee, until the Outstanding Amount has been reduced to zero, at the direction of the Servicer in Permitted Investments, which mature no later than the Deposit Date succeeding the date of such investment,
        including those offered by the Indenture Trustee or an Affiliate thereof.  No such investment shall be sold prior to maturity.  On each Payment Date, net investment earnings on the Reserve Fund shall be deposited in the Reserve Fund.  In the
        absence of such written investment direction, any amounts in the Reserve Fund shall remain uninvested.

     

    (b)            Subject to Section 6.01(c), the Indenture Trustee shall not in any way be held liable by reason of any insufficiency in the Reserve Fund resulting from any loss on any Permitted Investment included therein, except
        for losses attributable to the Indenture Trustee’s failure to make payments on any such Permitted Investments issued by the Indenture Trustee in its commercial capacity as principal obligor and not as trustee, in accordance with their terms.

     

    
      65

      
        

    

    

    

    (c)            If (i) the Servicer shall have failed to give investment directions for any funds on deposit in the Reserve Fund to the Indenture Trustee by [11:00 a.m.], New York City time (or such other time as may be agreed by
        the Administrator and Indenture Trustee), on any Business Day or (ii) a Default or Indenture Default of which a Responsible Officer of the Indenture Trustee shall have actual knowledge shall have occurred and be continuing with respect to the Notes
        but the Notes shall not have been declared due and payable pursuant to Section 5.02 or (iii) if the Notes shall have been declared due and payable following an Indenture Default and amounts collected or receivable from the Trust Estate are being
        applied in accordance with Section 5.05 as if there had not been such a declaration, then the Indenture Trustee shall, to the fullest extent practicable, invest and reinvest funds in investments that are Permitted Investments in accordance with
        standing instructions most recently given in writing by the Servicer.

     

    (d)            All amounts held in the 20[__]-[__] SUBI Collection Account shall be invested until the Deposit Date by the Indenture Trustee, at the written direction of the Servicer, in Permitted Investments.  Any investment
        earnings in the 20[__]-[__] SUBI Collection Account will be taxable to the holder of the Trust Certificate.  On each Deposit Date, the Issuer shall deposit all net income or other gain from the foregoing investments in respect of the related
        Collection Period into the 20[__]-[__] SUBI Collection Account.  In the absence of such written investment direction, any amounts on deposit in the 20[__]-[__] SUBI Collection Account shall remain uninvested.

     

    (e)            Amounts on deposit in the Note Distribution Account and the Certificate Distribution Account shall remain uninvested.

     

    (f)            Except as otherwise provided hereunder or agreed in writing among the parties hereto, the Servicer shall retain the authority to institute, participate and join in any plan of reorganization, readjustment, merger or
        consolidation with respect to the issuer of any securities held hereunder in the Accounts, and, in general, to exercise each and every other power or right with respect to each such asset or investment as individuals generally have and enjoy with
        respect to their own assets and investment, including power to vote on any securities.

    

    

    (g)            The Indenture Trustee is authorized to deposit uninvested funds in non-interest bearing, unsecured demand deposit accounts at affiliated banks, purchase and sell investment securities through or from affiliated
        banks and broker-dealers, invest funds in registered investment companies that receive investment management and custodial services from the Indenture Trustee or its affiliates, subject to the limitations set forth herein.

    

    

    (h)            The Issuer acknowledges that to the extent regulations of the Comptroller of the Currency or other applicable regulatory entity grant the Issuer the right or option to receive individual confirmations of security
        transactions at no additional cost, as they occur, the Issuer specifically waives the option to receive such confirmation to the extent permitted by law. The Indenture Trustee will furnish the Issuer periodic cash transaction statements that
        include detail for all investment transactions made by the Indenture Trustee hereunder.

    

    

    Section 8.06      Release of Trust Estate.

     

    
      66

      
        

    

    

    

    (a)            Subject to the payment of its fees and expenses pursuant to Section 6.07, the Indenture Trustee may, and when required by the provisions of this Indenture shall, execute instruments to release property from the lien
        of this Indenture, or convey the Indenture Trustee’s interest in the same, in a manner and under circumstances that are not inconsistent with the provisions of this Indenture.  No party relying upon an instrument executed by the Indenture Trustee
        as provided in this Article shall be bound to ascertain the Indenture Trustee’s authority, inquire into the satisfaction of any conditions precedent or see to the application of any monies.

     

    (b)            The Indenture Trustee shall, at such time as there are no Notes Outstanding and all sums due the Indenture Trustee pursuant to Section 6.07 have been paid, release any remaining portion of the Trust Estate that
        secured the Notes from the lien of this Indenture and release to the Issuer or any other Person entitled thereto any funds then on deposit in the 20[__]-[__] SUBI Collection Account and the Accounts.  Such release shall include delivery to the
        Issuer or its designee of the 20[__]-[__] SUBI Certificate and delivery to the Securities Intermediary under the Control Agreement of a certificate evidencing the release of the lien of this Indenture.  The Indenture Trustee shall release property
        from the lien of this Indenture pursuant to this Section only upon receipt of an Issuer Request.

     

    ARTICLE NINE

      

      SUPPLEMENTAL INDENTURES

     

    Section 9.01      Supplemental Indentures Without Consent of Noteholders.

     

    (a)            Without the consent of the Noteholders, but with prior notice made available by the Administrator to each Rating Agency and subject to the satisfaction of the Rating Agency Condition, the Issuer and the Indenture
        Trustee, when so requested by an Issuer Request, at any time and from time to time, may enter into one or more indentures supplemental hereto, in form satisfactory to the Indenture Trustee, for any of the following purposes:

     

    (i)            to correct or amplify the description of any property at any time subject to the lien of this Indenture, or better to assure, convey or confirm unto the Indenture Trustee any property subject
        or required to be subjected to the lien of this Indenture, or to subject additional property to the lien of this Indenture;

     

    (ii)            to evidence the succession, in compliance with the applicable provisions hereof, of another Person to the Issuer and the assumption by any such successor of the covenants of the Issuer
        contained herein and in the Notes;

     

    (iii)            to add to the covenants of the Issuer for the benefit of the Noteholders or to surrender any right or power herein conferred upon the Issuer;

     

    (iv)            to convey, transfer, assign, mortgage or pledge any property to or with the Indenture Trustee;

     

    (v)            to cure any ambiguity, correct or supplement any provision herein or in any supplemental indenture that may be defective or inconsistent with any other provision herein or in any supplemental
        indenture or make any other provisions with 

     

      

    
      67

      
        

    

    respect to matters or questions arising under this Indenture or in any supplemental indenture that shall not be inconsistent with
        the provisions of this Indenture; provided that such provisions do not adversely affect the interests of the Noteholders, as evidenced by an Officer’s Certificate of the Issuer;

     

    (vi)            to evidence and provide for the acceptance of the appointment hereunder by a successor trustee with respect to the Notes or to add to or change any of the provisions of this Indenture as
        shall be necessary to facilitate the administration of the trusts hereunder by more than one trustee, pursuant to the requirements of Article Six; or

     

    (vii)            to modify, eliminate or add to the provisions of this Indenture to such extent as shall be necessary to effect the qualification of this Indenture under the TIA or under any similar federal
        statute hereafter enacted and to add to this Indenture such other provisions as may be expressly required by the TIA.

     

    An opinion as to certain tax matters, as described under Section 9.01(b)(iii) below, must be delivered in connection with any amendment pursuant to this
      Section.

     

    The Indenture Trustee is hereby authorized to join in the execution of any such supplemental indenture and to make any further appropriate agreements and
      stipulations as may be therein contained.

     

    (b)            The Issuer and the Indenture Trustee, when requested by an Issuer Request, may enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to, or changing in any manner or
        eliminating any of the provisions of, this Indenture or for the purpose of modifying in any manner (other than the modifications set forth in Section 9.02, which require consent of the Noteholder of each Note affected thereby) the rights of the
        Noteholders under this Indenture; provided, however, that (i) such action shall not materially adversely affect the interests of any Noteholder (as evidenced by an Officer’s Certificate of the Issuer), (ii) the Rating Agency Condition shall have
        been satisfied with respect to such action, and (iii) such action shall not, as evidenced by an Opinion of Counsel, (A) affect the treatment of the Notes as debt for U.S. federal income tax purposes, (B) be deemed to cause a taxable exchange of the
        Notes for U.S. federal income tax purposes or (C) cause the Issuer, the Transferor or the Vehicle Trust to be characterized as an association or a publicly traded partnership, in either case taxable as a corporation for U.S. federal income tax
        purposes.

     

    (c)            Each amendment described above shall be deemed not to materially and adversely affect the interests of any holder of Securities, if the Rating Agency Condition is satisfied.

     

    Section 9.02      Supplemental Indentures With Consent of Noteholders.  The
      Issuer and the Indenture Trustee, when requested by an Issuer Request, also may, with the consent of Noteholders holding not less than a majority of the Outstanding Amount, by Act of such Noteholders delivered to the Issuer and the Indenture Trustee,
      enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to, or changing in any manner or eliminating any of the provisions of, this Indenture or of modifying in any manner the rights of the Noteholders under
      this Indenture subject to the satisfaction of the Rating Agency

     

    
      68

      
        

    

    

    

    Condition and provided that no such supplemental indenture shall, without the consent of the Noteholder of each Outstanding Note affected thereby:

     

    (a)            change the Note Final Scheduled Payment Date of or the date of payment of any installment of principal of or interest on any Note, or reduce the principal amount thereof, the interest rate thereon or the Redemption
        Price with respect thereto, change the provision of this Indenture relating to the application of collections on, or the proceeds of the sale of, the Trust Estate to payment of principal of or interest on the Notes, or change any place of payment
        where, or the coin or currency in which, any Note or the interest thereon is payable, or impair the right to institute suit for the enforcement of the provisions of this Indenture requiring the application of funds available therefor, as provided
        in Article Five, to the payment of any such amount due on the Notes on or after the respective due dates thereof (or, in the case of redemption, on or after the Redemption Date);

     

    (b)            reduce the percentage of the Outstanding Amount, the consent of the Noteholders of which is required for any such supplemental indenture or the consent of the Noteholders of which is required for any waiver of
        compliance with provisions of this Indenture or Indenture Defaults hereunder and their consequences provided for in this Indenture;

     

    (c)            modify or alter the provisions of the proviso to the definition of the term “Outstanding”;

     

    (d)            reduce the percentage of the Outstanding Amount required to direct the Indenture Trustee to direct the Owner Trustee to sell the Trust Estate pursuant to Section 5.04, if the proceeds of such sale would be
        insufficient to pay the Outstanding Amount plus accrued but unpaid interest on the Notes;

     

    (e)            modify any provision of this Section, except to increase any percentage specified herein or to provide that certain additional provisions of this Indenture or the other Basic Documents cannot be modified or waived
        without the consent of the Noteholder of each Outstanding Note affected thereby;

     

    (f)            permit the creation of any lien ranking prior to or on a parity with the lien of this Indenture with respect to any part of the Trust Estate or, except as otherwise permitted or contemplated herein, terminate the
        lien of this Indenture on any property at any time subject hereto or deprive any Noteholder of the security provided by the lien of this Indenture; or

     

    (g)            impair the right to institute suit for the enforcement of payment as provided in Section 5.07.

     

    Any such supplemental indenture shall be executed only upon delivery of an Opinion of Counsel to the same effect as in Section 9.01(b)(iii).

     

    It shall not be necessary for any Act of Noteholders under this Section to approve the particular form of any proposed supplemental indenture, but it
      shall be sufficient if such Act shall approve the substance thereof.

     

    
      69

      
        

    

    
    Promptly after the execution by the Issuer and the Indenture Trustee of any supplemental indenture pursuant to this Section, the Indenture Trustee shall
      mail to the Noteholders to which such amendment or supplemental indenture relates a notice setting forth in general terms the substance of such supplemental indenture.  Any failure of the Indenture Trustee to mail such notice, or any defect therein,
      shall not, however, in any way impair or affect the validity of any such supplemental indenture.

     

    Section 9.03      Execution of Supplemental Indentures.  In executing, or
      permitting the additional trusts created by, any supplemental indenture permitted by this Article or the modifications thereby of the trusts created by this Indenture, the Indenture Trustee shall be entitled to receive, and subject to Sections 6.01
      and 6.02, shall be fully protected in relying upon, an Opinion of Counsel stating that the execution of such supplemental indenture is authorized or permitted by this Indenture.  The Indenture Trustee may but shall not be obligated to enter into any
      such supplemental indenture that affects the Indenture Trustee’s own rights, duties, liabilities or indemnities under this Indenture or otherwise.  Any supplemental indenture which affects the amounts distributed to the Owner Trustee under Section
      5.04(b) of this Indenture shall require the Owner Trustee’s written consent.

     

    Section 9.04      Effect of Supplemental Indenture.  Upon the execution of
      any supplemental indenture pursuant to the provisions hereof, this Indenture shall be and shall be deemed to be modified and amended in accordance therewith with respect to the Notes affected thereby, and the respective rights, limitations of rights,
      obligations, duties, liabilities and immunities under this Indenture of the Indenture Trustee, the Issuer, the Owner Trustee and the Noteholders shall thereafter be determined, exercised and enforced hereunder subject in all respects to such
      modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and shall be deemed to be part of the terms and conditions of this Indenture for any and all purposes.

     

    Section 9.05      Reference in Notes to Supplemental Indentures.  Notes
      authenticated and delivered after the execution of any supplemental indenture pursuant to this Article may, and if requested by the Issuer shall, bear a notation in form approved by the Indenture Trustee as to any matter provided for in such
      supplemental indenture.  If the Issuer shall so determine, new Notes so modified as to conform, in the opinion of the Issuer, to any such supplemental indenture may be prepared and executed by the Issuer and authenticated and delivered by the
      Indenture Trustee in exchange for Outstanding Notes.

     

    Section 9.06      Conformity with Trust Indenture Act.  Every amendment to
      this Indenture and every supplemental indenture executed pursuant to this Article Nine shall conform to the requirements of the TIA as then in effect so long as this Indenture shall then be qualified under the TIA.

     

    ARTICLE TEN

      

      REDEMPTION OF NOTES

     

    Section 10.01      Redemption.

     

    
      70

      
        

    

    

    

    (a)            Pursuant to Section 2.19 of the Servicing Agreement, the Servicer shall be permitted at its option (the “Optional Purchase”) to purchase
        the interest in the 20[__]-[__] SUBI evidenced by the 20[__]-[__] SUBI Certificate from the Issuer on any Payment Date if, either before or after giving effect to any payment of principal required to be made on such Payment Date, the Note Balance
        is less than or equal to [5]% of the Initial Note Balance.  The purchase price for the 20[__]-[__] SUBI Certificate shall equal the sum of (i) the outstanding Note Balance, together with accrued interest thereon to the Redemption Date, and (ii) the
        aggregate amount of any accrued and unpaid fees, expenses and indemnities due and owing to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent, the Owner Trustee and the Asset Representations Reviewer, in each
        case to the extent such fees, expenses and indemnities have not been previously paid by the Issuer (the “Optional Purchase Price”), which amount shall be deposited by the
        Servicer into the 20[__]-[__] SUBI Collection Account on the Deposit Date relating to the Redemption Date.  If the Servicer exercises the Optional Purchase, the Notes shall be redeemed on the Redemption Date in whole, but not in part, for the
        Redemption Price.

     

    (b)            If the Servicer exercises the Optional Purchase, on the Business Day prior to the Redemption Date, prior to [11:00 a.m.], New York City time, the Paying Agent shall transfer the Optional Purchase Price, as part of
        the Available Funds from the 20[__]-[__] SUBI Collection Account, to the Note Distribution Account in an amount equal to the Redemption Price.  The excess, if any, of the Optional Purchase Price over the Redemption Price, shall be paid on the
        Redemption Date to the Indenture Trustee, the Note Registrar, the Certificate Registrar, the Paying Agent and the Owner Trustee, as applicable, as payment or reimbursement for the amount of any accrued and unpaid fees, expenses and indemnities due
        and owing to such parties.

     

    (c)            If the Notes are to be redeemed pursuant to this Section, the Administrator or the Issuer shall provide at least 20 days’ prior notice of the redemption of the Notes to the Indenture Trustee and the Owner Trustee,
        and the Indenture Trustee shall provide at least 10 days’ notice thereof to the Noteholders; provided however, the Accounts may only be closed in accordance with the provisions of the Basic Documents and only on or after the date that is 30 days
        following the date such notice was provided by the Administrator or the Issuer to the Indenture Trustee.

     

    Section 10.02      Form of Redemption Notice.  Notice of redemption under
      Section 10.01 shall be given by the Indenture Trustee by first-class mail, postage prepaid, mailed to each Noteholder as of the close of business on the Business Day immediately preceding the date of such notice at such holder’s address appearing in
      the Note Register.  In addition, the Administrator shall make notice available to each Rating Agency upon the redemption of the Notes, pursuant to the Issuer Administration Agreement.

     

    All notices of redemption shall state:

     

    (a)            the Redemption Date;

     

    (b)            the Redemption Price;

     

    
      71

      
        

    

    

    

    (c)            the place where the Notes to be redeemed are to be surrendered for payment of the Redemption Price (which shall be the office or agency of the Issuer to be maintained as provided in Section 3.02); and

     

    (d)            that on the Redemption Date, the Redemption Price will become due and payable upon each such Note and that interest thereon shall cease to accrue from and after the Redemption Date.

     

    Notice of redemption of the Notes shall be given by the Indenture Trustee in the name and at the expense of the Issuer.  Failure to give notice of
      redemption (or any defect therein) to any Noteholder shall not impair or affect the validity of the redemption of any other Note.

     

    Section 10.03      Notes Payable on Redemption Date.  The Notes to be
      redeemed shall, following notice of redemption as required by Section 10.02, become due and payable on the Redemption Date at the Redemption Price and (unless the Issuer shall default in the payment of the Redemption Price) no interest shall accrue
      on the Redemption Price for any period after the date to which accrued interest is calculated for purposes of calculating the Redemption Price.

     

    ARTICLE ELEVEN

      

      MISCELLANEOUS

     

    Section 11.01      Compliance Certificates and Opinions.

     

    (a)            Upon any application or request by the Issuer to the Indenture Trustee to take any action under any provision of this Indenture, the Issuer shall furnish to the Indenture Trustee and shall make available to each
        Rating Agency (i) an Officer’s Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with and (ii) an Opinion of Counsel stating that in the opinion of such
        counsel all such conditions precedent, if any, have been complied with, except that, in the case of any such application or request as to which the furnishing of such documents is specifically required by any provision of this Indenture, no
        additional certificate or opinion need be furnished.

     

    Every certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture shall include:

     

    (i)            a statement that each signatory of such certificate or opinion has read such covenant or condition and the definitions herein relating thereto;

     

    (ii)            a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;

     

    (iii)            a statement that, in the opinion of each such signatory, such signatory has made such examination or investigation as is necessary to enable such signatory to express an informed opinion as
        to whether or not such covenant or condition has been complied with; and

     

    
      72

      
        

    

    

    

    (iv)            a statement as to whether, in the opinion of each such signatory, such condition or covenant has been complied with.

     

    (b)            In addition to any obligation imposed in Section 11.01(a) or elsewhere in this Indenture:

     

    (i)            Prior to the deposit of any Collateral or other property or securities with the Indenture Trustee that is to be made the basis for the release of any property or securities subject to the
        lien of this Indenture, the Issuer shall furnish to the Indenture Trustee an Officer’s Certificate certifying or stating the opinion of each Person signing such certificate as to the fair value (within 90 days of such deposit) to the Issuer of the
        Collateral or other property or securities to be so deposited.

     

    (ii)            Whenever the Issuer is required to furnish to the Indenture Trustee an Officer’s Certificate certifying or stating the opinion of any signer thereof as to the matters described in clause (i)
        above, the Issuer shall also deliver to the Indenture Trustee an Independent Certificate as to the same matters, if the fair value of the property or securities to be so deposited and of all other such securities made the basis of any such
        withdrawal or release since the commencement of the then-current calendar year of the Issuer, as set forth in the certificates delivered pursuant to clause (i) above and this clause, is 10% or more of the Outstanding Amount, but such a certificate
        need not be furnished with respect to any securities so deposited, if the fair value thereof to the Issuer as set forth in the related Officer’s Certificate is less than $25,000 or less than 1% of the Outstanding Amount.

     

    (iii)            Other than with respect to any release described in clause (A) or (B) of Section 11.01(b)(v), whenever any property or securities are to be released from the lien of this Indenture, the
        Issuer shall also furnish to the Indenture Trustee an Officer’s Certificate certifying or stating the opinion of each Person signing such certificate as to the fair value (within 90 days of such release) of the property or securities proposed to be
        released and stating that in the opinion of such Person, the proposed release will not impair the security under this Indenture in contravention of the provisions hereof.

     

    (iv)            Whenever the Issuer is required to furnish to the Indenture Trustee an Officer’s Certificate certifying or stating the opinion of any signer thereof as to the matters described in clause
        (iii) above, the Issuer shall also furnish to the Indenture Trustee an Independent Certificate as to the same matters, if the fair value of the property or securities and of all other property, or securities (other than property described in
        clauses (A) or (B) of Section 11.01(b)(v)) released from the lien of this Indenture since the commencement of the then current calendar year, as set forth in the Officer’s Certificates required by clause (iii) above and this clause, equals 10% or
        more of the Outstanding Amount, but such Officer’s Certificate need not be furnished in the case of any release of property or securities if the fair value thereof as set forth in the related Officer’s Certificate is less than $25,000 or less than
        1% of the Outstanding Amount.

     

    (v)            Notwithstanding Section 2.08 or any other provision of this Section, the Issuer may (A) collect, liquidate, sell or otherwise dispose of the Collateral as and to the

     

    
      73

      
        

    

    

    

    extent permitted or required by the Basic Documents and (B) make cash payments out of the Accounts as and to the extent permitted or required by the
      Basic Documents.

     

    Section 11.02      Form of Documents Delivered to Indenture Trustee.  In
      any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so
      certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters
      in one or several documents.

     

    Any certificate or opinion of an Authorized Officer may be based, insofar as it relates to legal matters, upon a certificate or opinion of, or
      representations by, counsel.  Any such certificate of an Authorized Officer or Opinion of Counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of or representations by an officer or officers of the
      Administrator, the Transferor or the Issuer, stating that the information with respect to such factual matters is in the possession of the Administrator, the Transferor or the Issuer.

     

    Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other
      instruments under this Indenture, they may, but need not, be consolidated and form one instrument.

     

    Whenever in this Indenture, in connection with any application or certificate or report to the Indenture Trustee, it is provided that the Issuer shall
      deliver any document as a condition of the granting of such application, or as evidence of the Issuer’s compliance with any terms hereof, it is intended that the truth and accuracy, at the time of the granting of such application or at the effective
      date of such certificate or report (as the case may be), of the facts and opinions stated in such document shall in such case be conditions precedent to the right of the Issuer to have such application granted or to the sufficiency of such
      certificate or report.  The foregoing shall not, however, be construed to affect the Indenture Trustee’s right to rely upon the truth and accuracy of any statement or opinion contained in any such document as provided in Article Six.

     

    Section 11.03      Acts of Noteholders.

     

    (a)            Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given or taken by Noteholders may be embodied in and evidenced by one or more instruments of
        substantially similar tenor signed by such Noteholders in person or by agents duly appointed in writing; and except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments are delivered to the
        Indenture Trustee, and, where it is hereby expressly required, to the Issuer.  Such instrument or instruments (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the “Act” of the Noteholders signing such
        instrument or instruments.  Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Indenture and (subject to Section 6.01) conclusive in favor of the Indenture Trustee and the
        Issuer, if made in the manner provided in this Section.

     

    
      74

      
        

    

    

    

    (b)            The fact and date of the execution by any Person of any such instrument or writing may be proved in any manner that the Indenture Trustee deems sufficient.

     

    (c)            The ownership of Notes shall be proved by the Note Register.

     

    (d)            Any request, demand, authorization, direction, notice, consent, waiver or other action by a Noteholder shall bind the Noteholder of every Note issued upon the registration thereof or in exchange therefor or in lieu
        thereof, in respect of anything done, omitted or suffered to be done by the Indenture Trustee or the Issuer in reliance thereon, whether or not notation of such action is made upon such Note.

     

    Section 11.04      Notices.  All demands, notices and communications
      hereunder shall be in writing and shall be delivered or mailed by registered or certified first-class United States mail, postage prepaid, hand delivery, prepaid courier service, and addressed in each case as follows: (i) if to the Issuer c/o the
      Owner Trustee, at [________________________], Attention: [____________________], with a copy to the Administrator, at 300 Chestnut Ridge Road, Woodcliff Lake, New Jersey 07677, Attention: General Counsel, with a copy (which shall not constitute
      notice) to Reed Auerbach, Esq., Morgan, Lewis & Bockius LLP, 101 Park Avenue, New York, New York 10178; (ii) if to the Indenture Trustee, at the Corporate Trust Office; (iii) if to [_______], to [________________________], Email:
      [________________________], Attention: [________________________]; (iv) if to [_______], to [________________________], [________________________], Email: [________________________]; or (v) at such other address as shall be designated by any of the
      foregoing in a written notice to the other parties hereto.  Delivery shall occur only upon receipt or reported tender of such communication by an officer of the recipient entitled to receive such notices located at the address of such recipient for
      notices hereunder.

     

    Section 11.05      Notices to Noteholders; Waiver.  Where this Indenture
      provides for notice to Noteholders of any event, such notice shall be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first class, postage prepaid to each Noteholder affected by such event, at his address as
      it appears on the Note Register, not later than the latest and not earlier than the earliest date prescribed for the giving of such notice.  In any case where notice to Noteholders is given by mail, neither the failure to mail such notice nor any
      defect in any notice so mailed to any particular Noteholder shall affect the sufficiency of such notice with respect to other Noteholders, and any notice that is mailed in the manner herein provided shall conclusively be presumed to have been duly
      given.

     

    Where this Indenture provides for notice in any manner, such notice may be waived in writing by any Person entitled to receive such notice, either before
      or after the event, and such waiver shall be the equivalent of such notice.  Waivers of notice by Noteholders shall be filed with the Indenture Trustee but such filing shall not be a condition precedent to the validity of any action taken in reliance
      upon such a waiver.

     

    In case, by reason of the suspension of regular mail service as a result of a strike, work stoppage or similar activity, it shall be impractical to mail
      notice of any event of Noteholders when such notice is required to be given pursuant to any provision of this Indenture, then any

     

    
      75

      
        

    

    

    

    manner of giving such notice as shall be satisfactory to the Indenture Trustee shall be deemed to be a sufficient giving of such notice.

     

    Where this Indenture provides that notice be made available to each Rating Agency, notice will be made available to the Rating Agencies by the
      Administrator and failure to make such notice available shall not affect any other rights or obligations created hereunder, and shall not under any circumstance constitute an Indenture Default.

     

    Section 11.06      Effect of Headings and Table of Contents.  The Article
      and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof.

     

    Section 11.07      Successors and Assigns.  All covenants and agreements in
      this Indenture and the Notes by the Issuer shall bind its successors and assigns, whether so expressed or not.  All agreements of the Indenture Trustee in this Indenture shall bind its successors.

     

    Section 11.08      Severability.  In case any provision in this Indenture
      or in the Notes shall be invalid, illegal or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

     

    Section 11.09      Benefits of Indenture.  Nothing in this Indenture or in
      the Notes, express or implied, shall give to any Person, other than the parties hereto and their successors hereunder, the Noteholders (and, with respect to Sections 8.03 and 8.04, the Trust Certificateholders), the Owner Trustee, any other party
      secured hereunder and any other Person with an ownership interest in any part of the Trust Estate, any benefit or any legal or equitable right, remedy or claim under this Indenture.

     

    Section 11.10      Legal Holidays.  In any case where the date on which any
      payment is due shall not be a Business Day, then (notwithstanding any other provision of the Notes or this Indenture) payment need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made
      on the date on which nominally due, and no interest shall accrue for the period from and after any such nominal date except in the case of the Class A-1 Notes and Class A-2b Notes.

     

    Section 11.11      Governing Law.  This Indenture shall be governed by and
      construed in accordance with the laws of the State of New York without reference to its conflicts of law provisions other than Sections 5-1401 and 5-1402 of the New York General Obligations Law, and the obligations, rights and remedies of the parties
      hereunder shall be determined in accordance with such laws.  Regardless of any provision in any other agreement, for purposes of the UCC, New York shall be deemed to be the Securities Intermediary’s jurisdiction, and the law of the State of New York
      shall govern all issues specified in Article 2(1) of the Hague Securities Convention.

     

    Section 11.12      Counterparts.  This Indenture may be executed in any
      number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.  Each party agrees that this Indenture and any other documents to be delivered
      in connection herewith may be electronically signed (other than any such other document which is explicitly required by the

     

    
      76

      
        

    

    

    

    terms of this Indenture to be signed manually), and that any electronic signatures appearing on this Indenture or such other documents are the same as handwritten
      signatures for the purposes of validity, enforceability, and admissibility to the fullest extent permitted by law.

     

    Section 11.13      Recording of Indenture.  If this Indenture is subject to
      recording in any appropriate public recording offices, such recording is to be effected by the Issuer accompanied by an Opinion of Counsel (who may be counsel to the Indenture Trustee or any other counsel reasonably acceptable to the Indenture
      Trustee) to the effect that such recording is necessary either for the protection of the Noteholders or any other Person secured hereunder or for the enforcement of any right or remedy granted to the Indenture Trustee under this Indenture.

     

    Section 11.14      Trust Obligation.  No recourse may be taken, directly or
      indirectly, with respect to the obligations of the Issuer, the Owner Trustee or the Indenture Trustee on the Notes or under this Indenture or any certificate or other writing delivered in connection herewith or therewith, against (i) the Indenture
      Trustee or the Owner Trustee in its individual capacity, (ii) any Trust Certificateholder, (iii) any owner of a beneficial interest in the Issuer or (iv) any partner, owner, beneficiary, agent, officer, director, employee or agent of the Indenture
      Trustee or the Owner Trustee in its individual capacity, any Trust Certificateholder, the Owner Trustee or the Indenture Trustee of any successor or assign of the Indenture Trustee or the Owner Trustee in its individual capacity, except as any such
      Person may have expressly agreed (it being understood that the Indenture Trustee and the Owner Trustee have no such obligations in their individual capacity) and except that any such partner, owner or beneficiary shall be fully liable, to the extent
      provided by applicable law, for any unpaid consideration for stock, unpaid capital contribution or failure to pay any installment or call owing to such entity.  For all purposes of this Indenture, in the performance of any duties or obligations of
      the Issuer hereunder, the Owner Trustee shall be subject to, and entitled to the benefits of, the terms and provisions of Articles Six, Seven and Eight of the Trust Agreement.

     

    Section 11.15      No Petition.  The Indenture Trustee, by entering into
      this Indenture, and each Noteholder or Note Owner, by accepting a Note or in the case of a Note Owner, a beneficial interest in a Note, hereby covenant and agree that prior to the date that is one year and one day after the date upon which all
      obligations and payments under the Securitized Financing have been paid in full, they will not (and, to the fullest extent permitted by applicable law, the Indenture Trustee shall not have the power to) institute against, or join any Person in
      instituting against any Noteholder, any Note Owner, the UTI Beneficiary (and the general partner of the UTI Beneficiary that is a partnership, or the managing member of the UTI Beneficiary that is a limited liability company), the Vehicle Trustee,
      the Vehicle Trust, any Special Purpose Affiliate (and the general partner of any Special Purpose Affiliate that is a partnership, or the managing member of any Special Purpose Affiliate that is a limited liability company) that holds a beneficial
      interest in the Vehicle Trust, the Transferor, the Issuer, the Indenture Trustee or any Affiliate or beneficiary of the same, any bankruptcy, reorganization, arrangement, insolvency or liquidation proceeding or other proceedings under any United
      States federal or state bankruptcy or similar law.

     

    Section 11.16      No Recourse.  Each Noteholder or Note Owner, by
      acceptance of a Note or, in the case of a Note Owner, a beneficial interest in a Note, covenants and agrees that no recourse may be taken, directly or indirectly, with respect to the obligations of the Issuer, the

     

    
      77

      
        

    

    

    

    Owner Trustee or the Indenture Trustee on the Notes or under this Indenture or any certificate or other writing delivered in connection herewith or therewith against (i)
      the Indenture Trustee or the Owner Trustee in its individual capacity, (ii) any Trust Certificateholder, (iii) any owner of a beneficial interest in the Issuer or (iv) any partner, owner, beneficiary, agent, officer, director or employee of the
      Indenture Trustee or the Owner Trustee in its individual capacity, any Trust Certificateholder or any holder of a beneficial interest in the Issuer, the Owner Trustee or the Indenture Trustee or of any successor or assign of the Indenture Trustee or
      the Owner Trustee in its individual capacity, except as any such Person may have expressly agreed and except that any such partner, owner or beneficiary shall be fully liable, to the extent provided by applicable law, for any unpaid consideration for
      stock, unpaid capital contribution or failure to pay any installment or call owing to such entity.

     

    Section 11.17      Inspection.  The Issuer agrees that on reasonable prior
      notice it will permit any representative of the Indenture Trustee, during the Issuer’s normal business hours, to examine all the books of account, records, reports and other papers of the Issuer, to make copies and extracts therefrom, to cause such
      books to be audited by Independent certified public accountants and to discuss the Issuer’s affairs, finances and accounts with the Issuer’s officers, employees and Independent certified public accountants, all at such reasonable times and as often
      as may be reasonably requested.  The Indenture Trustee shall and shall cause its representatives to hold in confidence all such information, except to the extent disclosure may be required by law (and all reasonable applications for confidential
      treatment are unavailing) and except to the extent the Indenture Trustee may reasonably determine that such disclosure is consistent with its obligations hereunder.

     

    Section 11.18      Limitation of Liability of Owner Trustee.  The parties
      hereto are put on notice and hereby acknowledge and agree that (a) this Indenture is executed and delivered by [________________________], not individually or personally but solely as Owner Trustee of the Issuer, in the exercise of the powers and
      authority conferred and vested in it, (b) each of the representations, undertakings and agreements herein made on the part of the Issuer is made and intended not as personal representations, undertakings and agreements by [________________________]
      but is made and intended for the purpose of binding only the Issuer, (c) nothing herein contained shall be construed as creating any liability on [________________________], individually or personally, to perform any covenant either expressed or
      implied contained herein of the Issuer, all such liability, if any, being expressly waived by the parties hereto and by any Person claiming by, through or under the parties hereto, (d) [________________________] has made no investigation as to the
      accuracy or completeness of any representations and warranties made by the Issuer in this Indenture and (e) under no circumstances shall [________________________] be personally liable for the payment of any indebtedness or expenses of the Issuer or
      be liable for the breach or failure of any obligation, representation, warranty or covenant made or undertaken by the Issuer under this Indenture or any other related documents.

     

    Section 11.19      TIA Incorporation and Conflicts.  The provisions of TIA
      Sections 310 through 317 that impose duties on any Person (including the provisions automatically deemed included herein unless expressly excluded by this Indenture) are a part of and govern this Indenture, whether or not physically contained
      herein.  If any provision hereof limits, qualifies or

     

    
      78

      
        

    

    

    

    conflicts with another provision hereof that is required to be included in this Indenture by any of the provisions of the TIA, such required provision shall control.

     

    Section 11.20      Intent.  It is the intent of the Issuer that the Notes
      be characterized as debt for U.S. federal income tax purposes and the Issuer agrees and each purchaser of a Note (by virtue of the acquisition of such Note of an interest therein) shall be deemed to have agreed, to treat the Notes as debt for
      purposes of U.S. federal and state income tax and any other tax measured in whole or in part by income.

     

    Section 11.21      Intent of Parties; Reasonableness.  The Indenture
      Trustee and Issuer acknowledge and agree that the purpose of Section 3.09 of this Indenture is to facilitate compliance by the Issuer and the Depositor with the provisions of Regulation AB and related rules and regulations of the Commission.

     

    Neither the Issuer nor the Administrator (acting on behalf of the Issuer) shall exercise its right to request delivery of information or other
      performance under these provisions other than in good faith, or for purposes other than compliance with the Securities Act, the Exchange Act and the rules and regulations of the Commission thereunder (or the provision in a private offering of
      disclosure comparable to that required under the Securities Act).  Each of the parties agrees that (a) the obligations of the parties hereunder shall be interpreted in such a manner as to accomplish compliance with Regulation AB and (b) the parties’
      obligations hereunder will be supplemented and modified as necessary to be consistent with any such amendments, interpretive guidance provided by the Commission or its staff, or consensus among participants in the asset-backed securities markets, in
      respect of the requirements of Regulation AB, and the parties shall comply with reasonable requests made by the Issuer, the Administrator or the Indenture Trustee in good faith for delivery of additional or different information to the extent such
      information is freely available and deliverable (provided that, in the good faith determination of the Issuer, the Administrator or the Indenture Trustee, such additional or different information is required to comply with the provisions of
      Regulation AB).

     

    The Issuer (or the Administrator, acting on behalf of the Issuer) shall cooperate with the Indenture Trustee by providing timely notice of requests for
      information under these provisions and by reasonably limiting such requests to information required, in the reasonable judgment or the Issuer to comply with Regulation AB.

     

    Section 11.22      Communications with Rating Agencies.   If the Indenture
      Trustee shall receive any written or oral communication from any Rating Agency (or any of their respective officers, directors or employees) with respect to the transactions contemplated hereby or under the Basic Documents or in any way relating to
      the Notes, the Indenture Trustee agrees to refrain from communicating with such Rating Agency and to promptly (and, in any event, within one Business Day) notify the Administrator of such communication.  The Indenture Trustee agrees to act at the
      direction of the Administrator with respect to any communication to a Rating Agency and further agrees that in no event shall the Indenture Trustee engage in any oral communication with respect to the transactions contemplated hereby or under the
      Basic Documents or in any way relating to the Notes with any Rating Agency (or any of their respective officers, directors or employees) without the participation of the Administrator.

     

    
      79

      
        

    

    

    

    ARTICLE TWELVE

      

      ASSET REPRESENTATIONS REVIEW

     

    Section 12.01      Noteholder and Note Owner Requests for Vote on Asset
          Representations Review.  If the Indenture Trustee receives a notice from the Servicer pursuant to Section 4.1(a) of the Servicing Supplement regarding the occurrence of a Delinquency Trigger, then the Administrator shall confirm with
      the Indenture Trustee the method by which Noteholders and Note Owners may contact the Indenture Trustee in order to request a vote on whether to cause the ARR Leases to be reviewed by the Asset Representations Reviewer pursuant to the terms of the
      Asset Representations Review Agreement.  Noteholders and Note Owners may request a vote not later than ninety (90) days after the date on which the Form 10-D describing the occurrence of such Delinquency Trigger shall have been filed by the
      Administrator pursuant to the terms of Section 1.21 of the Issuer Administration Agreement; provided that, if the requesting party is a Note Owner and not a Noteholder, the Note Owner must include with its request a written certification that the
      requesting party is a Note Owner, together with one of the following additional forms of documentation of the requesting party’s status as a Note Owner: (A) a trade confirmation, (B) an account statement; (C) a letter from a broker-dealer that is
      acceptable to the Indenture Trustee or Administrator, as applicable; or (D) any other form of documentation that is acceptable to the Indenture Trustee or Administrator, as applicable (any such Note Owner who provides the required certification and
      documentation, a “Verified Note Owner”).  The Indenture Trustee shall promptly notify the Servicer and the Administrator if Noteholders and Verified Note Owners representing
      at least 5% of the outstanding aggregate principal amount of all Outstanding Notes (such requesting Noteholders and Verified Note Owners, collectively, the “Requesting Noteholders”)
      properly and timely request a vote to cause the ARR Leases to be reviewed by the Asset Representations Reviewer pursuant to the terms of the Asset Representations Review Agreement.

     

    Section 12.02      Noteholder and Note Owner Vote on Asset Representations Review. 
      Beginning promptly after receipt from the Administrator of a notice sent to the Indenture Trustee for distribution to Noteholders and Note Owners pursuant to Section 1.21(a)(ii) of the Issuer Administration Agreement, the Indenture Trustee shall
      cause the initiation of a review of the ARR Leases pursuant to the terms of the Asset Representations Review Agreement to be submitted to a yes or no vote of the Noteholders using the Indenture Trustee’s standard procedures for conducting a vote of
      Noteholders (with respect to Book-Entry Notes, as directed by the related Note Owners via the applicable Clearing Agency pursuant to its procedures for such votes).  If, by no earlier than the deadline specified by the Administrator pursuant to
      Section 1.21(a)(ii) of the Issuer Administration Agreement, (i) votes have been cast by Noteholders holding at least 5% of the aggregate outstanding principal amount of all Outstanding Notes and (ii) affirmative votes in favor of an Asset
      Representations Review have been cast by Noteholders representing at least a majority of the aggregate outstanding principal amount of all Outstanding Notes held by voting Noteholders, the Indenture Trustee will promptly notify the Servicer, the
      Administrator and the Asset Representations Reviewer that the requisite Noteholders have directed the Asset Representations Reviewer to perform a review of the ARR Leases for the purpose of determining whether such ARR Leases were in compliance with
      the representations and warranties made by the Servicer pursuant to Section 2.15(a) of the Servicing Supplement.

     

    
      80

      
        

    

    

    

    Section 12.03      Evaluation of Review Report.  If a Noteholder or a
      Verified Note Owner notifies the Indenture Trustee in writing that it considers any non-compliance of any representation with respect to any ARR Lease to be a breach of the applicable Basic Document, or requests in writing that any 20[__]-[__] Lease
      (including any ARR Lease) be reallocated (including, for the avoidance of doubt, as described in Section 4.2 of the Servicing Supplement), the Indenture Trustee will promptly forward that written notice to the Servicer.  The Indenture Trustee shall
      have no obligation to pursue or otherwise be involved in resolving any reallocation request, including any such request that is the subject of a dispute resolution proceeding, unless it is directed to do so by Noteholders representing not less than a
      majority of the Outstanding Amount and such Noteholders shall have offered to the Indenture Trustee security or indemnity satisfactory to it against the reasonable costs, expenses, disbursements, advances and liabilities that might be incurred by it,
      its agents and its counsel in compliance with such direction.  For the avoidance of doubt, if the Indenture Trustee does not agree to pursue or otherwise be involved in resolving any reallocation request, the related Noteholders may independently
      pursue dispute resolution in respect of such reallocation request in accordance with Section 4.2 of the Servicing Supplement.

     

    The Servicer will have the sole ability to determine if there was non-compliance with any representation or warranty made by it that constitutes a breach
      that materially and adversely affects the interest of the Issuer in the related ARR Lease, and whether to reallocate the related ARR Lease from the Issuer.

     

    Section 12.04      Dispute Resolution.  Any Noteholder or Verified Note
      Owner may pursue dispute resolution procedures as set forth in Section 4.2 of the Servicing Supplement.  If directed to do so by the Servicer with respect to any reallocation request, the Indenture Trustee will notify the related Requesting Party of
      the date when the 180-day period related to such reallocation request ends without resolution by the appropriate party and that the Requesting Party has 30 days to notify the Servicer if it wishes to pursue dispute resolution.  For the avoidance of
      doubt, the Indenture Trustee shall be under no obligation to monitor reallocation activity or to independently determine whether a reallocation request remains unresolved at the end of the related 180-day period.

     

    [SIGNATURE PAGE FOLLOWS]

     

    
      81

      
        

    

    IN WITNESS WHEREOF, the Issuer and the Indenture Trustee have caused this Indenture to be duly executed by their respective officers, thereunto duly
      authorized, all as of the day and year first above written.

     

    	 	
            BMW VEHICLE LEASE TRUST 20[__]-[__]

             

            

          
	 	
            By:  [________________________],

              not in its individual capacity but solely

              as Owner Trustee

             

            

          
	 	
            By: 
                ___________________________________________________                                                                                  

                Name:

                Title:

             

              

             

              

          
	 	
            [_________________],

              as Indenture Trustee

             

            

          
	 	
            By:_______________________________________________________
                                                                                                   

                Name:

                Title:

          

    

    

     

    

    

    
      82

      
        

    

    
    SCHEDULE I

     

    PERFECTION REPRESENTATIONS, WARRANTIES AND COVENANTS

     

    In addition to the representations, warranties and covenants contained in this Indenture, the Issuer hereby represents, warrants, and covenants to the
      Indenture Trustee as follows on the Closing Date:

     

    (1)            The Indenture creates a valid and continuing security interest (as defined in the applicable UCC) in the Collateral in favor of the Indenture Trustee, which security interest is prior to all other Liens and is
        enforceable as such as against creditors of and purchasers from the Issuer.

     

    (2)            The 20[__]-[__] SUBI Certificate constitutes a “general intangible,” “instrument,” “certificated security,” or “tangible chattel paper,” within the meaning of the applicable UCC. The Accounts and all subaccounts
        thereof, constitute either deposit accounts or securities accounts.

     

    (3)            All of the Collateral that constitutes securities entitlements (other than the 20[__]-[__] SUBI Certificate to the extent the 20[__]-[__] SUBI Certificate constitutes a certificated security) has been or will have
        been credited to one of the Accounts. The securities intermediary for each Account has agreed to treat all assets credited to the Accounts as “financial assets” within the meaning of the applicable UCC.

     

    (4)            The Issuer owns and has good and marketable title to the Collateral free and clear of any Liens, claim or encumbrance of any Person, excepting only liens for taxes, assessments or similar governmental charges or
        levies incurred in the ordinary course of business that are not yet due and payable or as to which any applicable grace period shall not have expired, or that are being contested in good faith by proper proceedings and for which adequate reserves
        have been established, but only so long as foreclosure with respect to such a lien is not imminent and the use and value of the property to which the Liens attaches is not impaired during the pendency of such proceeding.

     

    (5)            The Issuer has received all consents and approvals to the grant of the security interest in the Collateral hereunder to the Indenture Trustee required by the terms of the Collateral that constitutes instruments or
        payment intangibles.

     

    (6)            The Issuer has received all consents and approvals required by the terms of the Collateral that constitutes securities entitlements, certificated securities or uncertificated securities to the transfer to the
        Indenture Trustee of its interest and rights in the Collateral hereunder.

     

    (7)            The Issuer has caused or will have caused, within ten days after the effective date of the Indenture, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions
        under applicable law in order to perfect the security interest in the Collateral granted to the Indenture Trustee hereunder.

     

    
      I-1

      
        

    

    

    

    (8)            With respect to Collateral that constitutes an instrument or tangible chattel paper, either:

     

    	

          	a.	
            All original executed copies of each such instrument or tangible chattel paper have been delivered to the Indenture Trustee; or

          

     

    	

          	b.	
            Such instruments or tangible chattel paper are in the possession of a custodian and the Indenture Trustee has received a written acknowledgment from such custodian that such
              custodian is holding such instruments or tangible chattel paper solely on behalf and for the benefit of the Indenture Trustee; or

          

     

    	

          	c.	
            A custodian received possession of such instruments or tangible chattel paper after the Indenture Trustee received a written acknowledgment from such custodian that such custodian is
              acting solely as agent of the Indenture Trustee.

          

     

    (9)            With respect to the Accounts and all subaccounts thereof that constitute deposit accounts, either:

     

    	

          	a.	
            The Issuer has delivered to the Indenture Trustee a fully executed agreement pursuant to which the bank maintaining the deposit accounts has agreed to comply with all instructions
              originated by the Indenture Trustee directing disposition of the funds in the Accounts without further consent by the Issuer; or

          

     

    	

          	b.	
            The Issuer has taken all steps necessary to cause the Indenture Trustee to become the account holder of the Accounts.

          

     

    (10)            With respect to Collateral or Accounts or subaccounts thereof that constitute securities accounts or securities entitlements, either:

     

    	

          	a.	
            The Issuer has caused or will have caused, within ten days after the effective date of the Indenture, the filing of all appropriate financing statements in the proper filing office
              in the appropriate jurisdictions under applicable law in order to perfect the security interest granted in the Collateral to the Indenture Trustee; or

          

     

    	

          	b.	
            The Issuer has delivered to the Indenture Trustee a fully executed agreement (1) that provides that the agreement is governed solely by the law of New York and that the law of the
              State of New York shall govern all issues specified in Article 2(1) of the Hague Securities Convention, (2) pursuant to which the securities intermediary has agreed to comply with all instructions originated by the Indenture Trustee relating
              to the Accounts without further consent by the Issuer , and (3) with a securities intermediary that has and has had at all relevant times one or more offices (within the meaning of the Hague Securities Convention) in the United

          

     

    
      I-2

      
        

    

    

    

    States of America which satisfies the criteria provided in Article 4(1)(a) or (b) of the Hague Securities Convention; or

     

    	

          	c.	
            The Issuer has taken all steps necessary to cause the securities intermediary to identify in its records the Indenture Trustee as the person having a security entitlement against the
              securities intermediary in the Accounts so long as (1) the agreement governing the securities account satisfies the requirements of sub-clause (1) of the preceding clause (b), and (2) the securities intermediary satisfies the requirements of
              sub-clause (3) of the preceding clause (b).

          

     

    (11)            With respect to Collateral that constitutes certificated securities (other than securities entitlements), all original executed copies of each security certificate that constitutes or evidences the Collateral have
        been delivered to the Indenture Trustee, and each such security certificate either (i) is in bearer form, (ii) has been indorsed by an effective indorsement to the Indenture Trustee or in blank, or (iii) has been registered in the name of the
        Indenture Trustee.  Other than the transfer of the 20[__]-[__] SUBI and the 20[__]-[__] SUBI Certificate from the UTI Beneficiary to the Depositor under the SUBI Certificate Transfer Agreement, the transfer of the 20[__]-[__] SUBI and the
        20[__]-[__] SUBI Certificate from the Depositor to the Issuer under the Issuer SUBI Certificate Transfer Agreement and the security interest in the Collateral granted to the Indenture Trustee pursuant to the Indenture, none of the UTI Beneficiary,
        the Depositor or the Issuer has pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Collateral or the Accounts or any subaccounts thereof. The Issuer has not authorized the filing of, and is not aware of any
        financing statements against the Issuer that include a description of collateral covering the Collateral or the Accounts or any subaccount thereof other than any financing statement relating to the security interest granted to the Indenture Trustee
        hereunder or that has been terminated.

     

    (12)            None of the instruments, certificated securities or tangible chattel paper that constitute or evidence the Collateral has any marks or notations indicating that they have been pledged, assigned or otherwise conveyed
        to any Person other than the Indenture Trustee.

     

    (13)            Neither the Accounts nor any subaccounts thereof are in the name of any person other than the Issuer Entity or the Indenture Trustee. The Issuer Entity has not consented to the securities intermediary of any Account
        to comply with entitlement orders of any person other than the Indenture Trustee.

     

    As used in this Schedule I, “Collateral” has the meaning set forth in the Granting Clause of the Indenture.

     

    
      I-3

      
        

    

    
    EXHIBIT A

     

    [FORM OF CLASS A NOTE]

     

    SEE REVERSE FOR CERTAIN DEFINITIONS

     

    UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT
      FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH
      OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

     

    THE PRINCIPAL OF THIS NOTE IS PAYABLE AS SET FORTH HEREIN. ACCORDINGLY, THE OUTSTANDING PRINCIPAL AMOUNT OF THIS NOTE AT ANY TIME MAY BE LESS THAN THE
      AMOUNT SHOWN ON THE FACE HEREOF.

     

    TRANSFERS OF THE NOTES MUST GENERALLY BE ACCOMPANIED BY APPROPRIATE TAX TRANSFER DOCUMENTATION AND ARE SUBJECT TO RESTRICTIONS AS PROVIDED IN THE
      INDENTURE.

     

    THE HOLDER, BY ACCEPTANCE OF THIS NOTE, SHALL BE DEEMED TO HAVE AGREED TO TREAT THE NOTES AS DEBT FOR UNITED STATES FEDERAL AND STATE INCOME TAX PURPOSES
      AND FOR PURPOSES OF ANY OTHER TAX MEASURED IN WHOLE OR IN PART BY INCOME.

     

    
      A-1

      
        

    

    

    

    

    

     

    BMW VEHICLE LEASE TRUST 20[__]-[__]

     

    [BENCHMARK [plus][minus]]1 [__]% ASSET BACKED NOTE, CLASS [A-1] [A-2a] [A-2b] [A-3] [A-4]

     
      	
                           REGISTERED 

                           No. R-[___] 

            	
               
                                   $[_________] 

                 CUSIP NO.  [_________]

              

            

    

    

      

     

    BMW Vehicle Lease Trust 20[__]-[__], a statutory trust organized and existing under the laws of the State of Delaware (including any permitted successors
      and assigns, the “Issuer”), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of [______________________________] Dollars ($[__________]) in monthly installments on the [_] of each month, or if
      such day is not a Business Day, on the immediately succeeding Business Day, commencing on [__________] 20[__] (each, a “Payment Date”) until the principal of this Note is paid or made available for payment, and to pay interest on each Payment Date on
      the Class [A-1] [A-2a] [A-2b] [A-3] [A-4] Note Balance as of the preceding Payment Date (after giving effect to all payments of principal made on the preceding Payment Date), or as of the Closing Date in the case of the first Payment Date or if no
      interest has yet been paid, at [the rate per annum shown above]2 [Benchmark [plus][minus] [__]%]3 (the “Interest Rate”), in each case as and to the extent described below; provided, however, that the entire Class [A-1] [A-2a]
      [A-2b] [A-3] [A-4] Note Balance shall be due and payable on the earlier of [___________], 20[__] (the “Note Final Scheduled Payment Date”) and the Redemption Date, if any, pursuant to Section 10.01 of the Indenture. Interest on this Note will accrue
      for each Payment Date [from and including the preceding Payment Date (or, in the case of the initial Payment Date or if no interest has yet been paid, from and including the Closing Date) to but excluding such Payment Date]4 [from
      and including the [__] day of each calendar month (or, in the case of the initial Payment Date or if no interest has yet been paid, from and including the Closing Date) to but excluding the [__] day of the succeeding calendar month]5. 
      Interest will be computed on the basis of [actual days elapsed and a 360-day year.]6  [a 360-day year of twelve 30-day months.]7  The Issuer shall pay interest on overdue installments of interest at the Overdue Interest Rate to
      the extent lawful. Such principal of and interest on this Note shall be paid in the manner specified on the reverse hereof.

     

    The principal of and interest on this Note are payable in such coin or currency of the United States as at the time of payment is legal tender for
      payment of public and private debts. All payments made by the Issuer with respect to this Note shall be applied first to interest due and payable on this Note as provided above and then to the unpaid principal of this Note.

     

    

    

    

    1 Insert for the Class A-2b Notes.

    2 Insert for the Class A-1 Notes, Class A-2a Notes, Class A-3 Notes and Class A-4 Notes.

    3 Insert for the Class A-2b Notes.

    4 Insert this for the Interest for the Class A-1 Notes and Class A-2b Notes.

    5 Insert this for the Interest for the Class A-2a Notes, Class A-3 Notes and A-4 Notes.

    6 Insert this for the Interest for the Class A-1 Notes and Class A-2b Notes.

    7 Insert this for the Interest for the Class A-2a Notes, Class A-3 Notes and A-4 Notes.

    
      A-2

      
        

    

    

    

    Reference is made to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth on
      the face of this Note.

     

    Unless the certificate of authentication hereon has been executed by the Indenture Trustee the name of which appears below by manual signature, this Note
      shall not be entitled to any benefit under the Indenture referred to on the reverse hereof or be valid or obligatory for any purpose.

     

    

    

     

    
      A-3

      
        

    

    

    

    IN WITNESS WHEREOF, the Issuer has caused this instrument to be signed, manually or by facsimile, by its Authorized Officer as of the date set forth
      below.

     

    

    

     

    	 
            Dated:  _______________, 20[__]          

              

          	BMW VEHICLE LEASE TRUST 20[__]-[__],

              

            
	 	
            By: [_________________],

              not in its individual capacity but solely

              as Owner Trustee

             

            

             

            

          
	 	
            By:                                                                                  

                Name:

                Title:

             

              

          

     

    INDENTURE TRUSTEE’S CERTIFICATE OF AUTHENTICATION

     

    This is one of the Notes designated above and referred to in the within-mentioned Indenture.

     

     

    

    
      	 
              Dated:  _______________, 20[__]          

                

            	[_________________], not in its individual capacity, but solely as Indenture Trustee

                

              
	 	
               

              

            
	 	
              By:                                                                                  

                  Name:

                  Title:

               

                

            

    

    

     

    
      A-4

      
        

    

    

    

    [REVERSE OF NOTE]

     

    This Note is one of a duly authorized issue of Notes of the Issuer, designated as its “[Benchmark [plus][minus]]8 [__]% Asset Backed Notes,
      Class [A-1] [A-2a] [A-2b] [A-3] [A-4]” (herein called the “Notes”) issued under an Indenture, dated as of [__________], 20[__] (such indenture, as supplemented or amended, is herein called the “Indenture”), between the Issuer and [_________________],
      as indenture trustee (the “Indenture Trustee”, which term includes any successor Indenture Trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights and
      obligations thereunder of the Issuer, the Indenture Trustee and the Noteholders. The Notes are subject to all terms of the Indenture. All terms used in this Note that are defined in the Indenture, as supplemented or amended, shall have the meanings
      assigned to them in or pursuant to the Indenture, as so supplemented or amended.

     

    The Class A-1 Notes, the Class A-2a Notes, the Class A-2b Notes, the Class A-3 Notes, the Class A-4 Notes and the Class B Notes are and will be equally
      and ratably secured by the Collateral pledged as security therefor as provided in the Indenture. However, to the extent provided in the Indenture, each Class will receive principal payment sequentially so no principal payments shall be made in
      respect of the Class A-2a Notes and the Class A-2b Notes until the Class A-1 Notes have been paid in full, no principal payments shall be made in respect of the Class A-3 Notes until the Class A-2a Notes and the Class A-2b Notes have been paid in
      full, no principal payments shall be made in respect of the Class A-4 Notes until the Class A-3 Notes have been paid in full and no principal payments shall be made in respect of the Class B Notes until the Class A-4 Notes have been paid in full.

     

    Principal payable on the Notes will be paid on each Payment Date in the amount specified in the Indenture. As described above, the entire unpaid
      principal amount of this Note will be payable on the earlier of the applicable Note Final Scheduled Payment Date and the Redemption Date, if any, selected pursuant to the Indenture. Notwithstanding the foregoing, under certain circumstances, the
      entire unpaid principal amount of the Notes shall be due and payable following the occurrence and continuance of an Indenture Default, as described in the Indenture.  In such an event, principal payments on the Class A-1 Notes shall be made first and
      until paid in full, then principal payments on the remaining Classes of Class A Notes shall be made pro rata to the Noteholders entitled thereto until each Class is paid in full, and then, principal payments on the Class B Notes shall be made until
      paid in full.

     

    Payments of principal and interest on this Note due and payable on each Payment Date or Redemption Date shall be made by check mailed to the Person whose
      name appears as the registered holder of this Note (or one or more Predecessor Notes) on the Note Register as of the close of business on the related Record Date, except that with respect to Notes registered on the Record Date in the name of the
      nominee of The Depository Trust Company (initially, such nominee to be Cede & Co.), payments will be made by wire transfer in immediately available funds to the account designated by such nominee. Such checks shall be mailed to the Person
      entitled thereto at the address of such Person as it appears on the Note Register as of the applicable Record Date without requiring that this Note be submitted for notation of payment.

     

    

    

    

    8 Insert for the Class A-2b Notes.

    
      A-5

      
        

    

    

    

    Any reduction in the principal amount of this Note (or any one or more Predecessor Notes) affected by any payments made on any Payment Date or Redemption Date shall be
      binding upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange hereof or in lieu hereof, whether or not noted hereon. If funds are expected to be available, as provided in the Indenture,
      for payment in full of the remaining unpaid principal amount of this Note on a Payment Date or Redemption Date, then the Indenture Trustee, in the name of and on behalf of the Issuer, will notify the Person who was the registered holder hereof as of
      the Record Date preceding such Payment Date or Redemption Date by notice mailed within five days of such Payment Date or Redemption Date and the amount then due and payable shall be payable only upon presentation and surrender of this Note at the
      Corporate Trust Office of the Indenture Trustee or at the office of the Indenture Trustee’s agent appointed for such purposes located in The City of New York.

     

    As provided in the Indenture, the Servicer will be permitted at its option to purchase the interest in the 20[__]-[__] SUBI evidenced by the 20[__]-[__]
      SUBI Certificate from the Issuer on any Payment Date if, either before or after giving effect to any payment of principal required to be made on such Payment Date, the Note Balance is less than or equal to [5]% of the Initial Note Balance. The
      purchase price for the 20[__]-[__] SUBI Certificate shall equal the unpaid principal balances of the Notes, together with accrued interest thereon to the Redemption Date (the “Optional Purchase Price”), which amount shall be deposited by the Servicer
      into the 20[__]-[__] SUBI Collection Account on the Deposit Date relating to the Redemption Date.  In connection with an Optional Purchase, this Note will be redeemed on such Payment Date in whole, but not in part, for the Redemption Price.

     

    As provided in the Indenture and subject to certain limitations set forth therein, the transfer of this Note may be registered on the Note Register upon
      surrender of this Note for registration of transfer at the office or agency designated by the Issuer pursuant to the Indenture. No service charge will be charged for any registration of transfer or exchange of this Note, but the transferor may be
      required to pay a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any such registration of transfer or exchange.

     

    Each Noteholder or Note Owner, by acceptance of a Note or, in the case of a Note Owner, a beneficial interest in a Note, covenants and agrees that no
      recourse may be taken, directly or indirectly, with respect to the obligations of the Issuer, the Owner Trustee or the Indenture Trustee on the Notes or under the Indenture or any certificate or other writing delivered in connection therewith against
      (i) the Indenture Trustee or the Owner Trustee in its individual capacity, (ii) any owner of a beneficial interest in the Issuer or (iii) any partner, owner, beneficiary, agent, officer, director or employee of the Indenture Trustee or the Owner
      Trustee in its individual capacity, any holder of a beneficial interest in the Issuer, the Owner Trustee or the Indenture Trustee or of any successor or assign of the Indenture Trustee or the Owner Trustee in its individual capacity, except as any
      such Person may have expressly agreed and except that any such partner, owner or beneficiary shall be fully liable, to the extent provided by applicable law, for any unpaid consideration for stock, unpaid capital contribution or failure to pay any
      installment or call owing to such entity.

     

    It is the intent of the Issuer that the Notes be characterized as debt for U.S. federal income tax purposes and the Issuer agrees and each purchaser of a
      Note (by virtue of the

     

    
      A-6

      
        

    

    

    

    acquisition of such Note of an interest therein) shall be deemed to have agreed, to treat the Notes as debt for purposes of U.S. federal and state income tax and any other
      tax measured in whole or in part by income.

     

    This Note represents an obligation of the Issuer only and does not represent an interest in, recourse to or an obligation of either the Transferor, the
      UTI Beneficiary or any of their respective Affiliates.

     

    Each Noteholder or Note Owner, by accepting this Note or in the case of a Note Owner, a beneficial interest in this Note hereby covenant and agree that
      prior to the date that is one year and one day after the date upon which all obligations and payments under the Securitized Financing have been paid in full, they will not (and, to the fullest extent permitted by applicable law, the Indenture Trustee
      shall not have the power to) institute against, or join any Person in instituting against any Noteholder, any Note Owner, the UTI Beneficiary (and the general partner of the UTI Beneficiary that is a partnership, or the managing member of the UTI
      Beneficiary that is a limited liability company), the Vehicle Trustee, the Vehicle Trust, any Special Purpose Affiliate (and the general partner of any Special Purpose Affiliate that is a partnership, or the managing member of any Special Purpose
      Affiliate that is a limited liability company) that holds a beneficial interest in the Vehicle Trust, the Transferor, the Issuer, the Indenture Trustee or any Affiliate or beneficiary of the same, any bankruptcy, reorganization, arrangement,
      insolvency or liquidation proceeding or other proceedings under any United States federal or state bankruptcy or similar law.

     

    Prior to the due presentment for registration of transfer of this Note, the Owner Trustee, the Indenture Trustee and any agent of the Owner Trustee or
      the Indenture Trustee may treat the Person in whose name this Note (as of the day of determination or as of such other date as may be specified in the Indenture) is registered as the owner hereof for all purposes, whether or not this Note be overdue,
      and neither the Owner Trustee, the Indenture Trustee nor any such agent shall be affected by notice to the contrary.

     

    This Note, or any interest therein, may not be transferred to an “employee benefit plan” within the meaning of Section 3(3) of ERISA that is subject to
      ERISA, a “plan” described in Section 4975(e)(1) of the Code, any entity that is deemed to hold “plan assets” of any of the foregoing by reason of an employee benefit plan’s or other plan’s investment in such entity, or any governmental or church plan
      subject to applicable law that is substantially similar to the fiduciary responsibility provisions of ERISA or Section 4975 of the Code, unless such transferee represents, warrants and covenants that its purchase and holding of this note (i) will not
      result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code because it will satisfy the requirements of an applicable prohibited transaction exemption, if applicable, or (ii) in the case of such governmental
      or church plan, does not result in a non-exempt prohibited transaction or cause a non-exempt violation of any applicable law that is substantially similar to ERISA or Section 4975 of the Code.  By its acquisition of this Note in book-entry form or
      any interest therein, each transferee will be deemed to have represented, warranted and covenanted that it satisfies the foregoing requirements and the Indenture Trustee may rely conclusively on the same for purposes hereof.

     

    
      A-7

      
        

    

    

    

    The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the
      Issuer and the rights of the Noteholders under the Indenture at any time by the Issuer with the consent of Noteholders representing not less than a majority of the Outstanding Amount. The Indenture also contains provisions permitting Noteholders
      representing specified percentages of the Outstanding Amount, on behalf of all Noteholders, to waive compliance by the Issuer with certain provisions of the Indenture and certain past Defaults under the Indenture and their consequences. Any such
      consent or waiver by the Noteholder of this Note (or any one of more Predecessor Notes) shall be conclusive and binding upon such Noteholder and upon all future Noteholders of this Note and of any Note issued upon the registration of transfer hereof
      or in exchange hereof or in lieu hereof whether or not notation of such consent or waiver is made upon this Note. The Indenture also permits the Indenture Trustee to amend or waive certain terms and conditions set forth in the Indenture without the
      consent of the Noteholders.

     

    This Note is issuable only in registered form in denominations as provided in the Indenture, subject to certain limitations therein set forth.

     

    This Note and the Indenture shall be governed by and construed in accordance with the laws of the State of New York without reference to its conflicts of
      law provisions other than Sections 5-1401 and 5-1402 of the New York General Obligations Law, and the obligations, rights and remedies of the parties hereunder and thereunder shall be determined in accordance with such laws.

     

    No reference herein to the Indenture and no provision of this Note or the Indenture shall alter or impair the obligation of the Issuer, which is absolute
      and unconditional, to pay the principal of and interest on this Note at the times, place and rate and in the coin or currency herein prescribed.

     

    

    

     

    
      A-8

      
        

    

    

    

    ASSIGNMENT

     

    Social Security or taxpayer I.D. or other identifying number of assignee:

     

                                                                _________________________

     

    FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

     

    ________________________________________________________________________

     

    ________________________________________________________________________

      (name and address of assignee)

     

    the within Note and all rights thereunder, and hereby irrevocably constitutes and appoints attorney, 

    to transfer said Note on the books kept for registration thereof, with full power of substitution in the premises.

     

    Dated:9

     

    Signature Guaranteed:

     

    _________________________________

     

    

    

     

    

    

    

    9 The signature to this assignment must correspond with the name of the registered owner as it appears on the face of the within Note in every particular,
      without alteration, enlargement or any change whatsoever.

    
      A-9

      
        

    

    
    EXHIBIT B

     

    [FORM OF CLASS B NOTE]

     

    SEE REVERSE FOR CERTAIN DEFINITIONS

     

    UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT
      FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH
      OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

     

    THE PRINCIPAL OF THIS NOTE IS PAYABLE AS SET FORTH HEREIN. ACCORDINGLY, THE OUTSTANDING PRINCIPAL AMOUNT OF THIS NOTE AT ANY TIME MAY BE LESS THAN THE
      AMOUNT SHOWN ON THE FACE HEREOF.

     

    TRANSFERS OF THE NOTES MUST GENERALLY BE ACCOMPANIED BY APPROPRIATE TAX TRANSFER DOCUMENTATION AND ARE SUBJECT TO RESTRICTIONS AS PROVIDED IN THE
      INDENTURE.

     

    THE HOLDER, BY ACCEPTANCE OF THIS NOTE, SHALL BE DEEMED TO HAVE AGREED TO TREAT THE NOTES AS DEBT FOR UNITED STATES FEDERAL AND STATE INCOME TAX PURPOSES
      AND FOR PURPOSES OF ANY OTHER TAX MEASURED IN WHOLE OR IN PART BY INCOME.

     

    

    

     

    

    

    
      B-1

      
        

    

    

    

    BMW VEHICLE LEASE TRUST 20[__]-[__]

     

     [__]% ASSET BACKED NOTE, CLASS B

     
      
        	
                             REGISTERED 

                             No. R-[___] 

              	
                
                                     $[_________] 

                   CUSIP NO.  [_________]

                

              

      

      

      

       

    

    BMW Vehicle Lease Trust 20[__]-[__], a statutory trust organized and existing under the laws of the State of Delaware (including any permitted successors
      and assigns, the “Issuer”), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of [______________________________] Dollars ($[__________]) in monthly installments on the [_] of each month, or if
      such day is not a Business Day, on the immediately succeeding Business Day, commencing on [__________] 20[__] (each, a “Payment Date”) until the principal of this Note is paid or made available for payment, and to pay interest on each Payment Date on
      the Class B Note Balance as of the preceding Payment Date (after giving effect to all payments of principal made on the preceding Payment Date), or as of the Closing Date in the case of the first Payment Date or if no interest has yet been paid, at
      the rate per annum shown above (the “Interest Rate”), in each case as and to the extent described below; provided, however, that the entire Class B Note Balance shall be due and payable on the earlier of [___________], 20[__] (the “Note Final
      Scheduled Payment Date”) and the Redemption Date, if any, pursuant to Section 10.01 of the Indenture. Interest on this Note will accrue for each Payment Date from and including the [__] day of each calendar month (or, in the case of the initial
      Payment Date or if no interest has yet been paid, from and including the Closing Date) to but excluding the [__] day of the succeeding calendar month.  Interest will be computed on the basis of a 360-day year of twelve 30-day months.  The Issuer
      shall pay interest on overdue installments of interest at the Overdue Interest Rate to the extent lawful. Such principal of and interest on this Note shall be paid in the manner specified on the reverse hereof.

     

    The principal of and interest on this Note are payable in such coin or currency of the United States as at the time of payment is legal tender for
      payment of public and private debts. All payments made by the Issuer with respect to this Note shall be applied first to interest due and payable on this Note as provided above and then to the unpaid principal of this Note.

     

    Reference is made to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth on
      the face of this Note.

     

    Unless the certificate of authentication hereon has been executed by the Indenture Trustee the name of which appears below by manual signature, this Note
      shall not be entitled to any benefit under the Indenture referred to on the reverse hereof or be valid or obligatory for any purpose.

     

    

    

     

    
      B-2

      
        

    

    

    

    IN WITNESS WHEREOF, the Issuer has caused this instrument to be signed, manually or by facsimile, by its Authorized Officer as of the date set forth
      below.

     

    

    

     

    	 
            Dated:  _______________, 20[__]          

              

          	BMW VEHICLE LEASE TRUST 20[__]-[__],

              

            
	 	
            By: [_________________],

              not in its individual capacity but solely

              as Owner Trustee

             

            

             

            

          
	 	
            By:                                                                                  

                Name:

                Title:

             

              

          

     

    INDENTURE TRUSTEE’S CERTIFICATE OF AUTHENTICATION

     

    This is one of the Notes designated above and referred to in the within-mentioned Indenture.

     

     

    

    
      	 
              Dated:  _______________, 20[__]          

                

            	[_________________], not in its individual capacity, but solely as Indenture Trustee

                

              
	 	
               

              

            
	 	
              By:                                                                                  

                  Name:

                  Title:

               

                

            

    

    

     

    
      B-3

      
        

    

    

    

    [REVERSE OF NOTE]

     

    This Note is one of a duly authorized issue of Notes of the Issuer, designated as its [__]% Asset Backed Notes, Class B” (herein called the “Notes”)
      issued under an Indenture, dated as of [__________], 20[__] (such indenture, as supplemented or amended, is herein called the “Indenture”), between the Issuer and [_________________], as indenture trustee (the “Indenture Trustee”, which term includes
      any successor Indenture Trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights and obligations thereunder of the Issuer, the Indenture Trustee and the
      Noteholders. The Notes are subject to all terms of the Indenture. All terms used in this Note that are defined in the Indenture, as supplemented or amended, shall have the meanings assigned to them in or pursuant to the Indenture, as so supplemented
      or amended.

     

    The Class A-1 Notes, the Class A-2a Notes, the Class A-2b Notes, the Class A-3 Notes, the Class A-4 Notes and the Class B Notes are and will be equally
      and ratably secured by the Collateral pledged as security therefor as provided in the Indenture. However, to the extent provided in the Indenture, each Class will receive principal payment sequentially so no principal payments shall be made in
      respect of the Class A-2a Notes and the Class A-2b Notes until the Class A-1 Notes have been paid in full, no principal payments shall be made in respect of the Class A-3 Notes until the Class A-2a Notes and the Class A-2b Notes have been paid in
      full, no principal payments shall be made in respect of the Class A-4 Notes until the Class A-3 Notes have been paid in full and no principal payments shall be made in respect of the Class B Notes until the Class A-4 Notes have been paid in full.

     

    Principal payable on the Notes will be paid on each Payment Date in the amount specified in the Indenture. As described above, the entire unpaid
      principal amount of this Note will be payable on the earlier of the applicable Note Final Scheduled Payment Date and the Redemption Date, if any, selected pursuant to the Indenture. Notwithstanding the foregoing, under certain circumstances, the
      entire unpaid principal amount of the Notes shall be due and payable following the occurrence and continuance of an Indenture Default, as described in the Indenture.  In such an event, principal payments on the Class A-1 Notes shall be made first and
      until paid in full, then principal payments on the remaining Classes of Class A Notes shall be made pro rata to the Noteholders entitled thereto until each Class is paid in full, and then, principal payments on the Class B Notes shall be made until
      paid in full.

     

    Payments of principal and interest on this Note due and payable on each Payment Date or Redemption Date shall be made by check mailed to the Person whose
      name appears as the registered holder of this Note (or one or more Predecessor Notes) on the Note Register as of the close of business on the related Record Date, except that with respect to Notes registered on the Record Date in the name of the
      nominee of The Depository Trust Company (initially, such nominee to be Cede & Co.), payments will be made by wire transfer in immediately available funds to the account designated by such nominee. Such checks shall be mailed to the Person
      entitled thereto at the address of such Person as it appears on the Note Register as of the applicable Record Date without requiring that this Note be submitted for notation of payment. Any reduction in the principal amount of this Note (or any one
      or more Predecessor Notes) affected by any payments made on any Payment Date or Redemption Date shall be binding upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or

     

    
      B-4

      
        

    

    

    

    in exchange hereof or in lieu hereof, whether or not noted hereon. If funds are expected to be available, as provided in the Indenture, for payment in full of the remaining
      unpaid principal amount of this Note on a Payment Date or Redemption Date, then the Indenture Trustee, in the name of and on behalf of the Issuer, will notify the Person who was the registered holder hereof as of the Record Date preceding such
      Payment Date or Redemption Date by notice mailed within five days of such Payment Date or Redemption Date and the amount then due and payable shall be payable only upon presentation and surrender of this Note at the Corporate Trust Office of the
      Indenture Trustee or at the office of the Indenture Trustee’s agent appointed for such purposes located in The City of New York.

     

    As provided in the Indenture, the Servicer will be permitted at its option to purchase the interest in the 20[__]-[__] SUBI evidenced by the 20[__]-[__]
      SUBI Certificate from the Issuer on any Payment Date if, either before or after giving effect to any payment of principal required to be made on such Payment Date, the Note Balance is less than or equal to [5]% of the Initial Note Balance. The
      purchase price for the 20[__]-[__] SUBI Certificate shall equal the unpaid principal balances of the Notes, together with accrued interest thereon to the Redemption Date (the “Optional Purchase Price”), which amount shall be deposited by the Servicer
      into the 20[__]-[__] SUBI Collection Account on the Deposit Date relating to the Redemption Date.  In connection with an Optional Purchase, this Note will be redeemed on such Payment Date in whole, but not in part, for the Redemption Price.

     

    As provided in the Indenture and subject to certain limitations set forth therein, the transfer of this Note may be registered on the Note Register upon
      surrender of this Note for registration of transfer at the office or agency designated by the Issuer pursuant to the Indenture. No service charge will be charged for any registration of transfer or exchange of this Note, but the transferor may be
      required to pay a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any such registration of transfer or exchange.

     

    Each Noteholder or Note Owner, by acceptance of a Note or, in the case of a Note Owner, a beneficial interest in a Note, covenants and agrees that no
      recourse may be taken, directly or indirectly, with respect to the obligations of the Issuer, the Owner Trustee or the Indenture Trustee on the Notes or under the Indenture or any certificate or other writing delivered in connection therewith against
      (i) the Indenture Trustee or the Owner Trustee in its individual capacity, (ii) any owner of a beneficial interest in the Issuer or (iii) any partner, owner, beneficiary, agent, officer, director or employee of the Indenture Trustee or the Owner
      Trustee in its individual capacity, any holder of a beneficial interest in the Issuer, the Owner Trustee or the Indenture Trustee or of any successor or assign of the Indenture Trustee or the Owner Trustee in its individual capacity, except as any
      such Person may have expressly agreed and except that any such partner, owner or beneficiary shall be fully liable, to the extent provided by applicable law, for any unpaid consideration for stock, unpaid capital contribution or failure to pay any
      installment or call owing to such entity.

     

    It is the intent of the Issuer that the Notes be characterized as debt for U.S. federal income tax purposes and the Issuer agrees and each purchaser of a
      Note (by virtue of the acquisition of such Note of an interest therein) shall be deemed to have agreed, to treat the Notes as debt for purposes of U.S. federal and state income tax and any other tax measured in whole or in part by income.

     

    
      B-5

      
        

    

    

    

    This Note represents an obligation of the Issuer only and does not represent an interest in, recourse to or an obligation of either the Transferor, the
      UTI Beneficiary or any of their respective Affiliates.

     

    Each Noteholder or Note Owner, by accepting this Note or in the case of a Note Owner, a beneficial interest in this Note hereby covenant and agree that
      prior to the date that is one year and one day after the date upon which all obligations and payments under the Securitized Financing have been paid in full, they will not (and, to the fullest extent permitted by applicable law, the Indenture Trustee
      shall not have the power to) institute against, or join any Person in instituting against any Noteholder, any Note Owner, the UTI Beneficiary (and the general partner of the UTI Beneficiary that is a partnership, or the managing member of the UTI
      Beneficiary that is a limited liability company), the Vehicle Trustee, the Vehicle Trust, any Special Purpose Affiliate (and the general partner of any Special Purpose Affiliate that is a partnership, or the managing member of any Special Purpose
      Affiliate that is a limited liability company) that holds a beneficial interest in the Vehicle Trust, the Transferor, the Issuer, the Indenture Trustee or any Affiliate or beneficiary of the same, any bankruptcy, reorganization, arrangement,
      insolvency or liquidation proceeding or other proceedings under any United States federal or state bankruptcy or similar law.

     

    Prior to the due presentment for registration of transfer of this Note, the Owner Trustee, the Indenture Trustee and any agent of the Owner Trustee or
      the Indenture Trustee may treat the Person in whose name this Note (as of the day of determination or as of such other date as may be specified in the Indenture) is registered as the owner hereof for all purposes, whether or not this Note be overdue,
      and neither the Owner Trustee, the Indenture Trustee nor any such agent shall be affected by notice to the contrary.

     

    This Note, or any interest therein, may not be transferred to an “employee benefit plan” within the meaning of Section 3(3) of ERISA that is subject to
      ERISA, a “plan” described in Section 4975(e)(1) of the Code, any entity that is deemed to hold “plan assets” of any of the foregoing by reason of an employee benefit plan’s or other plan’s investment in such entity, or any governmental or church plan
      subject to applicable law that is substantially similar to the fiduciary responsibility provisions of ERISA or Section 4975 of the Code, unless such transferee represents, warrants and covenants that its purchase and holding of this note (i) will not
      result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code because it will satisfy the requirements of an applicable prohibited transaction exemption, if applicable, or (ii) in the case of such governmental
      or church plan, does not result in a non-exempt prohibited transaction or cause a non-exempt violation of any applicable law that is substantially similar to ERISA or Section 4975 of the Code.  By its acquisition of this Note in book-entry form or
      any interest therein, each transferee will be deemed to have represented, warranted and covenanted that it satisfies the foregoing requirements and the Indenture Trustee may rely conclusively on the same for purposes hereof.

     

    The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the
      Issuer and the rights of the Noteholders under the Indenture at any time by the Issuer with the consent of Noteholders representing not less than a majority of the Outstanding Amount. The Indenture also contains provisions permitting Noteholders
      representing specified percentages of the Outstanding

     

    
      B-6

      
        

    

    

    

    Amount, on behalf of all Noteholders, to waive compliance by the Issuer with certain provisions of the Indenture and certain past Defaults under the Indenture and their
      consequences. Any such consent or waiver by the Noteholder of this Note (or any one of more Predecessor Notes) shall be conclusive and binding upon such Noteholder and upon all future Noteholders of this Note and of any Note issued upon the
      registration of transfer hereof or in exchange hereof or in lieu hereof whether or not notation of such consent or waiver is made upon this Note. The Indenture also permits the Indenture Trustee to amend or waive certain terms and conditions set
      forth in the Indenture without the consent of the Noteholders.

     

    This Note is issuable only in registered form in denominations as provided in the Indenture, subject to certain limitations therein set forth.

     

    This Note and the Indenture shall be governed by and construed in accordance with the laws of the State of New York without reference to its conflicts of
      law provisions other than Sections 5-1401 and 5-1402 of the New York General Obligations Law, and the obligations, rights and remedies of the parties hereunder and thereunder shall be determined in accordance with such laws.

     

    No reference herein to the Indenture and no provision of this Note or the Indenture shall alter or impair the obligation of the Issuer, which is absolute
      and unconditional, to pay the principal of and interest on this Note at the times, place and rate and in the coin or currency herein prescribed.

     

    

    

     

    
      B-7

      
        

    

    

    

    ASSIGNMENT

     

    Social Security or taxpayer I.D. or other identifying number of assignee:

     

                                                                _________________________

     

    FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

     

    ________________________________________________________________________

     

    ________________________________________________________________________

      (name and address of assignee)

     

    the within Note and all rights thereunder, and hereby irrevocably constitutes and appoints attorney, 

    to transfer said Note on the books kept for registration thereof, with full power of substitution in the premises.

     

    Dated:10

     

    Signature Guaranteed:

     

    _________________________________

     

    

    

    

    

    

    10 The signature to this assignment must correspond with the name of the registered owner as it appears on the face of the within Note in every particular,
      without alteration, enlargement or any change whatsoever.

    
      B-8

      
        

    

    
    EXHIBIT C

     

    SERVICING CRITERIA TO BE ADDRESSED IN THE INDENTURE TRUSTEE’S ASSESSMENT OF
      COMPLIANCE

     

    The assessment of compliance to be delivered by the Servicer, shall address, at a minimum, the criteria identified as below as “Applicable Servicing
      Criteria”:

     

    	
            Reference

          	
            Criteria

          	 
	 	
            General Servicing Considerations

          	 
	
            1122(d)(1)(i)

          	
            Policies and procedures are instituted to monitor any performance or other triggers and events of default in accordance with the transaction agreements.

          	 
	
            1122(d)(1)(ii)

          	
            If any material servicing activities are outsourced to third parties, policies and procedures are instituted to monitor the third party’s performance and compliance
              with such servicing activities.

          	 
	
            1122(d)(1)(iii)

          	
            Any requirements in the transaction agreements to maintain a back-up servicer for the receivables are maintained.

          	 
	
            1122(d)(1)(iv)

          	
            A fidelity bond and errors and omissions policy is in effect on the party participating in the servicing function throughout the reporting period in the amount of
              coverage required by and otherwise in accordance with the terms of the transaction agreements.

          	 
	
            1122(d)(1)(v)

          	
            Aggregation of information, as applicable, is mathematically accurate and the information conveyed accurately reflects the information.

          	 
	 	
            Cash Collection and Administration

          	 
	
            1122(d)(2)(i)

          	
            Payments on receivables are deposited into the appropriate custodial bank accounts and related bank clearing accounts no more than two business days following
              receipt, or such other number of days specified in the transaction agreements.

          	 
	
            1122(d)(2)(ii)

          	
            Disbursements made via wire transfer on behalf of an obligor or to an investor are made only by authorized personnel.

          	
            X

          
	
            1122(d)(2)(iii)

          	
            Advances of funds or guarantees regarding collections, cash flows or distributions, and any interest or other fees charged for such advances, are made, reviewed and
              approved as specified in the transaction agreements.

          	 
	
            1122(d)(2)(iv)

          	
            The related accounts for the transaction, such as cash reserve accounts or accounts established as a form of overcollateralization, are separately maintained (e.g.,
              with respect to commingling of cash) as set forth in the transaction agreements.

          	 

    

    

    
      C-1

      
        

    

    

    

    
      	
              Reference

            	
              Criteria

            	 

    

    	
            1122(d)(2)(v)

          	
            Each custodial account is maintained at a federally insured depository institution as set forth in the transaction agreements. For purposes of this criterion,
              “federally insured depository institution” with respect to a foreign financial institution means a foreign financial institution that meets the requirements of Rule 13k-1(b)(1) of the Securities Exchange Act.

          	 
	
            1122(d)(2)(vi)

          	
            Unissued checks are safeguarded so as to prevent unauthorized access.

          	 
	
            1122(d)(2)(vii)

          	
            Reconciliations are prepared on a monthly basis for all asset-backed securities related bank accounts, including custodial accounts and related bank clearing
              accounts. These reconciliations (A) are mathematically accurate; (B) are prepared within 30 calendar days after the bank statement cutoff date, or such other number of days specified in the transaction agreements; (C) are reviewed and
              approved by someone other than the person who prepared the reconciliation; and (D) contain explanations for reconciling items. These reconciling items are resolved within 90 calendar days of their original identification, or such other number
              of days specified in the transaction agreements.

          	 
	 	
            Investor Remittances and Reporting

          	 
	
            1122(d)(3)(i)

          	
            Reports to investors, including those to be filed with the Commission, are maintained in accordance with the transaction agreements and applicable Commission
              requirements. Specifically, such reports (A) are prepared in accordance with timeframes and other terms set forth in the transaction agreements; (B) provide information calculated in accordance with the terms specified in the transaction
              agreements; (C) are filed with the Commission as required by its rules and regulations; and (D) agree with investors’ or the trustee’s records as to the total unpaid principal balance and number of receivables serviced by the Servicer.

          	 
	
            1122(d)(3)(ii)

          	
            Amounts due to investors are allocated and remitted in accordance with timeframes, distribution priority and other terms set forth in the transaction agreements.

          	
            X

          
	
            1122(d)(3)(iii)

          	
            Disbursements made to an investor are posted within two business days to the Servicer’s investor records, or such other number of days specified in the transaction
              agreements.

          	
            X

          
	
            1122(d)(3)(iv)

          	
            Amounts remitted to investors per the investor reports agree with cancelled checks, or other form of payment, or custodial bank statements.

          	
            X

          
	 	
            Pool Asset Administration

          	 
	
            1122(d)(4)(i)

          	
            Collateral or security on receivables is maintained as required by the transaction agreements or related receivables documents.

          	 
	
            1122(d)(4)(ii)

          	
            Receivables and related documents are safeguarded as required by the transaction agreements

          	 
	
            1122(d)(4)(iii)

          	
            Any additions, removals or substitutions to the asset pool are made, reviewed and approved in accordance with any conditions or requirements in the transaction
              agreements.

          	 

    

    

    
      C-2

      
        

    

    

    

    
      	
              Reference

            	
              Criteria

            	 

    

    	
            1122(d)(4)(iv)

          	
            Payments on receivables, including any payoffs, made in accordance with the related receivables documents are posted to the Servicer’s obligor records maintained no
              more than two business days after receipt, or such other number of days specified in the transaction agreements, and allocated to principal, interest or other items (e.g., escrow) in accordance with the related receivables documents.

          	 
	
            1122(d)(4)(v)

          	
            The Servicer’s records regarding the receivables agree with the Servicer’s records with respect to an obligor’s unpaid principal balance.

          	 
	
            1122(d)(4)(vi)

          	
            Changes with respect to the terms or status of an obligor’s receivables (e.g., loan modifications or re-agings) are made, reviewed and approved by authorized
              personnel in accordance with usual customary procedures.

          	 
	
            1122(d)(4)(vii)

          	
            Loss mitigation or recovery actions (e.g., forbearance plans, modifications and deeds in lieu of foreclosure, foreclosures and repossessions, as applicable) are
              initiated, conducted and concluded in accordance with usual customary procedures.

          	 
	
            1122(d)(4)(viii)

          	
            Records documenting collection efforts are maintained during the period a receivable is delinquent in accordance with the transaction agreements. Such records are
              maintained on at least a monthly basis, or such other period specified in the transaction agreements, and describe the entity’s activities in monitoring delinquent receivables including, for example, phone calls, letters and payment
              rescheduling plans in cases where delinquency is deemed temporary (e.g., illness or unemployment).

          	 
	
            1122(d)(4)(ix)

          	
            Adjustments to interest rates or rates of return for receivables with variable rates are computed based on the related receivables documents.

          	 
	
            1122(d)(4)(x)

          	
            Regarding any funds held in trust for an obligor (such as escrow accounts): (A) such funds are analyzed, in accordance with the obligor’s receivables documents, on
              at least an annual basis, or such other period specified in the transaction agreements; (B) interest on such funds is paid, or credited, to obligors in accordance with applicable receivables documents and state laws; and (C) such funds are
              returned to the obligor within 30 calendar days of full repayment of the related receivables, or such other number of days specified in the transaction agreements.

          	 
	
            1122(d)(4)(xi)

          	
            Payments made on behalf of an obligor (such as tax or insurance payments) are made on or before the related penalty or expiration dates, as indicated on the
              appropriate bills or notices for such payments, provided that such support has been received by the servicer at least 30 calendar days prior to these dates, or such other number of days specified in the transaction agreements.

          	 
	
            1122(d)(4)(xii)

          	
            Any late payment penalties in connection with any payment to be made on behalf of an obligor are paid from the servicer’s funds and not charged to the obligor,
              unless the late payment was due to the obligor’s error or omission.

          	 
	
            1122(d)(4)(xiii)

          	
            Disbursements made on behalf of an obligor are posted within two business days to the obligor’s records maintained by the servicer, or such other number of days
              specified in the transaction agreements.

          	 

    

    

    

    

    
      C-3

      
        

    

    
      	
              Reference

            	
              Criteria

            	 

    

    	
            1122(d)(4)(xiv)

          	
            Delinquencies, charge-offs and uncollectible accounts are recognized and recorded in accordance with the transaction agreements.

          	 
	
            1122(d)(4)(xv)

          	
            Any external enhancement or other support, identified in Item 1114(a)(1) through (3) or Item 1115 of Regulation AB, is maintained as set forth in the transaction
              agreements.

          	 

    

    

     

     

    By:  _______________________________

      Name:

      Title:

     

    

    

  

  C-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]